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Calix[4]resorcinarenes functionalised with glycosidic ligands on their lower rim 
have received little interest compared to analogues bearing carbohydrates on 
the upper rim. In this study, series of novel macrocyclic glycoclusters bearing 
mono- or disaccharides on the lower rim of a calix[4]resorcinarene core were 
prepared. Calix[4]resorcinarenes can exist as conformational isomers so each 
glycocluster was isolated and characterised as the pure conformer, where 
possible.  
Amongst the distinct features of this work is that Lewis acid catalysis was used 
for the synthesis of calix[4]resorcinarenes by condensation of resorcinol, or its 
2-substitued analogues, with an aldehyde. Also, rather than linking the 
glycosidic moieties to the pre-formed calix[4]resorcinarene, the glycosidic 
aldehydes were assembled prior to condensation with the resorcinols. 
Significantly, acylation of the glycoclusters facilitated separation of each 
conformational isomer. 
Amongst the aldehydes used for condensation were glycosylated derivatives of 
hydroxybenzaldehydes, compounds with a short alkyl spacer between the 
glycosidic aryl moiety and the aldehydic carbonyl group, and a number with an 
alkyl or polyether spacer that did not contain any aryl group. Following a study 
of the condensation products from the reaction of each series of aldehydes with 
resorcinol, 2-methylresorcinol or pyrogallol it became clear that the distribution 
of conformational isomers could be predicted, influenced greatly by the 
properties of the starting materials. 
Finally, it was demonstrated that deprotection of a conformational isomer 
obtained during the initial studies gave a glycosylated calix[4]resorcinarene 
III 
 
which is fully soluble in aqueous media. Such compounds may have great 
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1.1 Supramolecular Chemistry 
Supramolecular chemistry has been defined as the chemistry beyond the 
molecule, while a ‘supermolecule’ is formed by intermolecular interactions 
between two or more covalently bonded molecules or ions. These non-covalent 
bonding interactions include hydrophobic effects, π–π interactions, hydrogen 
bonding, electrostatic interactions and dispersion interactions (Williams and 
Westwell 1998). 
Supramolecular chemistry can be classified into two principal streams, host-
guest chemistry and self-assembly. Donald Cram established the term of host-
guests chemistry: his definition was that the host is a molecule, larger than the 
guest, which possesses a cavity and binding sites which can associate with or 
envelope around the smaller guest molecule, whose binding sites diverge in the 
complex (Figure 1) (Cram 1986). 
Whereas self-assembly is the non-covalent aggregation between two or more 
molecules, they are equal in size and no species acts as a host for the other. 
This process is spontaneous but may be affectted by solvation or templating 




Figure 1: The formation of a supramolecular system (Host-guest interaction) 
and (self-assembly) from small building blocks (adapted from Tiwari and Uzun 
2015) 
 
1.2 Types of host molecules  
Host molecules consist of two main classes: acyclic (podands) or cyclic 
(macrocyclic, macrobicyclic, etc). A podand is an acyclic or branching host 
contain a number of binding sites that are located at intervals along the length 
of the molecule or around a common spacer (Ali et al., 2018). 
A macrocyclic host is cyclic compound contain a number of binding sites that 
are coordinated round the closed system. Macrocyclic organic host molecules 
consist of major classes such as: crown ethers, cyclodextrins, cucurbiturils, 
calix[n]arenes and calix[4]resorcinarenes. The latter are well-characterised 
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building blocks for the creation of supramolecular assemblies (Sherman 2003). 
Calix[n]arenes and calix[4]resorcinarenes can be functionalised readily and 
their hydrophobic cavities can be exploited as hosts for sensing and drug 
delivery applications (Delbianco et al., 2015). However, studies of the behaviour 
of most synthetic macrocycle compounds have taken place in non-polar organic 
solvents, whereas all of the host-guest interaction events in nature occur in 
water (Murray et al., 2017). This provides two main challenges for 
supramolecular chemistry in aqueous media: to make the host molecules 
soluble in aqueous media whilst retaining their gross shape and cavity size 
and/or to exploit the influence of water in non-covalent interactions (Liu et al., 
2019). The synthesis of receptors for use in aqueous media presents 
challenges also: the availability of building blocks for their construction is 
limited, certain interactions with the guest must be targeted to avoid the 
competitive effect of water and encapsulation and/or molecular recognition in 
aqueous media must be achievable with the desired guest molecules (Murray 
et al., 2017). 
 
1.2.1 Calix[n]arenes 
Calix[n]arenes comprise of four phenol units linked via methylene or bridges at 
the 2- and 6-positions relative to the hydroxyl group. Calix[n]arenes can adopt 
several conformations due to two possible modes for inversion of the phenol 
unit: the oxygen through the annulus rotation and the 4-substituent through the 
annulus rotation, should there be a substituent in the 4-position relative to the 
phenolic hydroxyl group. These conformations are: cone, partial-cone, 1,2-
alternate and 1,3-alternate (Figure 2) (Otsuka and Shinkai 1996; Arnott 2018). 
The cone conformation is the most favourable conformation for calix[4]arenes 
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due to stabilisation of the structure by intramolecular hydrogen bonding 
interactions between the hydroxy groups (Sardjono and Rachmawati 2017). 
 
Figure 2: The conformations of calix[4]arenes (Hoskins & Curtis 2015) 
 
Structural studies using X-ray analysis, 1H-NMR spectroscopy and theoretical 
calculations showed that the cone conformation between calix[n]arenes of 
different sizes are slightly different depending on the size of the macrocyclic 
ring. For example, homooxacalix[3]arenes adopt a cone conformation but the 
ring is more flexible than calix[4]arenes (Araki et al., 1993). Calix[4]arenes and 
calix[5]arenes adopt a high symmetry cone conformation via the intramolecular 
hydrogen bonds between neighbouring hydroxy groups, whereas the 
calix[6]arenes adopt a winged or hinged conformation due to a slight 
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deformation of the ring. Calix[7]arenes and calix[8]arenes adopt a pleated-loop 
conformation because of the increase in deformation of the ring and disruption 
of the intramolecular hydrogen-bonds (Gutsche and Bauer 1985). 
In 1981 Gutsche et al. suggested the one-pot synthesis of calix[n]arenes by 
condensation of 4-tert-butylphenol with aqueous formaldehyde under basic 
conditions (KOH, NaOH), leading to the formation of calix[4]arenes, 
calix[6]arenes and calix[8]arenes dependent on the reaction conditions used 
(Scheme 1) (Gutsche et al., 1981). 
 








Calix[n]arenes are inherently hydrophobic and are typically insoluble in water. 
Also, conformational flexibility in the larger calix[n]arenes limits their practical 
use as solubilising agents in drug delivery. The introduction of polar moieties on 
the upper or lower rim of the calix[n]arene core can increase the affinity of 
calix[n]arenes towards guest molecules through additional interactions 
(Madasamy et al., 2017; Athar et al., 2018). Indeed, the synthesis of 
functionalised calix[n]arenes which are stable in water may provide candidate 
host molecules for use in the pharmaceutical field (Moussa et al., 2018).  
Attachment of polar functional groups to the upper or lower rim either directly or 
by using a linker enables calix[n]arenes to construct supramolecular 
amphiphiles by forming host-guest inclusion complexes dependent upon non-
covalent interactions. This may lead to a change in the affinity of guest 
molecules towards water, stabilisation of a formulation, physical isolation of 
components from a mixture of compounds and aid in monitoring the 
physicochemical properties of the guest. Such modifying groups are sulfonates 
(Fahmy et al., 2018), amines (Granata et al., 2017), phosphonates (Mo et al., 
2016), amino acids (Gasparello et al., 2019), saccharides (Aleandri et al., 
2013), peptides (Mutihac et al., 2011), guanidinium groups (Samanta et al., 
2017) and poly (ethylene oxide) (PEG groups) (Yu et al., 2009). 
 
1.2.1.1 Synthesis of calix[n]arene which are soluble in water 
The 4-tert-butyl calix[4]arene 1 was used to prepare a series of amphiphilic 4-
phosphonic acid calix[n]arenes 2a-g with an alkyl chain at the lower rim; these 
compounds were soluble in water and in DMSO at high pH (>10), with certain 
compounds (n= 4, R= H, C6H13, C8H17 and n= 5, R= H) were soluble at neutral 
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pH. The C4v symmetrical cone conformation predominated in the synthesis of 
these phospholipid analogues (Scheme 2). 
 





The toxicity of 4-phosphonic acid calix[n]arenes 2a-g has been examined: 
mixed retinal cells proved to be more sensitive than rat pheochromocytoma 
cells to the toxic effect related to these compounds. 4-Phosphonic acid 
calix[n]arenes with hydroxyl group at the lower rim, showed reduced toxicity 
with pheochromocytoma cells can tolerate to at least 1.0 mg mL-1 
concentrations for 2a and 2g. In addition, the aggregation of these 
phospholipids has been studied and showed that 4-phosphonic acid 
calix[4]arenes (n= 4, R= C8H17) could form micelles with a diameter of 4-5 nm 
which offer stability over a wide range of pH values and also able to incorporate 
the antioxidant curcumin. Also, these micelles showed reduced toxicity towards 
pheochromocytoma cells compared to 2c in monomeric form, thereby making 
them potential compounds for targeted drug delivery (Martin et al., 2012).  
 
1.2.1.2 Calix[n]arene biocompatibility and use in drug 
delivery  
Calix[n]arenes have structural characteristics that are favourable for design and 
development of components in drug delivery systems: a variety of different 
conformations of each calix[n]arene are available which can be readily 
functionalised on both upper- and lower rims. They possess a hydrophobic 
cavity capable of forming complexes with small guest molecules and ions and a 
number of calix[n]arene molecules can aggregate to create inclusion complexes 
with larger molecules. Additionally, several calix[n]arenes with antiviral (HIV), 
antifungal, antibacterial, antimicrobial agents, antithrombotic and anticancer 




When the host-guest complex encounters the target cells, the drug molecule is 
released and interacts with the affected cell, whilst the host leaves the body 
without any side effect (Rodik et al., 2009; Perret and Coleman 2011). 
Calix[n]arenes are relatively non-toxic and do not evoke immune responses 
(Yang and de Villiers 2004). Their applications in the pharmaceutical field have 
not been approved yet by the Food and Drug administration (FDA) but the lack 
of toxicity enhances attention on their use in medicines and other proposed 
applications in biological systems. For example: for the encapsulation of neutral 
organic guests by water soluble calix[4]arenes, as enzyme mimics, as ligands 
for the molecular recognition of cell surface proteins, as scaffolds for magnetic 
resonance imaging agents, as gene transfection vectors and in drug delivery 
(Bagnacani et al., 2008; Khan et al., 2017; Bonaccorso et al., 2017; Alex et al., 
2018). 
Several types of nanostructures, such as micelles, vesicles and nanotubes, 
result from self-assembly of amphiphilic calixarenes because of the substituent 
groups, molecular structure and experimental conditions used. Shinkai et al. 
explained that the conformation of calix[n]arenes plays a key role in their 
aggregation behaviour and the cone conformation typically forms globular 
micelles in aqueous media (Shinkai et al., 1986; Arimori et al., 1995). 
In addition, Strobel et al. found that the nature of ionic functional groups on the 
calix[n]arene also play a crucial role in controlling the aggregation behaviour of 
amphiphilic calix[n]arenes: for example, trimethylammonium-substituted 
calix[4]arenes form micelles, whereas calix[4]arenes with carboxyl groups tend 
to form vesicles. Such dominance of the size and the shape of aggregates and 
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associated properties are very important for creating systems for drug and gene 
therapy (Strobel et al., 2006). 
Although a few studies into the capability of calix[n]arenes to solubilise drugs 
have been reported these mostly relate to the commercially available or readily 
prepared anionic sulfonated derivatives, 4-sulfonatocalix[4]arenes for example 
(Chen et al., 2016; Athar et al., 2017).  
 
1.2.1.2.1 Sulfonatocalix[n]arenes 
This class of cyclooligomers are widely used as host molecules for different 
organic and inorganic compounds: 4-sulfonatocalix[n]arenes have attracted 
great attention in the last two decades because of their solubility in aqueous 
media (> 0.1 mol/L) (Khokhar et al., 2017) and low toxicity (Da Silva et al., 
2004; Lazar et al., 2004). Also investigated are their catalytic properties, 
selective binding ability, biological compatibility and their role as a carrier in 
drug delivery. Another possible pharmaceutical application that has been 
examined is their ability to increase the therapeutic effect of a drug moiety 
(Perret and Coleman 2011; Ostos et al., 2017).  
The highly water-soluble 4-sulfonatocalix[4]arene 3 has been used in a study 
into the aggregation properties of α-tocopherol (α-T) 4 due to the biological 
significance of vitamin E. α-Tocopherol, works as a natural antioxidant, 
represents the main form of vitamin E, and exists in the cellular concentration 
and the blood than other forms of vitamin E. It has been established that 
vitamin E acts as radical scavenging by delaying or preventing the chronic 
disease related to free radicals. α-Tocopherol with hydrophilic phenol moiety 
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and long alkyl chain conducts as an amphiphile, therefore it places beneath 
aqueous insoluble vitamins (Figure 3).  
 
Figure 3: Structures of 4-sulfonatocalix[4]arene and Vitamin E (Ashwin et al., 
2018) 
The encapsulation of (α-T) within 4-sulfonatocalix[4]arene in solution has been 
studied by employing cyclic voltammetry (CV) and fluorescence spectroscopic 
techniques. The critical aggregation concentration value (CAC) of pure vitamin 
E is reduced a half in the presence of 4-sulfonatocalix[4]arene. The measured 
quenching (107 M-1s-1) and binding constant (103 M-1) values showed good 
binding tendency of vitamin E with 4-sulfonatocalix[4]arene. The Job’s plot 
method has also confirmed the (1:1) binding stoichiometry of 4-
sulfonatocalix[4]arene and (α-T). The host-guest inclusion complex in the solid 
state has been successfully prepared and proved the cavity packed with lipid 
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soluble (α-T) inside the cavity of 4-sulfonatocalix[4]arene using CV, FT-IR, 
SEM, XRD and 1H-NMR characterization (Ashwin et al., 2018).  
Supramolecular host-guest chemistry has attracted increased attention due to 
the reversible nature of complex formation (complexation and decomplexation) 
(Figure 4) (Yang et al., 2014). In 2009, Wheate et al. used 4-
sulfonatocalix[4]arene as a nanocarrier for the dinuclear platinum anticancer 
drug, trans-[{PtCl(NH3)2}2µ-dpzm]
2+ (di-Pt; where dpzm= 4,4’-
dipyrazolylmethane). It was noticed that 4-sulfonatocalix[4]arene binds to di-Pt 
in 1:1 ratio, it is low binding constant or partial encapsulation does not provide 
steric hindrance to prevent binding the metal complex to guanosine. The 
system releases the platinum species upon in vivo administration due to blood 
serum content is high in the body (Wheate et al., 2009).  
Liu et al. reported the stoichiometric inclusion complexes between 4-
sulfonatocalix[4]arene with anticancer drugs topotecan and irinotecan. One- 
and two-dimensional NMR and UV-vis spectroscopies and DSC were used to 
confirm complex formation (Wang et al., 2011; Wang et al., 2011).  
The binding between 4-sulfonatocalix[6]arene and vitamin B6 was investigated 
by Song et al. in an acidic or basic media. Release of the guest molecule could 





Figure 4: Presentation of the formation of inclusion complexes based on 
calix[n]arenes and their decomplexation (Zhou et al., 2015)  
Coleman and Perret showed that any modifications on the parent calix[n]arene 
structure, such as mono-substitution of 4-sulfonatocalix[n]arenes, can evoke 
surprising changes in their complexation with biomolecules, particularly, they 
showed an increased performance to bind the aspartic acid and the glutamic 
acid groups which will have reflections in the recognition of protein (Perret and 
Coleman 2011).  
Contrary to other reports in the literature, Da Silva et al. reported the haemolytic 
properties of a number of 4-sulfonato-calix[n]arene derivatives having pendant 
groups at the lower rim (Figure 5): they found that the haemolytic effect rises 
with the size of the macrocyclic ring. For example, 30% haemolysis of human 
erythrocytes was observed for 4-sulfonatocalix[8]arene at a concentration of 
200 mM. The haemolysis effect was lower for 4-sufonatocalix[6]arene and 4-
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sulfonatocalix[4]arene, at 8% and 0.5% respectively at the same 200 mM 
concentration.  
 
Figure 5: Presentation of different water soluble 4-sulfonatocalix[n]arenes 
 (Da Silva et al., 2004) 
In all cases, introduction of a methoxy-carboxylate function on the lower rim 
leads to a decrease in haemolytic behaviour at 50 mM concentration and 
above. The presence of an ethoxy-amine function on the lower rim enhanced 
the haemolytic effect for 4-sulfonatocalix[4]arene 5d and 4-
sulfonatocalix[6]arene 6d at all concentrations but decreases the impact for 4-
sufonatocalix[8]arene 7d derivatives (Da Silva et al., 2004).  
Amphoteric calix[8]arene 8 presenting negatively charged sulfonate groups on 
the upper rim and positively charged quaternary ammonium groups on the 
lower rim has been reported by Xiao et al. (Xue et al., 2013). It displayed pH-
sensitive loading and release of the hydrophobic drug ciprofloxacin into the 
cavity of the calix[8]arene (Figure 6).  
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It was proposed that the calix[8]arenes load the drug at neutral pH by self-
assembly of calix[8]arene molecules through the electrostatic bonds between 
both rims. At higher or lower pH, the amphoteric calix[8]arene complexes 
disassemble and can evoke drug release (Xue et al., 2013). 
 




The ability of cationic calix[n]arenes to solubilise and deliver drugs across 
biological membranes has not been investigated in depth. Aminocalix[n]arenes 
have been investigated for their ability to self-assemble and for molecular 
interaction with DNA (Shahgaldian et al., 2008). 
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Ukhatskaya et al. studied the solubilising effect and complexing ability of 
cationic aminocalix[4]arene (Figure 7): they reported that the calix[4]arene 
enhanced the solubility of paracetamol, lidocaine and ketoprofen in aqueous 
media, notably more effectively when compared to cyclodextrins. The highest 
increase in solubility was noticed for steroidal drugs, 17β-estradiol for example. 
Results from dynamic light scattering (DLS) and transmission electron 
microscopy (TEM) showed that the calix[4]arene perhaps exists in vesicles 
aggregates of two diverse size populations. Correlation data of the relationship 
between physical and physio-chemical properties of the drugs and the 
solubilising effect of aminocalix[4]arene 9 supports the suggestion that the 
mechanism of solubilisation depends on the interaction between the drug and 
aggregates of 9 rather than forming inclusion complexes of 
drug/aminocalix[4]arene (Ukhatskaya et al., 2010). 
 






1.2.1.2.3 Phosphorylated calix[4]arene 
Curcumin, like other natural products, has been found to reduce the risk of 
developing different types of cancers (Chen et al., 2017). The employment of 
curcumin in drug design is also appealing due to the fluorescence spectrum 
and can be tracked simply in vitro and in vivo. However, the clinical application 
of curcumin is still challenging due to its low stability and bioavailability. By 
delivering it in nanoparticulate carriers it is likely to be effective against various 
cancers, but against therapeutically aggressive and highly heterogeneous 
disease like Triple-negative breast cancer (TNBC). Development of nanocarrier 
could assist to increase curcumin efficiency against this form of cancer. 
Phosphorylated calix[4]arene amphiphile 10, which contain hydrophilic 
phosphate moieties on the upper rim and hydrophobic chains on the lower rim 
(Figure 8), has been developed to improve the solubility, stability and anti-
tumour activity of curcumin (Chen et al., 2017).  
 
Figure 8: Phosphorylated calix[4]arene (Chen et al., 2017) 
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Curcumin-loaded phosphorylated calix[4]arene micelles were generated 
utilising a thin-film dispersion method. These loaded micelles showed a shell-
core structure, small particle size (3.86±0.32 nm) with small size distribution 
(PDI) (0.125±0.078). The micelles displayed high curcumin loading capacity 
(loading ratio, 17.10±1.25%) as determined by HPLC coupled to a tandem MS 
in positive ESI mode by examining the retention time and peak area for 
curcumin. 
Cell culture studies indicated that phosphorylated calix[4]arenes can release 
curcumin or other payload in response to a change in pH and hence can 
effectively inhibit (TNBC) in vitro and in vivo. These micelles assist the 
capability of curcumin to inhibit proliferation, migration, and invasion. In addition 
to their ability of increasing apoptosis and reducing the nuclear activity of β-
catenin and androgen receptor and destroy breast cancer stem cells (BCSCs). 
These effects reflected the strong capability to reduce the growth of tumour 
sphere by BT-549 in mice without causing clear side effects within 14 days of 
treatment (Chen et al., 2017).  
 
1.2.1.2.4 PEGylated calix[5]arenes 
Two classes of amphiphilic PEGylated calix[5]arenes 13 and 14 were prepared 
directly from 4-methylcalix[5]arene 11 and 4-tert-butylcalix[5]arene 12 (Scheme 
3). Their aggregation properties were examined in water and the possibility of 
compound 13 to act as drug delivery system was also investigated using Rose 
Bengal, a fluorescent dye use for spectrophotometric determination and is also 





Scheme 3: Synthesis of 4-substituted PEGylated calix[5]arenes 
 (Pisagatti et al., 2018)  
The aggregation behaviour of the two derivatives was studied using 1H or 
DOSY NMR and AFM. The 1H-NMR spectra of compound 13 and compound 14 
in D2O showed broad signals indicating that the aggregation process is 
happening in this solvent due to their amphiphilic character. Diffusion Ordered 
NMR spectroscopy, (DOSY) analysis using 0.4 mM of both derivatives, showed 
diffusion coefficients of low values (Dobs = 1.17 × 10
−10 and 0.73 × 10−10 m2s−1 
for compound 13 and 14 respectively). The critical micellar concentrations 
(CMC) values were determined to be low also (4.5 µM (14.7 mg/L) and 0.5 µM 
(1.7 mg/L) for compound 13 and compound 14 respectively). The AFM 
topography images showed different aggregation features: compound 13 forms 
relatively small-sized assemblies, but by contrast compound 14 predominately 
assemblies into large circular aggregates. These differences in morphologies 
and CMC values are possibly ascribed to the differences in conformational 
mobility of the two calix[5]arenes, which in turn can be attributed to the size of 
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substituents present on the upper rim. The thermal release of Rose Bengal 
from the micellar environment of PEGylated calix[5]arene 13 was tested by 
increasing the temperature of the solution, it was seen that λmax of Rose Bengal 
shifted back from 563 nm to 553 nm referring to the release of the drug from the 
micellar core (Pisagatti et al., 2018).  
 
1.2.1.2.5 Carboxylated calix[6]arene 
Carboxylated calix[6]arenes (Figure 9) have been investigated for their 
capability to form 1:1 inclusion complexes with esters of aminoacids, tryptophan 
for example, in a liquid-liquid extraction system. The interaction between the 
ammonium cation of the guest molecule and the oxygen atoms of the 
calix[6]arene was the driving force for complexation. The structure and the 
stoichiometry of the complexes formed were elucidated by spectroscopic 
analysis and systematic studies of liquid-liquid extraction method using a Job 





Figure 9: Molecular structure of 4-tert-octylcalix[6]arene hexacarboxylic acid 
derivative (Oshima et al., 2002) 
Induced circular dichroism (ICD) spectrum of 4-tert-octylcalix[6]arene 15 was 
observed when the guest molecule was complexed, such phenomenon is 
based on the asymmetric rearrangement of the host by including the amino acid 






1.3 Glycoclusters and glycodendrimers 
Dendrimers refer to a class of complex and branched structures with a 
symmetric and regular spherical shape. Whereas, clusters are small 
compounds with fewer repeating arms. The first dendrimers were described by 
Vogtle in 1978 (Buhleier et al., 1978), then the field exploded in the early 1980s 
(Tomalia and Fréchet 2002). 
Glycodendrimers are scaffolds functionalised with carbohydrate chains based 
on different cores such as cyclodextrins, fullerenes, calix[n]arenes, 
calix[4]resorcinarenes and neo-glycopeptides (Figure 10) (Reina and Rojo 
2015; Delbianco et al., 2015; Bojarová and Křen 2016).  
 
Figure 10: General structures of glycodendrimers, glycoclusters and 
glycodendrons (Delbianco et al., 2015)  
These systems, modulated with carbohydrates provide valuable platforms for 
the synthesis of multivalent frameworks, allowing conjunction of a multiple 
number of peripheral functional groups for biological recognition purposes 
(carbohydrate-protein interaction (Cousin and Cloninger 2016; Denavit et al., 




The inner sphere of a dendrimer can be used as a container for gene or drug 
delivery (Svenson and Tomalia 2012). These systems have been used as 
vaccines, anticancer drugs, antibacterial agents and imaging reporters (Shiao 
and Roy 2012).  
 
1.2.1.2.6 Glycosylated calix[n]arenes 
Glycocalixarenes are a subclass of calix[n]arenes bearing at least one 
saccharide unit anchored to their structure; glycocalix[n]arenes that possess 
two or more saccharide units are called multivalent glycocalix[n]arenes (Baldini 
et al., 2007; Dondoni and Marra 2010). These compounds have received great 
attention in bioorganic and supramolecular chemistry due to their ability to 
interact with biologically active macromolecules. As a consequence of this 
association they may be beneficial in hindering a number of adhesion 
phenomena, such as toxin adhesion to cells, infection by pathogenic viruses 
and bacteria and tumour progression and migration (Varki 1993; Lee and Lee 
1995; Lis and Sharon 1998; Gabius et al., 2011).  
Glycocalixarenes have been shown to recognise and associate with proteins 
due to multivalent interactions between the protein and the saccharide residues 
on the glycocalixarene. In nanomedicine, glycocalixarenes could be potentially 
useful, via covalent or noncovalent binding processes (Figure 11): they can 
load many type of cargo, such as drugs, fluorescent labels, radioactive or 
paramagnetic probes and immunoadjuvant units like tripalmitoyl-S-
glycerylcysteinyl-serine for potential applications extending from diagnosis to 
therapy. Anticancer vaccine was synthesised by clustering of four glycomimetic 
antigen units onto calix[4]arene matrix conjucated with an immunoadjuvant unti. 
This unit determines the extent of immune response of vaccine candidate 
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(Geraci et al., 2008). On the other hand, these macrocycles can form 
supramolecular formulations to detect ovarian and other gynecologic cancers at 
the early stages by forming host-gust recognition with the biomarker, 
Lysophosphatidic acid (LPA) exists in different concentrations in plasma for 
healthy and patients posses gynecologic cancers (Yu and Chen 2019). Due to 
their lipophilic cavity, calixarenes can complex with small molecules in aqueous 
media through the hydrophobic effect (Figure 11a). Besides, upper or lower rim 
functionalisation with polar groups permits association with polar guests, anions 
and cations (Casnati et al., 2003; Baldini et al., 2012). 
 
Figure 11: Noncovalent (a and c) and covalent (b) interactions of the 
glycocalixarene load with the cargo via complexation (a), bond formation (b) 
and self-assembly (c) (Sansone and Casnati 2013) 
 
The synthesis of calix[4]arene based glycoconjugates at the upper and the 
lower rim with four saccharide units can convert the lipophilic calixarene 
structure into a water soluble species, thereby providing a multivalent agent for 




1.2.1.2.6.1 Upper rim glycosylation  
1.2.1.2.6.1.1 Synthesis of calix[4]arene O-glycoside 
Calix[4]arene glycosides with four carbohydrates at the upper rim have been 
prepared starting from calix[4]arene 16, which was converted to 
tetrahydroxymethylated calix[4]arene 19 via the tetrapropoxy derivative 17 and 
the tetraaldehyde 18 (Scheme 4). 
Glycosylation of compound 19 by using thioethyl galactoside 20 afforded the 
water soluble (up to 5 mM) tetrakis-O-galactosyl calixarene 21 together with the 
ether-bridged by-product bis-O-galactosyl calixarene 22 in a very low yield. 
Coupling of compound 19 with thioethyl lactoside 23 afforded the capped 
glycocalix[4]arene 24 (intramolecular ether bridge) in low yield as the only 





Scheme 4: Synthesis of tetrakis-O-galactosyl calixarene and ether bridge bis-O- 








1.2.1.2.6.1.2 Synthesis of calix[n]arenes N-glycosides 
Four glycocalix[n]arenes having α-mannoside groups at the upper rim have 
been synthesised as multivalent ligands for DC-SIGN (Dendritic Cell-Specific 
ICAM-3 Grabbing Nonintegrin). However, the conformational mobility, the 
valency of the scaffold and the spacer between the scaffold and the ligating 
units were different in order to estimate the possible effect of these 
glycocalix[n]arenes towards receptor.  
Tetramannosylthioureidocalix[4]arenes 27a and 27b (Scheme 5) bearing propyl 
groups at the lower rim and the mannosides units linked to the upper rim by 
ethylthioureido linker, are locked in the cone and 1,3-alternate conformation, 
respectively. 
Hexamannosylcalix[6]arene 27c with methyl units at the lower rim, displays a 
multivalency and is conformationally mobile. Mannosylcalix[4]arene 27d is 
analogous to compound 27a but the mannosyl residues are connected to the 
macrocycle through the thiourea unit (Scheme 5).  
The behaviour of deprotected mannosyl products 29a-d in water was recorded 
by 1H-NMR spectra in D2O solution and as expected they showed different 
solubility in water. Compounds 29a and 29d showed very low solubility in water 
and very broad signals were noticed in the spectra at room temperature, 
probably due to strong self-assembly in solution. Conversely, compound 29b, 
which is locked in the 1,3-alternate conformation, was highly soluble in water 
and sharp 1H NMR signals appeared in the spectrum at room temperature. 
Compound 29c showed similar behaviour to compound 29a in water with broad 
signals in the spectrum at room temperature. The relative diversity in the 
behaviour of these compounds in solution can be related to the relative 
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configuration of hydrophilic and lipophilic sites in the structures (Morbioli et al., 
2017).  
 






1.2.1.2.6.2 Lower rim glycosylation 
Calix[4]arene 16 was reacted with tetra-O-acetyl-α,β-D-glucopyranose 30 by 
Mitsunobu reaction: this gave a mixture of two compounds, α,α-bisglucoside 31 
and α,β-bisglucoside 32 in 1:1 ratio (Scheme 6). The 1H and 13C NMR analysis 
clearly confirmed the cone conformation of the glycocalixarenes. Also, the 13C 
NMR spectra demonstrated the diametrical 1,3-substitution in 31. The 
hydrolysis of both compounds afforded the unprotected calix[4]arene glycosides 
33 and 34, but these compounds exhibited low water solubility which 
consequently limits their use in processes which rely upon molecular 
recognition interactions (Marra et al., 1995).  
 






In 1872 Baeyer reported that a crystalline product can be formed by the 
addition of sulfuric acid to a mixture of resorcinol and benzaldehyde (Baeyer 
1872). Afterwards, Michael reported that these compounds were produced by 
the condensation of an equal ratio of resorcinol and benzaldehyde with the lost 
of an equal number of water molecules (Michael 1883). In 1940, Niederl and 
Vogel proposed the cyclic tetrameric structure of these compounds when they 
found the ratio between the resorcinol- and the aldehyde-derived residues is 
4:4 by molecular weight determination (Niederl and Vogel 1940). In 1968, 
Erdtman finally proved the structure of these compounds by single crystal X-ray 
analysis (Erdtman et al., 1968).   
Calix[4]resorcinarenes are cyclic oligomers that can serve as building blocks for 
a variety of applications, including nanocapsule formation (Pan et al., 2015), 
nanoparticle formation (Shalaeva et al., 2018), catalysis (Jose et al., 2017), 
dendrimers in biological systems (Mendoza-Cardozo et al., 2019), as NMR 
solvating agents (Wenzel 2014), in the synthesis of cavitands (Moussaoui et al., 
2017), carcerands (Warmuth 2012). They have also attracted special interest in 
the fields of biotechnology, microelectronics and others.  
Calix[4]resorcinarenes can exist predominantly in five isomeric conformations 
(Hogberg 1980; Hogberg 1980; Tunstad et al., 1989): crown (C4v), boat (C2v), 












The relative configuration of the residues at CH-bridges can also be used to 
denote the stereoisomeric forms: all-cis (rccc), cis-cis-trans (rcct), cis-trans-
trans (rctt) and trans-cis-trans (rtct) (Figure 13). 
 
Figure 13: The configuration of calix[4]resorcinarene (Patil et al., 2016)  
The individual configuration of substituents on the methylene bridges can adopt 
either ‘axial’ or ‘equatorial’ positions within C symmetric resorcinarenes. The 
integration of these criteria leads to a clear descriptions of the stereoisomeric 
calix[4]resorcinarenes. Experimentally, the all-cis isomers have been found to 
adopt either C4 symmetry (crown conformation) or C2v symmetry (boat 
conformation) predominantly. 
Generally, the boat conformation is determined as a crown conformation due to 
the rapid interconversion between the two boat isomers gives a time averaged 
crown conformation (Figure 14). But, the interconversion between the boat and 
other isomers doesn’t happen because covalent bonds would need to be 






Figure 14: (boat-crown-boat) interconversion of rccc calix[4]resorcinarene 
(Glushko et al., 2017)  
All these confomers are expected to form in a reaction to prepare a 
calix[4]resorcinarene, with the ratio of different isomers being mainly dependent 
on the reaction conditions used. Under homogenous acidic conditions, the 
product ratio depends on the thermodynamic stability of isomers due to the 
reversible condensation reaction under these conditions (Weinelt and 
Schneider 1991). Under heterogeneous conditions, the product ratio is 
determined by the relative solubility of various isomers in the reaction solvent 
used (Hogberg 1980). 
Isolation and purification of calix[4]resorcinarenes can be difficult because their 
synthesis can deliver different conformations (Figure 12) and also because they 
can form supramolecular complexes with solvents (Payne and Oliver 2018). 
Studies have showed that calix[4]resorcinarenes in which the hydroxyl groups 
are unsubstituted and the substituents on the methylene bridge are in the rccc 
arrangement exist solely in the crown conformation in both solid and solution 
phases. Usually the conformation obtained is determined by the hydrogen 





1.2.2.1 Synthesis of calix[4]resorcinarenes 
The most common synthetic route to calix[4]resorcinarenes remains heating the 
starting materials in a mixture of aqueous mineral acid and an alcohol to allow 
the formation of the thermodynamically stable product which possesses a cone-
like ‘crown’ conformation (Scheme 7) (Högberg 1980; Egberink et al., 1992). 
And there is no point for condensation of formaldehyde with resorcinol under 
these conditions because of it is high reactivity, formaldehyde lead to the 
formation a copolymer with resorcinol. 
 
Scheme 7: Synthesis of calix[4]resorcinarene (Castillo-Aguirre et al., 2017)  
The acid-catalysed synthesis of substituted calix[4]resorcinarenes from the 
reaction of 2-nitroresorcinol, 2,6-dihydroxybenzoic acid and 2-acetylresorcinol 
with formaldehyde only yields dimeric or polymeric compounds. An alkaline 
medium is more appropriate for condensation of resorcinols bearing an 
electron-withdrawing group between the phenolic hydroxyl groups 35a-c; this 
method also permits the synthesis of the completely unsubstituted 




Scheme 8: Synthesis of calix[4]resorcinarenes from 2-substituted resorcinols 
and formaldehyde (Bourgeois and Stoeckli-Evans 2005)  
Deleersnyder et al. have showed that lanthanide(III), iron(III), and copper(II) 4-
toluenesufonates and lanthanide(III) nitrobenzenesulfonate can be used as 
efficient catalysts for the reaction of resorcinol with aromatic or aliphatic 
aldehydes to form calix[4]resorcinarenes. They observed that two 
diastereoisomers, the all-cis (rccc) and the cis-trans-trans (rctt) isomers are 
formed in the reaction of resorcinol with benzaldehyde. Moreover, the ratio of 
each isomer depends on the reaction conditions used (the time and the metal 
ion) and a good yield is gained after 24 h with only a catalytic 0.1 mol% of 





Barrett et al. reported the use of ytterbium(III) triflate nonahydrate as a catalyst 
in the synthesis of calix[4]resorcinarenes to avoid the problems encountered 
with Bronsted and other Lewis acids. Under these conditions, it was found that 
the reaction of resorcinol with a number of aliphatic aldehydes under standard 
conditions (48 h) afforded the desired all-cis isomers in high yields. In contrast, 
reaction of resorcinol with benzaldehyde gave the kinetically favoured rctt 
diastereoisomer 37b and the thermodynamically favoured rccc isomer 37a in 
89% yield overall and an rctt:rccc ratio of 0.7:1.0. Following a longer reaction 
time (216 h) the reaction mixture was shown to be composed only of the all-cis 
isomer (Scheme 9) (Barrett et al., 1999). 
 
i: [Yb(H2O)9](OTf)3, EtOH, reflux for 48 h 
Scheme 9: Ytterbium(III) triflate catalysed synthesis of calix[4]resorcinarenes 





The use of bismuth triflate Bi(OTf)3 (5 mol%) has been shown to be an efficient 
catalyst for calix[4]resorcinarene synthesis from aliphatic and aromatic 
aldehydes conducted in ethanol giving calix[4]resorcinarenes in good yields. 
The condensation of resorcinol with aliphatic aldehydes required up to a day 
and gave only the thermodynamically favoured the all-cis (rccc) isomer 39a and 
40a: with benzaldehyde only 75 min was needed for completion, the product 
obtained was a mixture of (rccc) 37a and (rctt) 37b isomers in a ratio (37a: 
37b= 0.78:1.0) (Scheme 10).  
When the reaction was allowed to continue for 8 days, the product was only the 
all-cis isomer 37a and no other isomer was found by 1H-NMR spectroscopy. 
When the diastereomeric mixture obtained from 75 min reaction time was 
resubjected to the reaction conditions for 10 days, the product was a mixture 
which consisted mostly of the (rccc) isomer 37a (37a: 37b=1.0:0.11) (Peterson 




Scheme 10: Bismuth triflate Bi(OTf)3 catalysed synthesis of 
calix[4]resorcinarenes (Peterson et al., 2003)  
A range of Lewis acids were used by Iwanek and co-workers as catalysts for 
the condensation of 1,3-dimethoxybenzene 42 and isovaleraldehyde 43 in 
chloroform solvent. Among them, only SnCl4 catalysed this reaction selectively 
and enhanced the formation of all-cis isomer 44a in a high yield. However, 
three conformers were obtained with other Lewis acids, the cone (rccc) and 
diamond (rcct) predominating over the chair (rctt) isomer in all cases (Scheme 
11). Only branched chain aldehydes undergo reaction in chloroform; changing 
the solvent to diethyl ether for the reaction of 1,3-dimethoxy benzene with 
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straight-chain aldehydes led to the formation of the crown conformer of 
octamethoxycalix[4]resorcinarene with only small amounts of other isomers 
being found (Iwanek and Syzdol 1999). 
 
Scheme 11: Lewis acid catalysed synthesis of octamethoxy 







It has been reported that partially alkylated resorcinol does not produce 
cyclooligomeric products by reaction with aldehydes in an alcoholic acidic 
medium (Weinelt and Schneider 1991; Timmerman et al., 1996). However, 
octamethylcalix[4]resorcinarenes have been synthesised by using a Lewis acid 
catalyst (Iwanek and Syzdol 1999; Morikawa et al., 2006), this was the 
incentive to employ Lewis acids in the condensation reaction of resorcinol 
monoethers 45 and 46 with octanal 47 and dodecanal 48 (Scheme 12) 
(McIldowie et al., 2000). 
 
Scheme 12: Lewis acid catalysed the reaction of partially alkylated resorcinol 





Yttrium(III) nitrate hexahydrate has also been shown to be an efficient and safe 
Lewis acid for the synthesis of some calix[4]resorcinarenes derived from 
aromatic aldehydes as a mixture of two diastereoisomers (Scheme 13). The 
reaction was carried out at 120 0C in a preheated oil bath under solvent free 
conditions. They found that this method not only gave a high yield but was also 
fast, cheap and facile (Arami et al., 2015).  
 
37: Ar= C6H5, 52a: Ar= , b: Ar= 2-OH-3MeO-C6H3, c: Ar= 2-ClC6H4, d: Ar= 
4-MeOC6H4, e: Ar= 4-Cl-C6H4, f: Ar= 3-Br-C6H4, g: Ar= 2-NO2-C6H4, h: Ar= 4-Me-C6H4  
Scheme 13: Synthesis of calix[4]resorcinarenes using Yttrium(III) nitrate 
(Arami et al., 2015)  
Roberts et al. prepared a number of calix[4]resorcinarenes from the reaction of 
resorcinol and aldehydes using 4-toluenesulfonic acid as a catalyst by grinding 
the starting materials in a mortar and pestle for a few minutes (Roberts et al., 
2001). Calix[4]resorcinarenes prepared in this way are generally isolated in two 
isomeric forms, C4v rccc and C2h rctt isomers. For C-methyl and C-C6H4-4’-O-
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octyl-calix[4]resorcinarenes the rccc isomer predominates, whilst for C-C6H4-2’-
OH-calix[4]resorcinarene the C2h isomer predominates and for C-C6H4-4’-
O(CH2)4Br calix[4]resorcinarene both isomers are produced. This method is 
simple, gives high yields and can be applied to reactions of resorcinol with a 
wide range of aldehydes (Scheme 14) (Cave et al., 2001).  
 
Scheme 14: Reaction of resorcinol and aldehyde under solvent-free conditions  






Microwaves have also been used as a tool for the synthesis of organic 
compounds. The use of microwaves provides rapid heating, reduces the 
reaction time in addition to reducing the amount of acid catalyst required to give 
high yields of calix[4]resorcinarenes. Sardjono et al. reported the synthesis of 
C-3,7-dimethyl-7-hydroxycalix[4]resorcinarene 58 by using resorcinol and 7-
hydroxycitronellal 57 under 4-toluenesulfonic acid catalysis using microwave 
irradiation (Scheme 15). The reaction conditions gave higher yields in short 
reaction times (˂3-7 minutes) compared to the same reaction but under acidic 
conditions (Sardjono et al., 2018). 
 
Scheme 15: Synthesis of C-3,7-dimethyl-7-hydroxycalix[4]resorcinarene 
 (Sardjono et al., 2018)  
As mentioned beforehand, amphiphilic cyclophanes have a specific association 
style which is different from conventional surfactants which can be considered 
as being between that for classical surfactants and biological molecules. 
Analogues of these cyclophanes have been synthesised by modifying the 
macrocyclic scaffolds. Calix[n]arene molecules open the field to extend the 
range of intermolecular interactions leading to association by attaching 
functional groups on both rims of calix[n]arenes. Therefore, calix[n]arenes 
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present enormous possibility for the design of supramolecular assemblies. It is 
also worth noting that the introduction of different substituents onto 
calix[4]resorcinarene scaffolds modulates their capacity and selectivity for 
complexing ions (Hidayat et al., 2007), organic molecules (Pollok et al., 2017; 
Puttreddy et al., 2017), heavy metals (Jumina et al., 2019) and increased 
antioxidant activity (Li et al., 2017). Alongside this, different types of 
nanostructures such as micelles, vesicles, fibers and capsules can be formed 
(Ryzhkina et al., 2004; Kazakova et al., 2004; McKinlay et al., 2005; Sun et al., 
2008; Syakaev et al., 2008). 
  
1.2.2.2 Synthesis of water soluble calix[4]resorcinarene 
Functionalisation of calix[4]resorcinarenes via reaction with hydroxyl groups on 
the upper rim increases the size of the calix[4]resorcinarene cavity, thus 
developing the ability and selectivity to form complexes with guest compounds. 
The introduction of hydroxyethyl groups into the molecular structure of a 
calix[4]resorcinarene amphiphile may also simplify the hydrogen bonding 
contribution to the self-assembly. Thus, the formation of supramolecular 
architectures can change dependent on the equilibrium between the hydrophilic 
and lipophilic properties of calix[4]resorcinarenes.  
The synthesis of octa-2-hydroxyethyl calix[4]resorcinarenes 60a-f has been 
achieved by the acid catalysed reaction of 1,3-di(2-hydroxyethoxy) benzene 59 
with different alkyl aldehydes (Scheme 16). Their association properties in 
mixed water-organic solvent systems and their ability to solubilise a model dye 
and drugs have been explored. It was found that the association behaviour and 
surface properties of calix[4]resorcinarenes is depended on their structure and 
the co-solvent nature. Only pentyl substituted calix[4]resorcinarene shows 
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surface activity in water-DMSO and water-DMF mixtures, while no surface 
activity happens in the mixed water-THF solution. Calix[4]resorcinarenes of 
poor hydrophobicity associate via open pattern and form large aggregates (DH 
ca. 300–400 nm), while, calix[4]resorcinarene of higher hydrophobicity 
associate through closed pattern with formation small micelle-like aggregates 
(ca.10–20 nm) (Pashirova et al., 2014).  
 
Scheme 16: Synthesis of octa-2-hydroxyethyl calix[4]resorcinarenes 60a-f 
(Pashirova et al., 2014)  
It has been shown that the interaction between Fe(II) or Fe(III) ions with π-faces 
of aromatic biomolecules, plays a crucial role in physiological processes (Ma 
and Dougherty 1997). On this basis, the synthesis of a host molecule and the 
ability to complex a phenol (guest) by the assistance of Fe(II) ions has been 
investigated in aqueous solvents using quantum-chemical and 
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photoluminescence (PL) methods (Kunsági-Máté et al., 2004). The host C-
methyl calix[4]resorcinarene octacarboxylate 62 has been prepared by the 
hydrolysis of the octaester-C-methyl calix[4]resorcinarene 61 in refluxing 
alcoholic potassium hydroxide (Scheme 17) (Iwanek 1998).  
 
Scheme 17: Synthesis of C-methyl calix[4]resorcinarene octacarboxylate  
(Iwanek 1998; Kunsági-Máté et al., 2004)  
The result showed that calix[4]resorcinarene octacarboxylate forms 1:2 
stoichiometric complexes with phenols in aqueous media at room temperature, 
and the strength of complexation reduces in solvents which possess high 
permittivity. However, previous investigations suggested that Fe(II) ions prefer 
coordination to the aromatic ring of compound 62 via cation-π interactions 
rather than the carboxylate units of the molecule (Kunsági-Máté et al., 2003), 
thus, they are able to raise slightly the weak (π-π) interaction between the host 
and the guest. Consequently, the aqueous soluble calix[4]resorcinarene 
octacarboxylate constitute stable complex (sandwich-like) with the phenol by 





Three water soluble N-Alkyl ammonium calix[4]resorcinarene chloride receptors 
66, 68 and 70 bearing four terminal hydroxyl groups at the lower rims were 
prepared via Mannich condensation reaction of calix[4]resorcinarene 64 with 
amines (ethanolamine, cyclohexyl amine and benzyl amine) in the presence of 
an excess of formaldehyde to form tetrabenzoxazines 65, 67 and 69. Ring 
opening of the tetrabenzoxazines under reflux in an acidic medium gave 66, 68 
and 70 (Scheme 18). The receptor 66 is also functionalised with four terminal 
hydroxyl groups at the upper rims, rendering it more water soluble (35 mg/mL). 
The receptor 68 possesses four rigid cyclohexyl fragments at the upper rims, 
and the other receptor 70 is functionalised with four benzyl fragments at the 
upper rims.   
These receptors with varying hydrophilicity of the substituents on the upper rim 
exist in the crown conformation (C4v) as noticed from their 
1H-NMR spectra. The 
study also demonstrated stabilisation of these compounds in water by 
possessing a hydrophobic cavities and hydrophilic (cation-anion) interaction on 
the upper rim.  
The complexation properties of receptors with three water soluble viologen 
derivative guests were investigated using Isothermal Titration Calorimetry (ITC), 
NMR and fluorescence studies in water. ITC analyses showed binding 
constants of 103 M-1. The hosts showed higher affinity towards guests with 
acetylmethyl group over the methyl viologen guest due to the hydrogen bonding 
interaction between (cation-anion) of the host and carbonyl groups of the guest 





Scheme 18: Synthesis of water soluble N-Alkyl ammonium 




1.2.2.3 Calix[4]resorcinarenes in drug delivery and 
biocompability 
Nanotechnology not only has shown a great promise in different fields of 
science and technology, it also has biomedical relevance in the therapy and 
diagnosis of varied disease states (Banerjee 2018). Nanotechnology in drug 
delivery has opened new field of nanosized carriers of size ≤100 nm with 
various abilities and applications. Drug delivery systems are used to enhance 
the solubility, alter the biodistribution of their drug loads or particularly to 
monitor the period and rate of drug loading and release (Valand et al., 2015).  
Drug carriers are specifically synthesised for targeting specific tissues, cells or 
organs of the human organism and to trigger release of the cargo such as drug, 
diagnostic reporter or gene molecule upon arrival to their target site (Sinha et 
al., 2006). These carriers work in a stimulus reactive manner depending on 
external or internal stimuli (pH or temperature variation) that can alter the ability 
of the carrier to release the cargo (Morozova et al., 2016). Drug delivery 
systems have also been created to improve the efficacy and safety of 
administration of toxic therapies, especially anticancer drugs. Integration of 
cage-like molecules in nanoparticle drug carriers is expected to increase their 
capability to efficiently combine drugs by creating strong host-guest inclusion, 
and minimize premature drug release due to absence the affinity among the 
carrier and the drug molecule (Zangabad et al., 2017). 
Nanocontainers based upon amphiphilic molecules incorporate these features 
and are able to enhance the solubility of poorly soluble drugs in aqueous 
media. At increased concentrations, micelles form spontaneously from the self-
aggregation of amphiphilic molecules, the hydrophobic part of amphiphilic 
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molecule forming the micelle core, while the hydrophilic parts form the shell of 
the micelle. When used as a drug carrier, the micelle solubilises nonpolar drugs 
via encapsulation within the micelle core, whereas the hydrophilic part ensures 
the system retains stability in solution (Morozova et al., 2018).  
 
A series of amphiphilic carboxycalix[4]resorcinarenes 71a-f with varying 
hydrophobicity was made with different substituents at the lower rim (Figure 15) 
and used to investigate the solubility of an azo-derivative of isatin 72 bearing an 
ammonium group in aqueous solution. It was observed that the isatin derivative 






Figure 15: Structures of carboxycalix[4]resorcinarenes and the isatin drug 





The toxicity of the macrocycles 71a-f is characterised by low haemotoxicity at a 
solution concentration of 0.5 mM, with the exception of C8-
carboxyresorcinarene which showed reduced toxicity with dilution. The low 
haemolytic toxicity of carboxyl-substituted calix[4]resorcinarenes is probably 
due to the existence of the ionic head groups in the structure. As a 
consequence of this low toxicity, such calix[4]resorcinarenes can be used for 
the construction of supramolecular systems for solubilisation of therapeutic 
agents (Syakaev et al., 2018).  
In aqueous solution, the macrocycles self-associated and solubilised the isatin 
derivative by inclusion of it into the hydrophobic part of the molecule (amongst 
the lower rim substituents). It was observed that the solubilisation effect 
increases with changing the structure and length of hydrophobic part of 
macrocycles. In the case of C5-carboxyresorcinarene 71a and compound 71f, 
the macrocycle cannot provide enough hydrophobic microenvironment for the 
isatin and the existence of ions in solution hinders the efficient interaction and 
solubilisation. The most significant self-association was observed for the C11-
carboxyresorcinarene, which increased the solubility of substrate only slightly 
due to more dense surface charge which reduced the permeability of the 
substrate into the hydrophobic part. The C12-O-Ph-carboxy 
calix[4]resorcinarene self-associates due to the presence of oxy-phenylene 
groups at the lower rim, increasing the solubility of isatin by additional π-π 
interaction. Finally, C8-carboxyresorcinarene and C5-O-Ph-
carboxyresorcinarene showed the highest loading ability for the isatin 
derivative; the increased hydrophobicity in the co-associates of the macrocycles 
with substrate led to the formation of a large supramolecular system through a 
clustering effect (Syakaev et al., 2018).  
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Calix[4]resorcinarene substituted with N-methylethanolamine residues on the 
upper rim and ethylsulfonate groups on the lower rim (Figure 16) was used to 
facilitate the release hydrophobic drugs, including antitumour drug 2,2’-
bibenzimidazole (BBI) and Sudan I from ionic surfactant 
cetyltrimethylammonium bromide (CTAB) micelles.   
 
Figure 16: Molecular structure of calix[4]resorcinarene (Kashapov et al., 2016)  
In aqueous solution, calix[4]resorcinarene self-assembles into vesicles of 
different shapes and sizes. The driving force for the self-assembly is probably 
due to noncovalent interactions and π-stacking of the aromatic walls, together 
with the strong hydrogen bonding interaction between the hydroxyl groups and 
the methylated ethanolamine.  
The addition of calix[4]resorcinarene 73 to surfactant micellar solution of CTAB 
results in the electrostatic interaction between lower rim substituents of the 
calix[4]resorcinarene and surfactant head group, which may trigger the 
transformation from spherical micellar to vesicles structure. It was noticed that 
the small globular micelles convert into vesicles upon the addition of a small 
amount of calix[4]resorcinarene, which enhances the rapid and complete 
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release of the sequestered hydrophobic drugs from CTAB in response to 73 
(Kashapov et al., 2016).  
Generally, calix[4]resorcinarenes with long alkyl chains on the lower rim exist in 
the cone or boat conformation of the macrocycle, which leads to self-
association of calix[4]resorcinarene into micelle-like aggregates. One of the 
ways to increase the aqueous solubility of calix[4]resorcinarene and to reduce 
its toxicity is by introducing hydrophilic substituents such as polyethyleneglycol, 
polycaprolactone and polylactic acid residues which are known to be 
biocompatible. The modulation of calix[4]resorcinarenes with such groups leads 
to formulation hyperbranched three-dimensional structures with higher aqueous 
solubility and low viscosity.  
Polyethyleneglycol has good water solubility and low toxicity which in turn 
makes it the most employed polymer in the production of different therapeutic 
agents and nanomaterials. Thus, conjugation of polyethyleneglycol and 
calix[4]resorcinarene  will produce an amphiphilic structure with increased 
binding features and hence lead to increase in the time to release the drug 
captured by calix[4]resorcinarene-PEG conjugated micelles, 
tetraundecylcalix[4]resorcinarene 74 bearing methoxy polyethyleneglycol 
chains at the upper rim has been synthesised to investigate this purpose 





Figure 17: Tetraundecylcalix[4]resorcinarene–methoxy PEG conjugate  
(Ermakova et al., 2018)  
In aqueous solution, they are able to self-associate and form small micellar 
structures with average diameters of 9-18 nm. In phosphate-buffered saline 
solution or in physiological sodium chloride solution, these compounds form 
multimicellar associations with averaged diameters of 142-164 nm and become 
thermo-responsive (Figure 18). The obtained macrocycle exhibits low 
haemolytic toxicity. It is able to encapsulate various hydrophobic organic 
substrates, including drugs (naproxen, doxorubicin, ibuprofen and quercetin). 
The encapsulation occurs by permeation of the drug molecule into the micelles 
and further interaction with the aromatic hydrophobic wall of the macrocycle. 
This leads to slow release of substrate in vitro. Temperature-dependent release 
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of doxorubicin from the micelles was demonstrated by heating the 
supramolecular drug container in 0.9% NaCl solution (Ermakova et al., 2018).    
 
Figure 18: Proposed scheme of macrocycle self-association (Ermakova et al., 
2018) 
 
Sulfonatomethylated calix[4]resorcinarenes with various lengths of hydrophobic 
chains on the lower rim (methyl, pentyl, heptyl) act as hosts to a number of 
biologically active compounds with different physico-chemical properties (Figure 
19). Aliphatic, aromatic and cationic guests were chosen to study the effect of 
sizes, polarities, shapes, charge character and symmetry on the aggregation 
process with the influence of solvent on these systems. The guests used 
included dimephosphon, xymedon, tetramethylammonium bromide, choline, 
tyramine, neurotransmitters theophylline, tetrabutylammonium chloride, 1-
methyl-4,4’-bipyridinium phosphorus hexafluoride and methylviologen (Syakaev 






Figure 19: The chemical structures of sulfonatomethylated 
calix[4]resorcinarenes (Syakaev et al., 2012)  
It was noticed that quite small changes in the length of the hydrophobic chain 
on the lower rim of calix[4]resorcinarene can alter their aggregation properties. 
While calix[4]resorcinarene with pentyl moieties form head to tail structures 
when packed, calix[4]resorcinarene with heptyl substituent is aggregated into 
micelle-like structures in water and water-methanol solutions. There was no 
evidence of aggregation of sulfonatomethylated calix[4]resorcinarene with a 
methyl group on the lower rim. The solubilising of guest molecules was more 
efficient by aggregation of calix[4]resorcinarene with pentyl moieties due, in this 
case, to two calix[4]resorcinarenes forming a capsule for inclusion of the guest 
molecules. The association with guest molecules by the aggregation of the host 
with pentyl tail on the lower rim was increased for uncharged guests, whereas 
there was nearly complete binding of the ammonium cation. The formation of 
host-guest complex may lead to an increase or decrease in the size of the 
aggregates with preservation of the head to tail packing mode of 
calix[4]resorcinarenes 76 (Syakaev et al., 2012).  
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Mycophenolate mofetil (MMF) is an effective immunosuppressive agent that 
does not cause reduction of bone marrow activity and is important in treatment 
of inflammatory glomerular disease. The drug is practically insoluble in water 
(43 µg mL-1). Sulfonatocalix[4]resorcinarene 78 was chosen to interact with 
MMF in order to improve its solubility and dissolution rate in aqueous media 
with changing the  bioavailability. In the solid state the inclusion complexes was 
proved using aqueous phase solubility studies, HPLC, Thermal analysis, 
Powder X-ray diffraction studies, UV-Vis and FT-IR spectroscopy (Menon et al., 
2011).   
The result referred to the formation of an inclusion complex between MMF: 
Sulfonatocalix[4]resorcinarene at a 1:2 ratio with stability constant 2285 M-1 in 
aqueous solution (Scheme 19). FT-IR studies did not show any significant 
differences indicating that no new chemical bond was produced in the complex. 
Differential Scanning Calorimetry and X-ray studies showed reduced 
crystallinity of the complex (drug: sulfonatocalix[4]resorcinarene). This was 
apparent from the absence of an endotherm in the DSC thermogram and no 
diffraction peaks in the X-ray diffractogram as compared to those in the physical 
mixture of each substrate alone. In vivo studies showed reduced toxicity of the 
pure drug MMF after complexation with an increase in the LD50 value of the 





Scheme 19: Inclusion complex of mycophenolate mofetil: 




Patel et al. prepared the inclusion complex between the anticonvulsant drug 
lamotrigine 80 with sulfonatocalix[4]resorcinarene 78 and investigated the 
dissolution properties of the drug in the complex. The inclusion complex in the 
solid state was studied by various analytical techniques comprising PXRD, FT-
IR and DSC. Studies also included the solubility of the drug versus the 
complexed species in the aqueous phase, and in vitro and in vivo release of the 
drug was studied (Patel et al., 2013). 
The result of their studies showed the formation (1:1) inclusion complex of 
sulfonato calix[4]resorcinarene: lamotrigine with a stability constant of 854.1 M-1 
in water (Scheme 20). The FT-IR spectra showed the absence the free amino 
groups of the drug and formation intermolecular hydrogen bonding between the 
drug and the carrier. The X-ray diffractogram studies showed reduced 
crystallinity of the drug in the complex as compared with those in the physical 
mixture of each pure compound. The acute toxicity studies showed that after 
complexation the toxicity of the pure drug lamotrigine decreased and the 





Scheme 20: Inclusion complex of sulfonatocalix[4]resorcinarene: lamotrigine 










1.2.2.4 Calix[4]resorcinarene glycosides 
Various drug delivery systems have been evaluated and developed to enhance 
the therapeutic efficiency of cancer treatments, but there remain challenges 
associated with limited transportation efficacy of drugs to the target tissues and 
also some types of cancer have progressed resistance towards anticancer 
therapies (Pillai 2014; Soni et al., 2017). 
Many strategies have been recognised to improve drug delivery systems that 
preferentially and selectivity deliver the dosage to the target cells and reduce 
the delivery to non-target sites (Jain et al., 2017). For this objective, one of the 
more obvious methods for drug targeting is the use of ligands that will 
overcome the undesirable toxic effects related to the conventional drug carriers. 
Glycosidic ligand structures have been combined with different nanocarriers to 
investigate tumour-targetting due to aberrant glycosylation in tumour cells (Cai 
et al., 2018). Besides targetting the drug, carbohydrates conjugated with 
different carriers like dendrimers, liposomes, nanoparticles, etc. may also offer 
other varied beneficial features, including biostability, bioadhesion, enhanced 
aqueous solubility as well as reduced toxicity (Latxague et al., 2018).  
Calix[4]resorcinarenes appended with monosaccharides on the upper rim and 
long alkyl chain on the lower rim were introduced in the late 1990s (Fujimoto et 
al. 1997). These compounds form (1:1) stable inclusion complexes with guests 
in water. Such guests include fluorescent dyes and 8-anilinonaphthalene-1-
sulfonate (ANS). The carbohydrate residues form hydrogen bonds with ConA-
Sepharose gel and allow absorbance of the complex on a silica surface (Figure 
20). The uptake system of calix[4]resorcinarene galactoside with a fluorescent 
dye as a guest can be delivered to hepatocytes that contain asialoglycoprotein 
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receptors on the surface which recognize the terminal galactose; the specific 
binding was confirmed by fluorescent microscopy (Fujimoto et al., 2000). 
 
Figure 20: The use of calix[4]resorcinarene glucosides to deliver guest 
molecule to the surface of sepharose gel immobilised Con A via forming a 
ternary complex between the host/guest with the Con A-immobilised on the gel  
(Delbianco et al., 2015)  
In general, the success of gene treatments depends upon the evolution of new 
effective gene delivery vehicles. The groups of Aoyama (Aoyama et al., 2003; 
Aoyama 2004) and Ungaro (Sansone et al., 2006) have developed 
calix[4]arenes and calix[4]resorcinarenes as gene delivery vectors (Ortiz Mellet 
et al., 2010). 
Aoyama and co-workers (Aoyama 2005) synthesised calix[4]resorcinarene 
amphiphiles 81-83 having eight disaccharide units (lactose, cellobiose or 
maltose) and long hydrophobic chains (Figure 21a). In water, these compounds 
81-83 were found to undergo irreversible aggregation into micellar 
nanoparticles of size 4.3-4.8 nm and an aggregation number about of 6 
molecules per micelle (Aoyama et al., 2003; Nakai et al., 2003). The driving 
force for the formation these micellar glycol-nanoparticles was ascribed to the 
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hydrophobic interactions among the multiple undecanoic moieties in 
conjunction with H-bonding between the saccharide residues (Figure 21b).  
Addition of sodium phosphate led to aggregation these micellar into larger 
structures of diameter 50-300 nm resembling saccharide wrapped micelles. The 
complexation between phosphate ions and glyco-nanoparticles highlights their 
potential applications as gene carriers. According to gel electrophoresis data, 
these compounds 81-83 are able to bind DNA molecules at a ratio of 0.2-0.3 
molecules per DNA molecule. This refers to a stoichiometry of two GNPs 
(glyco-nanoparticles) per DNA helical pitch. Glyco-nanoparticles 82 with 
cellobiose units in the presence of plasmid DNA can form artificial glycoviruses 
of about 54 nm in diameter. In contrast, glyco-nanoparticles 81 and 83 with 
lactose and maltose fragments form larger particles (200-300 nm). Notably, the 
zeta potential of glyco-nanoparticle 81-83 complexes with DNA was about 0 
mV, indicating cluster saccharide residues with charge masking (Aoyama 
2005).  
Transfection trials on HeLa and HepG2 cells showed that cellobiose 
glycoviruses with a viral size up to 20 nm performed as efficient gene carriers 
for HeLa cells and was 1000-fold more active than maltose- and lactose-
glycoviruses. In contrast, the transfection ability of lactose-coating glycoviruses 








Figure 21: (a) Structures of calix[4]resorcinarene glycosides and (b) 
Hierarchical growth of amphiphilic calix[4]resorcinarene bearing disaccharides 






1.2.2.4.1 Synthesis of glycosylated calix[4]resorcinarenes 
1.2.2.4.1.1 Upper rim glycosylation  
Calix[4]resorcinarene glucosides with C8-C13 hydrophobic alkyl chains at the 
lower rim and eight glucose moieties on the upper rim, in which each phenolic 
hydroxyl group is conjugated to the glucose residue through an ethoxy group 
have been synthesised (Scheme 21). The calix[4]resorcinarene glucosides thus 
prepared possessed enhanced scaffold flexibility and several of these 
amphiphiles were tested for their ability to increase the stability of four specific 
proteins, including a G-protein coupled receptor. All of these compounds were 
highly soluble in water (>10 % (w/v)) and showed micelle stability as a result of 
elongating the alkyl chain length, especially for calix[4]resorcinarene with C13 
alkyl chain 86f, the compound was completely water soluble even at 10%. 
These compounds were also characterised in terms of their critical micelle 
concentrations (CMC) and the hydrodynamic radius measured by using 
dynamic light scattering. The CMC values changed from 2 µM to 10 µM, these 
values were dropped with elongating the alkyl chain length, referring to 
depending CMC values on the macrocycles hydrophobicity. It was also 
observed that micellar formation of these glucosides of small micelle size which 









Scheme 21: Synthesis of octa-2-glucoseethoxytetraalkyl calix[4]resorcinarenes 
(Hussain et al., 2017) 
 
1.2.2.4.1.2 Lower rim glycosylation 
The synthesis of two specific topologies of tetravalent glycoclusters of 
calix[4]resorcinarene, the chair rctt and boat rccc stereoisomers has been 
reported by Soomro and co-workers (Soomro et al., 2011). The introduction of 
carbohydrate groups at the lower rim was conducted through the synthesis of 
calix[4]resorcinarene bearing alkynyl residues 88a and 88b (Scheme 22) 
suitable for conjugation with azide functionalised galactoside 89a and lactoside 
89b through Cu-catalysed azide-alkyne click chemistry (CuAAC) (Scheme 23). 
The deprotection of the acetate groups was then carried out under 




Although the glycoclusters 91 possessed limited solubility a range of techniques 
were used to measure the binding affinity towards lectins. The Enzyme-linked 
lectin assays (ELLA) results produced for the galactose glycoclusters 91aG and 
91bG showed high affinity for Pseudomonas aeruginosa (PA-IL) and the 
topology of these glycoclusters could not cause any difference in binding 
features (Soomro et al., 2011). 
 
Scheme 22: Synthesis of tetrapropargylated calix[4]resorcinarenes  





Scheme 23: Synthesis of isomeric calix[4]resorcinarene-based glycoclusters 













Calix[4]pyrogallolarene or hydroxyresorc[4]arene can be easily prepared by 
acid catalysed condensation of aldehydes with pyrogallol (Negin et al., 2014). 
Usually, the result is the all-cis (rccc) bowl-like cyclic oligomer, though other 
studies showed that the all-cis (boat/cone) are the kinetically stable conformers 
and rctt (chair) is the thermodynamically more stable conformer for 
calix[4]pyrogallolarenes. The formation of specific conformer is affected by 
many factors including reaction conditions, type of substituent and conformer 
solubility in certain solvents (Maerz et al., 2010; Patil et al., 2016). 
Calix[4]pyrogallolarenes can be functionalised by changing the nature of the 
substituent on the aldehyde starting materials, which may later assist 
modification of the lower rim of the cyclic tetramer. On the upper rim, hydroxyl 
groups are the obvious site for chemical reactions: they can be modified with 
phosphoryl groups (Nikolelis et al., 2009), acetyl hydrazine groups (Podyachev 
et al., 2007), carboxymethyl groups (Pod et al., 2004) and imidazolium groups 
(Kim et al., 2004). It is noteworthy that studies involving the O-acetylation of 
calix[4]pyrogallolarenes with acetic anhydride in pyridine showed that the chair 
conformation is the main product of the reaction and the reaction conditions do 
not induce conformational changes if the conformation is originally fixed in chair 
conformer (Han et al., 2007; Yan et al., 2007; Waidely et al., 2015). However, in 
these studies there is no evidence to the formation crown conformer from these 
reactions.  
In order to prove what happens to the crown conformation, Casas-Hinestroza 
and Maldonado, in their studies showed that the resulting acid catalysed 
condensation reaction an equal amounts of benzaldehyde and pyrogallol in 
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ethanol, C-tetra(phenyl)calix[4]pyrogallolarene was obtained as a mixture of two 
conformations in the ratio of 43% crown to 57% chair (Scheme 24), Acetylation 
of a mixture of C-terta(phenyl)calix[4]pyrogallolarene crown and chair 
conformers, showed that the chair conformer keeps its conformation, while the 
cone changed to boat conformation. 1H-NMR experiments at different 
temperatures showed that increased conformational changes reduce the ability 
to separate the conformers. Alterations of substituents on the lower rim 
provides different conformer ratios due to differing interactions, with 
considerable differences in the nature of substituents on calix[4]pyrogallolarene 
lower rim providing equally considerable variation in conformer ratios (Casas-
Hinestroza and Maldonado 2018).  
 
Scheme 24: Synthesis of C-tetra(phenyl)calix[4]pyrogallolarene  
(Casas-Hinestroza and Maldonado 2018)  
The presence of twelve hydroxyl group on the upper rim exhibits high polarity, 
π-rich cavity and their favourable structure has led to calix[4]pyrogallolarenes 
being widely used as a starting material in the synthesis of carcerands (Chopra 
and Sherman 1997), in complexation studies (Pfeiffer et al., 2014) and in the 
synthesis of liquid-crystal material (Cometti et al., 1990).  
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Calix[4]pyrogallolarenes self-assembled into large nano-capsules or 
supramolecular structures have been studied in the solid state and in solution 
based on inter- or intramolecular hydrogen bonding (Journey et al., 2017; Wang 
et al., 2018). Generally, the twelve hydroxyl groups lead to stabilisation of 
calix[4]pyrogallolarene assembly by hydrogen bonds and consequently a 
number of guests such as solvents, ammonium salts, hydrocarbons, metal ions 
and other organic molecules can be entrapped in to the large cavity (Bowley et 
al., 2014; Beyeh et al., 2015; Galan and Ballester 2016; Zhang et al., 2017). 
Calix[4]pyrogallolarenes have been used for stabilisation of active species by 
using cocrystallisation method. Stabilisation of these species has attracted 
increased attention, by which not only confer us to store and characterise these 
active species but also to their potential applications as catalysis reactions and 
as drug delivery. For example, a pharmaceutical gabapentin largely used in the 
treatment of neuropathic pain and epilepsy, has been employed in such 
cocrystallisation process with calix[4]pyrogallolarenes as both compounds have 
hydrogen bond donating and accepting regions result in the formation of 
cocrystals with increased pharmaceutical properties to assist targeted drug 
delivery, improve bioavailability, solubility, staibility and dissolution rates 
compared to that of the drug alone (Fowler et al., 2011; Fujisawa et al., 2018; 







1.2.4 Cavitands and carcerands 
Cavitands are synthetic molecules that possessing enforced cavities, molecular 
vessels with a large size able to accommodate other organic molecules, ions or 
atoms inside their cavity and then trigger them in a dynamic balance with the 
solvent (Figure 22). In the early 1980s, Cram prepared cavitand from 
calix[4]resorcinarene by linking the hydroxy groups of relative aromatic rings of 
one or two atoms with covalent linkages giving rigid receptor, has been widely 
studied in supramolecular chemistry (Cram 1983; Nguyen et al., 2018). 
 
Figure 22: Calix[4]resorcinarene cavitand structure  
The chemical linking of two cavitand molecules via the substituents existed in 2-
position to the main resorcinol hydroxyl lead to formation rigid three-
dimensional structures called either carcerands (Figure 23) or hemicarcerands 
relying on the number of bridges created among the two cavitands and present 
or absence the pores in the hollow structure by which the guest molecules are 
able to enter or release (Cram 1988; Cram 1983).  
Carceplexes are the inclusion complexes of one or two guest molecules of the 
solvent used in the last step of the carcerand synthesis because the 
dimensions of the cavity opening are too small making strong steric hindrances 
for guest escaping. While carcerands formed by coupling two cavitand 
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molecules of four bridges, Hemicarcerands are missing one or more bridges of 
the carcerand molecule, guests are more freely for mobile exchange in solution, 
thus, the chemical properties of hemicarcerands similar to cavitands more than 
to carcerands (Nuwaysir et al., 1992).  
 
Figure 23: Carcerand structure  
The parent cavitands are insoluble in aqueous media; water solubility was 
investigated by attachment hydrophilic or charged groups to the upper or lower 
rim of calix[4]resorcinarene-based cavitands, the solubility of cavitands relying 
on the nature and the number of attached moieties. The hydrophobic force is 
also expected to have a great effect on the complexation process of cavitands 




1.2.4.1 Synthesis of water soluble cavitands 
Hydroxyl group footed methylene bridged cavitands 97 was prepared by 
selective bridging of chlorobromomethane with dodecol 96, afforded by the acid 
catalysed condensation of 2-methylresorcinol 95 and 2,3-dihydrofuran 63 
(Mezo and Sherman 1998). Sherman et al. reported the synthesis of a water 
soluble cavitands by conversion the hydroxyl groups into the feet of cavitands 
to phosphonate group (Scheme 25). Binding studies of these cavitands towards 
various organic guests ((CH3)2CO, CH3CN, Toluene, Benzene, CHCl3, 
CH3CH2CO2CH3, CH3CO2CH2CH3, CH3CO2CH3), were investigated in water 
using the general methods with binding constants are in range 10-103 and 
subjected to rapid exchange on the 1H-NMR timescale. Solutions were 
prepared with different host concentrations and constant guest concentrations 
in D2O (50 mM (NH4)2CO3, pD= 9.4), the chemical shift of guest protons were 
obtained from the 1H-NMR spectra gave an indication to 1:1 complexing ratio 
(Gui and Sherman 2001).  
 
Scheme 25: Synthesis of water soluble cavitand (Mezo and Sherman 1998; Gui 
and Sherman 2001) 
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Two cavitand molecules, octaamine 99 and octa acid 100 are soluble in water 
under acidic or basic conditions (Figure 24), respectively and form capsule with 
the hydrophobic organic guests, capsule formation is dependent only on the pH 
of the solution, under acidic solution in case of ocata amine cavitand and under 
basic conditions with the octaacid cavitand.  
 
Figure 24: Structures of octa amino and octa acid cavitands (Raj et al., 2018)  
Octaacid cavitand are able to form different complexes with guests of various 
sizes or shapes at pH>8.5 in water. It was noticed that octa acid cavitand form 
1:1 complexes with the organic guest of hydrophobic frame and hydrophilic 
head substituent. It forms 1:2 or 2:2 host-guest complexes with other 
hydrophobic guest molecules relying on the size and shape, such guests 
naphthalene, pyrene, anthracene and tetracene. The dynamic of the capsular 
assembly-disassembly and the equilibrium behaviour could be controlled by 
changing the acidity or basicity of the solution. It was noticed that the 
hydrophobicity of the guest can alter the rate of the disassembling, the rate 
slow down with guest of more hydrophobicity, while, guests of less 
hydrophobicity, the disassembling completely occur of cavitand 100 at pH 4.9. 
This event has been monitored using three fluorescence hydrophobic guests: 
coumarin-1, coumarin-153 or coumarin-480 that showed that emission and 
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absorption spectral properties are dependent on solvent polarity, thus the 
capsule opening (polar) and closed capsule (non-polar) (Raj et al., 2018). 
 
1.2.4.2 Glycosylated cavitands 
Calix[4]resorcinarene based malotoside amphiphiles with four hydrophilic 
groups at the upper rim and four alkyl chains of various lengths at the lower 
rims have been prepared by attaching maltoside substituents to the central 
calix[4]resorcinarene scaffold either directly or by linking to the ethylene glycol 
and the hydroxyl groups of each resorcinol subunit have been linked by 
methylene group (Scheme 26). All the calix[4]resorcinarene amphiphiles expect 
for amphiphiles with C5- alkyl chain, showed water solubility in a medium 
range (1-5% w/v) and headed to precipitate after a short time, referred to limited 
solubility and stability of these micelles in water. Calix[4]resorcinarene based 
maltoside with C5-alkyl chain at the lower rim was poorly soluble in water (<1% 
w/v), but for those with ethylene glycol linker and same alkyl chain were slightly 
higher than the calix[4]resorcinarene cavitand without linker. Generally, the 
micelles formed by these compounds were unstable due to rigid structure did 








a) Aldehyde, ethanol/HCl, 80 0C; b) bromochloromethane, DMF, 80 0C; c) AIBN, NBS, 
benzene, 80 0C; d) K2CO3, acetone/H2O, 80 
0C; e) NaH, ethylene glycol, DMF, 80 0C; f) 
AgOTf, 2,4,6-collidine, DCM, perbenzoylated maltosylbromide, 0 0C to RT; g) NaOMe, 
MeOH, RT 
Scheme 26: Synthesis of calix[4]resorcinarene cavitand based maltoside 
(Hussain et al., 2017) 
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1.4 Aims and objectives 
The aim of this research involved the synthesis of a library of novel 
calix[4]resorcinarene glycosides that bear carbohydrate residues on the bottom 
rim of the hydrophobic box-like cavity. Calix[4]resorcinarene glycosides can be 
synthesised by reacting resorcinol or it is derivatives (2-methylresorcinol and 
pyrogallol) with differently functionalised aldehydes which contain protected 
carbohydrate units in the presence of Lewis acid catalysis. As 
calix[4]resorcinarene synthesis is affected directly by the starting material and 
the reaction conditions used, a series of glycosylated aldehydes was used to 
react with resorcinols to study their effects on the conformation, configuration 
and isomer ratios. In this context, a series of glycosylated derivatives of 
hydroxybenzaldehydes was used to prepare calix[4]resorcinarene glycosides 
bearing mono or disaccharides containing units at the methine bridges. Another 
series of calix[4]rersorcinarenes characterised by having different functional 
groups in 2-positions of resorcinol units was also prepared.  
Glycosidic aldehydes bearing an alkyl spacer to separate the arylglucoside from 
the aldehyde group or alkyl spacer without aromatic unit were also used in 
calix[4]resorcinarene synthesis.  
The conformational isomers of these glycoclusters was determined in most 
cases by acylation of the product calix[4]resorcinarenes, isolation and 
characterisation of all the configurational isomers. The results of this research 
may be used to identify isomers to provide new agents that have potential for 
drug solubilisation.  
Finally, one of the requirements of a calix[4]resorcinarene glycocluster that will 
be used for drug delivery is that it must be soluble in aqueous media.  
This was investigated by solvolysis of all the protecting acyl groups from one 
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butyrated calix[4]resorcinarene glycoside isolated during this research. This 


























CHAPTER 2: SYNTHESIS AND CHARACTERISATION OF 


































Carbohydrates play a vital role in many biological processes. Many pathological 
and physiological events, such as cell trafficking, intercellular connection, 
immune response and tumour cell growth, occur as a result of the interaction of 
carbohydrate groups with lectins, cell surface proteins which lack enzymatic 
and immunogenic activity (Geissner and Seeberger 2016). The interaction 
between monovalent saccharide probes and lectins is usually weak but 
presentation of a large number of glycoside moieties to the receptor ensures a 
better or specific association. Molecules which display a large number of 
carbohydrate residues available for protein interactions are called glycoclusters 
(Laaf et al., 2018), a particular group of multivalent neoglycoconjugates (Jebali 
et al., 2017). Multivalency is related to the capability of a molecule to bind 
another molecule via noncovalent interactions. In this case, the valency is the 
number of ligating residues displayed by a molecule which are available for 
non-covalent interaction with complementary residues on another, separate 
molecular species.  
The concept of multivalency in interaction with biologically important molecules 
has been applied to supramolecular chemistry, with the aim of gaining a better 
understanding of the multivalent effect (Cecioni et al., 2012). Whilst multivalent 
ligands are different in their topologies, they generally consist of a core which is 
covalently linked to the peripheral ligating moieties, perhaps via linkers 
(spacers).  
A variety of molecules can be used as the core scaffold for a multivalent ligand, 
from those with low valency such as monosaccharides, benzene derivatives, 
cyclodextrins, fullerenes, calix[n]arenes and calix[4]resorcinarenes to 
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compounds with high valency, such as dendrimers, liposomes and 
nanoparticles (Delbianco et al., 2016; Compostella et al., 2017; Latxague et al., 
2018). 
Glycoconjugates based on calix[n]arenes or calix[4]resorcinarenes consist of 
carbohydrate residues bonded on to a functionalised scaffold that displays a 
defined number of phenolic hydroxyl groups for further decoration. There are 
several reports in the literature of the conjugation of calix[n]arene or 
calix[4]resorcinarene matrices with carbohydrate units in order to enhance the 
solubility of these compounds in aqueous media, hence increasing their binding 
potential to lectins (Cecioni et al., 2009; Cecioni et al., 2011). Furthermore, 
calix[n]arenes are considered as suitable scaffolds for multivalent glycoclusters 
due to the availability of different scaffold sizes and conformations. This affects 
the valency and the spatial orientation of the carbohydrate residues in the 
glycocalix[n]arenes (Giuliani et al., 2015).  
Calix[4]resorcinarenes are related to calix[n]arenes and are formed from the 
condensation of resorcinol with an aldehyde to form a ‘container’ oligomer with 
analogous structural, conformational and binding features to those of 
calix[n]arenes. Calix[4]resorcinarenes have been widely used for the creation 
and implementation of novel architectures due to their rigid structure, highly 
symmetrical concave cavities and aromatic groups capable of further reaction 
(Sanabria et al., 2018).  
Calix[4]resorcinarenes display eight phenolic hydroxyl units on their upper rims 
that provide useful handles for additional chemical modulation of these 
matrices. In addition, the presence of four pendant groups on their lower rims, 
defined by the aldehyde used in the synthesis, make them more generally 
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applicable in supramolecular chemistry than calix[n]arenes. These structural 
characteristics, amongst others, have enabled further studies into 
calix[4]resorcinarenes as important scaffolds for decoration with carbohydrate 
residues.  
Much work on the synthesis and biological employment of 
calix[4]resorcinarene-based glycoclusters which bear carbohydrates on the 
upper rim was done in Aoyama’s laboratory in Japan beginning from mid 
1990s. Since then, further reports of calix[4]resorcinarene based 
glycoconjugates with mono- or disaccharide residues on either the upper rim or 
the lower rim have appeared.  
In 1999, Fujimoto et al. reported the synthesis of calix[4]resorcinarene 
glycoside possessing sialic acid residues at the upper rim and four undecyl 
alkyl chains at the lower rim 113 (Fujimoto et al., 1999). Calix[4]resorcinarene 
octaamine 110 was converted into the octa(chloroacetamide) 111, which was 
then reacted with the protected sialyl thiol 112. The target glycocluster was 
afforded after hydrolysis of the protecting groups in 84% overall yield (Scheme 



















Other calix[4]resorcinarene based cluster glycosides (Scheme 28) were 
prepared in three-step strategies starting from the corresponding 
calix[4]resorcinarenes. These were converted to ethyl calixarylacetate 114a and 
114b by alkylation with ethylbromoacetate and heating with acetone/K2CO3. An 
amidation reaction was later performed using an excess of diamines to convert 
the ester group in 114a and 114b to amide group 115a-d with free terminal 
amine groups, which in turn reacted with glycosyl isothiocyanate 116 in 
refluxing DMSO/DCM mixture to give the corresponding thiourea-bridged 






















Scheme 28: Synthesis of calix[4]resorcinarene with glycoside residues and 






Sakhaii and co-workers reported the stepwise synthesis of divalent 
glucocalix[4]resorcinarene through condensation of glucosyl aldehydes in the 
open form with 1,3-dimethoxybenzene. This reaction firstly yielded only 
diphenyl substituted glucitols (dimer) and any other attempts to obtain a 
calix[4]resorcinarene with four carbohydrate residues linked at the methylene 
bridges failed (Sakhaii et al., 2002). However, calix[4]resorcinarene bearing 
mixed substituents at the methylene bridges had already been reported by 
Rumboldt et al. who developed a two-step strategy to obtain 
calix[4]resorcinarenes with alternating alkyl or aryl substituents (Rumboldt et al., 
1998). Sakhaii et al. used this strategy for the condensation of hexanal 119 with 
the gluco derivative 118 to give the corresponding calix[4]resorcinarene 
glucoside 120 (scheme 29). The reaction yielded only one conformational 
isomer which was the (rctc) diamond conformer, based on NMR analysis and in 
silico modelling (Sakhaii et al., 2002).  
 
Reagents and conditions: BF3.Et2O, CH2Cl2, 1.5 h 
Scheme 29: Calix[4]resorcinarene glucoside prepared by Lewis acid induced 
ring closure reaction (Titov et al., 2013) 
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Octafunctionalised calix[4]resorcinarenes with carbohydrate residues on the 
upper rim, have been synthesised by functionalising calix[4]resorcinarenes with 
2-aminoethyl groups 110 on the upper rim which, when reacted with a series of 
unprotected oligosaccharide lactones such as D-lactonolactone, 
maltopentaose- lactone, D-cellobiosolactone, D-maltolactone and heptaose-
lactone 121, directly produced a series of calix[4]resorcinarene glycoclusters 
81-83 and 122 with eight saccharide residues which terminate in either glucose 
or galactose (Scheme 30). Usually the spacer between the scaffold and the 
saccharide units is important to determine the efficiency of the interaction 
between the multivalent ligand and the targeted biomolecules. This is especially 
important when the orientation the binding sites of the receptor protein enables 
the formation of a multivalent complex, and the spacers should be long enough 
to permit the interaction of all the ligating groups simultaneously bearing in mind 











Scheme 30: Synthesis of hydroxylated octavalent glycocalix[4]resorcinarenes 
 (Sansone et al., 2011) 
 
Two glyco-calix[4]resorcinarenes bearing 14 terminating residues of galactose 
and linked each to the other by different linkers 123 (Figure 25), were 
synthesised and tested for their ability to bind to rat hepatocarcinoma cells. It 
was found that the two linked glycocalix[4]sorcinarenes could adhere selectively 
to pathological cells instead of the healthy cells, then surround the solid tumour 
by creating a network which should delay tumour growth or inhibit metastasis 




Figure 25: Glycocalix[4]resorcinarene for potential site-directed anticancer 
agents (Sansone et al., 2011) 
 
Another method to conjugate disaccharide residues at the upper rim of a 
calix[4]resorcinarene scaffold was described by Hayashida et al. via alkylation 
the tetrathiolated cavitand 124 with a bromoethyl glycoside 125 in the presence 
of Cs2CO3. After hydrolysis the corresponding glycosylated 
calix[4]resorcinarene 126 presenting four maltose residues linked to the 
macrocyclic backbone through bridges of sulphide was produced (Scheme 31) 




Scheme 31: Calix[4]resorcinarene glycocluster prepared by alkylation of the 




Oshovsky et al. reported the synthesis of thiourea cavitand glycoclusters 133-
136: Reaction of tetrakis(aminomethyl) cavitand 127 with the thiocyanate 
derivatives of peracetylated glucose, galactose and cellobiose in pyridine at 
room temperature yielded the protected saccharide-thiourea functionalised 
cavitands 129, 130 and 132. Cavitand 131 was prepared from the reaction of 
pentyl derivative 128 with protected glucosyl isothiocyanate. Subsequent 
deacetylation of compounds 129-132 afforded saccharide-thiourea 
functionalised cavitands 133-136. The solubilities of thiourea cavitand 
glycoclusters 133-136 in water was 0.5, 0.6, 0.8 and >300 mM L-1 respectively, 
the higher solubility of cavitand 136 in water reflecting the influence of four 
disaccharide residues. The solubility of 136 in water was even higher than the 
solubility of cavitands bearing dendritic surface with 45 tetraethylene glycol 











Calix[4]resorcinarenes provide the opportunity to attain different conformations 
of macrocycles bearing carbohydrates at the lower rim in two specific 
diastereoisomers, the rccc boat and rctt chair.   
Tetravalent glucocalix[4]resorcinarenes bearing protected glucose residues 
have been prepared successfully using Lewis acid catalysis (Curtis 1997). The 
reaction of the tetraacetoxyglucoside of 4-hydroxybenzaldehyde with resorcinol 
in the presence of aluminium(III) chloride gave two isomeric products which 
were isolated as their octabutyrates, major isomer 137a and minor isomer 
137b. The absolute configuration of the major isomer 137a was determined 
using Xray crystallography. However, the absolute configuration of the minor 
isomer 137b remains undetermined. In fact, the accurate isomer distributions 
and configurations of the other compounds reported have not been confirmed 
definitively. Efforts to recognise and identify any conformational isomers of 
other published compounds of calix[4]resorcinarenes derived from the 
tetraacetoxyglucoside of 3-, or 2-hydroxybenzaldehyde have, however, been 
unsuccessful with the exception of calix[4]resorcinarenes derived from the 
tetraacetoxyglucoside of 4-hydroxybenzaldehyde. 
The aim of the research presented in this chapter was to repeat the synthesis of 
137a and 137b reported in the original article (Curtis 1997). This included 
synthesis of calix[4]resorcinarenes derived from the tetraacetoxyglucoside of 4-, 
3-, or 2-hydroxybenzaldehyde and the novel calix[4]resorcinarene derived from 
the tetraacetoxygalactoside of 4-hydroxybenzaldehyde. Isolation and 
identification of the conformational isomers contained within the crude reaction 
mixtures of calix[4]resorcinarene glucosides which was not previously achieved 
from the crude reaction mixtures of calix[4]resorcinarene glucosides before 
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acylation and isolate the pure conformational isomers as the octabutyrate in 
each case.  
 
2.2 Synthesis of calix[4]resorcinarene glucosides  
As part of synthetic approaches concentrated on selective functionalisation of 
the methine bridge units of calix[4]resorcinarenes with carbohydrate residues, 
the strategy employed which allows introduction of glucose-containing units at 
the lower rim began with the synthesis of glucosylated benzaldehydes suitable 
for condensation with resorcinol under Lewis acid catalysis. 
The method used for the synthesis of calix[4]resorcinarene glucosides was 
adapted from that described by Curtis, which used an equimolar ratio of 
resorcinol and glycosidic aldehyde reactants followed by butyration in a two-
step procedure (Scheme 33) (Curtis 1997). 
The rationale behind butyration of the free hydroxyl units was to confer 
increased solubility of the calix[4]resorcinarene products in organic solvents 
and consequently aid separation of the expected conformational isomers from 




Reagents and conditions: (i) aluminium(III) chloride in nitrobenzene, 48-72 h, 
Et2O: THF, (ii) butyric anhydride, pyridine, heating at 80 
0C overnight 





In order to prepare such simple calix[4]resorcinarene-based glycoclusters, the 
monoglycosidic aldehydes must firstly be produced.  
Most carbohydrates occurring naturally are in nature connected via O-glycosyl 
bond at positions 1 or 6 on the carbohydrates, for this reason, it was decided to 
prepare aldehydes bearing carbohydrates groups linked through the same 
bonds on the 1 position, led to the formation O-linked glycosides.  
 
         α-Glucose                   β-Glucose                         β-Glucose 
                                                 (Carbon numbered)          (Carbon numbered) 
 
In addition, protected carbohydrates were used rather than sugars with free 
hydroxyl groups in order to get glycosidic aldehydes with enhanced solubility in 











2.2.1 Glycosylation of aromatic aldehydes (General method) 
The commercially available 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
138 as a donor of glucose moiety was separately coupled with aromatic 
aldehydes (4-, 3- and 2-hydroxybenzaldehyde) 139-141 in 1:1 molar ratio in the 
presence of silver oxide as a catalyst in MeCN using the Koenigs-Knorr method 
(Scheme 34) (Stavila et al., 2008). The reaction proceeded to give 142, 143, in 
69% and 65% yield, respectively, after purification using standard silica gel 
column chromatography. In all cases the reaction yields were acceptable but 
not higher as a result of incomplete conversion of the aromatic aldehydes to the 
glycosidic aldehydes as showed on TLC, even after subjecting the reaction for 
longer periods of time. 
 
Scheme 34: Synthesis of glucosylated benzaldehyde 142-144 
In case of compound 144, the yield was lower at 27% as a result of formation of 
an isomeric glucoside in addition to the starting material 2-
hydroxybenzaldehyde. This method was confirmed to be suitable for 
glycosylation of all aldehydes that was undertaken, since it gives the glycosides 
in a short reaction time 4 h, the reaction solvent is readily removed under 
reduced pressure, the work up was easy and the catalyst promotes the leaving 
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group departure and inversion of configuration of acetobromo-α-D-glucose with 
the formation of the thermodynamically more stable β-glycoside by nucleophilic 
substitution of alcohol. 
The stereochemistry of the product observed is 1,2 trans as a result of 
participation of the acetyl group at 2-position during glycosidation by 
intramolecular nucleophilic addition, producing an orthoester with the α-
orientation at the anomeric position. This intermediate is responsible for the 
introduction of the nucleophile on the β-position, the phenomenon being called 
neighbouring group participation (Scheme 35). The β anomeric configuration 
glycoside bond was proved by NMR (Wang et al., 2007; Laville et al., 2004; 
Chen et al., 2012).  
 
Scheme 35: Mechanism for Koenigs–Knorr glycosidic reaction showing 







2.2.2 Synthesis of calix[4]resorcinarene glucoside 145 
Once the tetraacetoxyglucoside of 4-hydroxybenzaldehyde 142 (Figure 26) had 
been prepared the next step was to react it with resorcinol 35d. The synthesis 
of the calix[4]resorcinarene was undertaken by Lewis acid catalysis using AlCl3. 
This leads to the formation of an oxonium ion. The first step assumed the fast 
formation of intermediate 2, then by slow formation of the intermediate 6 either 
by the reaction of two molecules of the intermediate 4, or by the intermediate 5. 
Finally, the liner tetramer 6 undergoes fast cyclisation to give the 
calix[4]resorcinarene in the crown conformation (Scheme 36) (Boxhall et al., 
2003).  
 
Figure 26: 1H NMR spectrum of tetraacetoxyglucoside of 4-





Scheme 36: Mechanism of Lewis acid catalysed formation of 




The 1H NMR spectrum of the crude mixture of product isolated showed the 
presence of residual nitrobenzene but also an indication that there may only be 
one major conformer produced from the reaction upon treatment at room 
temperature and for 2 days reaction time. It is noteworthy, that no further 
change was noticed on allowing the reaction to proceed for any further time. 
Isolation and purification of this compound was conducted using preparative 
TLC using DCM: MeOH (4.5:0.5) as eluent, which led to isolation of a single 
band. The 1H NMR spectrum obtained in d6-acetone clearly shows the presence 
of one isomer as shown by two equivalent signals in the region in the spectrum 
5.72-5.84 ppm for the methine bridge protons. A similar result was obtained 
when the mixture obtained from a separate, identical reaction was treated to 
column chromatography (Figure 27). The structure of this compound is also 
supported by mass spectrometry analysis. The spectrum gave molecular ion at 
m/z 1106.3512 that corresponds to (M+2NH4)
2+. (Expected: m/z 1106.3506) 














Figure 27: (a) 1H NMR and (b) 13C NMR spectra of calix[4]resorcinarene 
glucoside 145 recovered after preparative TLC in d6-acetone 
 
2.2.3 Synthesis of fully acylated glucocalix[4]resorcinarene 137 
Due to the difficulties faced in isolation of the calix[4]resorcinarene glucosides 
and their limited solubility in a polar solvent, esterification of the crude mixture 
of calix[4]resorcinarene glucosides was undertaken by employing an excess of 
butyric anhydride and pyridine at an elevated temperature (80 0C). The 
mechanism involves the nucleophilic addition of a phenolic hydroxyl group to 
the electrophilic carbonyl of butyric anhydride, this addition produced an 
unstable intermediate which underwent elimination of a carboxylate anion to 
deliver an ester (Scheme 37). The acylated product is more amenable to 




Scheme 37: Esterification mechanism 
The 1HNMR spectrum of the octabutyrated mixture showed the presence of 
three inequivalent signals in the region 5.83-6.07 ppm characteristics for the 
aromatic core protons, though it was difficult to assign the methine bridge 
protons because their signals overlapped with those characteristic for the 
carbohydrate residues. TLC showed two spots, one for a major isomer and the 
other for a minor isomer with other unidentifiable species, leading to the 
inference that, as anticipated, the mixture includes two isomers.  
Isolation and purification these two isomers were undertaken by silica gel 
column chromatography using EtOAc: Pet. ether (2:1) as eluent. The 1H NMR 
spectrum of the major isomer showed four resonances for the aromatic ring 
protons of the calix[4]resorcinarene highlighting the fact that the resorcinol 
residues are in two different environments. Two singlets were observed for the 
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methine bridge protons at 5.47 and 5.56 ppm (Figure 28), which was in 
agreement with spectrum of a previously described chair conformer of 
calix[4]resorcinarene by Hogberg (Hogberg 1980). The structure of 137a is also 
supported by mass spectrometry analysis. The spectrum gave molecular ion at 
m/z 1386.5177 that corresponds to (M+2NH4)
2+. (Expected: m/z 1386.5179) 
(Appendix 5). The crystal structure for the major conformational isomer has 
been obtained Curtis 1998, and shows clearly that the tetraglucosylated 
calix[4]resorcinarene has the rctt chair configuration displaying the substituents 
on the methine bridges. The consequence of this is that the carbohydrate 
residues are displayed outwards from the central hydrophobic core of the 

















Figure 28: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 




Figure 29: A view of the structure of the fully acylated major isomer of 4-
glucosyl calix[4]resorcinarene derived from Xray crystallography (Curtis 1998)  
The minor isomer was isolated in lower yield 4% following purification in 
comparison with the major isomer which was obtained in 40% yield after 
purification. The 1H NMR analysis showed four singlets for the protons in the 
resorcinol units and a single doublet resonance for the methine bridge protons. 
This data exhibit that, as previously reported for compounds with aromatic rings 
substituted on the methine bridges, the minor product has the rccc isomer 





The structure of 137b is also supported by mass spectrometry analysis. The 
spectrum gave molecular ion at m/z 1386.5170 that corresponds to (M+2NH4)
2+. 
(Expected: m/z 1386.5179) (Appendix 6). Notably, the crystal structure of this 
compound had not been obtained, but is expected to be a C2v symmetric 
flattened boat, as noticed from the resonance of the aromatic rings of the 















Figure 30: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 
calix[4]resorcinarene glucoside octabutyrate 137b (minor isomer) in CDCl3 
 
2.2.4 Synthesis of calix[4]resorcinarene glucoside 146 
The synthesis of the calix[4]resorcinarene glucoside 146 was carried out 
according to the general procedure from the tetraacetoxyglucoside of 3-
hydroxybenzaldehyde (Figure 31) and resorcinol in a 1:1 molar ratio using AlCl3 
solution in nitrobenzene as a catalyst. The reaction time needed for the 
formation this compound was longer than that for compound 145 and extended 
from 48 to 72 h. Isolation and purification of this tetravalent glycocluster was 
conducted in two stages, using column chromatography eluting with DCM: 
MeOH (4.5:0.5), then using chromatotron chromatography eluting with DCM: 
MeOH: EtOAc (4:0.4:0.6), which furnished pure material of the title compound. 
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A similar result was also obtained using preparative TLC. The 1H NMR 
spectrum (d6-acetone) presented three equivalent singlets in the region 
5.50-5.63 ppm for methine bridge protons referring to the presence of only one 
isomer (Figure 32). The structure of 146 is also supported by mass 
spectrometry analysis. The spectrum gave molecular ion at m/z 1106.3500 that 
corresponds to (M+2NH4)
2+. (Expected: m/z 1106.3506) (Appendix 2). 
 
Figure 31: 1H NMR spectrum of tetraacetoxyglucoside of 3-





Figure 32: 1H NMR spectrum of calix[4]resorcinarene glucoside 146 recovered 
after chromatotron chromatography in d6-acetone 
The direct acylation of the crude calix[4]resorcinarene glucoside 146 was 
performed according to the general procedure used for butyration of compound 
145. TLC of the crude octabutyrated mixture showed one major spot with other 
spots for the starting material and unknown compounds, on separation by silica 
gel column chromatography using EtOAc: Pet. ether (2:1) as eluent. The 1H 
NMR spectrum of the major fraction showed a single doublet resonance for the 
protons at the methine bridges at 5.48 ppm (Figure 33). The structure of 147 is 
also supported by mass spectrometry analysis. The spectrum gave molecular 
ion at m/z 1386.5181 that corresponds to (M+2NH4)
2+. (Expected: m/z 









Figure 33: (a) 1H NMR and (b) 13C NMR spectra of calix[4]resorcinarene 
glucoside octabutyrate 147 in CDCl3 
 
2.2.5 Synthesis of calix[4]resorcinarene glucoside 148 
The synthesis of the calix[4]resorcinarene glucoside 148 proceeded similarly to 
compounds 145 and 146 but starting from the tetraacetoxyglucoside of 2-
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hydroxybenzaldehyde (Figure 34) and resorcinol in 1:1 molar ratio using AlCl3 
solution in nitrobenzene as a catalyst. The reaction time extended for 72 h to 
give this compound in a low yield 22%. The 1H NMR spectrum of the crude 
mixture was complicated and it was difficult to characterise the resonance of 
the methine bridge protons or the number of isomers obtained for this 
compound. Many attempts had been employed to separate the pure 
calix[4]resorcinarene glucoside but eventually column chromatography eluting 
DCM: EtOAc: 2-propanol (4:0.5:0.35) followed by preparative TLC using DCM: 
MeOH (4.5:0.5) as eluent furnished one isomer of this compound as identified 
by 1H NMR spectrum (Figure 35). The structure of 148 is also supported by 
mass spectrometry analysis. The spectrum gave molecular ion at m/z 
1106.3497 that corresponds to (M+2NH4)
2+. (Expected: m/z 1106.3506) 





Figure 34: 1H NMR spectrum of tetraacetoxyglucoside of 2-





Figure 35: 1H NMR spectrum of calix[4]resorcinarene glucoside 148 recovered 
after preparative TLC in d6-acetone 
Acylation of the crude precipitate 148 prepared directly without preceding 
purification was carried out depending upon the procedure had already been 
described for acylation of compounds 145 and 146. The TLC showed one major 
spot and other light spots for unknown compounds, column chromatography 
was performed using EtOAc: Pet. ether (2:1) as eluent. The 1H NMR spectrum 
of the major isolated fraction showed doublet peak for the bridging hydrogens 
resonating at 5.80 ppm. Four singlets in the region 5.92-7.35 ppm 
characteristics for the aromatic protons in the macrocycle, therefore, similarly to 
previously obtained data is expected that this octaester has also the rctt chair 
diastereoisomer with C2h symmetry (Figure 36). The structure of 149 is also 
supported by mass spectrometry analysis. The spectrum gave molecular ion at 
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m/z 1386.5182 that corresponds to (M+2NH4)
2+. (Expected: m/z 1386.5179) 











Figure 36: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 
calix[4]resorcinarene glucoside octabutyrate 149 in CDCl3 
 
2.3 Synthesis of novel calix[4]resorcinarene galactoside  
A three step procedure was formulated for the synthesis of galactose bearing 
calix[4]resorcinarene required bromination of the commercial 1,2,3,4,6-penta-O-
acetyl-β-D-galactose 150 by the protocol described in the literature (Mitchell et 
al., 2001). Then, 2,3,4,6-tetra-O-acetyl-α-bromo-D-galactopyranose 151 was 
reacted with 4-hydroxybenzaldehyde under similar conditions to that described 
for glucosylation of compounds 139-141, to furnish the corresponding 
acetylated glycosidic aldehyde 152 in 74% after purification using column 




The beta galactoside was obtained as a major product under these conditions 
(Scheme 38).  
 
Figure 37: 1H NMR spectrum of tetraacetoxygalactoside of 4-
hydroxybenzaldehyde 152 in CDCl3 
 




It has been reported that calix[4]resorcinarene bearing methoxy substituents 
can be prepared by BF3.Et2O catalysis condensation of 3-alkoxy phenol or 1,3-
dimethoxybenzene with different aldehydes to form calix[4]resorcinarene 
tetraalkyl or octaalkyl ethers (McIldowie et al., 2000; Boxhall et al., 2003; 
Ogoshi et al., 2009).  
Therefore, in our study, we wished to synthesise the novel tetrameric 
calix[4]resorcinarene bearing galactose motifs using boron trifluoride BF3.Et2O 
as Lewis acid catalysis. By coupling resorcinol to compound 152 in Et2O as 
solvent, yielded the desired compound as yellow crystals after 24 h of reaction 
at r.t (Scheme 39). 
This reaction proceeded smoothly and faster than using AlCl3 as a catalyst for 
glucosylated calix[4]resorcinarene precursors. Additionally, the 1H NMR and 
13C-NMR of the crude product, were clearer and less complex than that usually 
seen for those compounds due to trap the nitrobenzene and the solvent used in 
the extraction step which is normally occurs by the cavity of 










Reagents and conditions: (i) BF3.Et2O, 24 h, Et2O (ii) butyric anhydride, 
pyridine, heating at 80 0C overnight  





The 1HNMR spectrum in (d6-acetone) showed characteristic signals of acetyl 
groups 1.94-2.24 ppm, characteristic signals for the glucose hydrogens 4.19-
4.55, 5.18-5.66 ppm, methine bridge units between the aromatic rings at 5.71, 
5.80 and 5.86 ppm, the fragments of the resorcinol units were confirmed in the 
spectrum with a chemical shift among 6.08-6.65; 7.28-7.81 ppm, and the 
aromatic protons of substituted glucose 6.72-7.13 ppm. These results led to the 















Figure 38: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 
calix[4]resorcinarene galactoside 153 (mixture of two isomers) in d6-acetone 
The calix[4]resorcinarene 153 was exposed to acylation conditions identical to 
those applied for compounds 145, 146 and 148. Generating mixture of two 
octaester-tetra(galactophenyl)calix[4]resorcinarenes 154a and 154b as 
identified by the 1HNMR analysis of this mixture in CDCl3, and appearance of 
three non-equivalent signals 5.96-6.21 ppm for the aromatic core protons of the 
macrocyclic. However, signals for the hydrogens at the methine bridges were in 
the characteristic range of the galactose protons, and was difficult to assign 





The TLC of the crude mixture was done prior to separation by column 
chromatography using EtOAc: Pet. ether (1.5:1) as eluent, and showed clearly 
the presence of two spots in close proximity to each other for a major and for a 
minor isomer, in addition to other light spots for unknown compounds.  
The major diastereoisomer product was isolated in 14% yield, the 1H NMR in 
CDCl3 showed the presence of four signals for the aromatic hydrogens of 
resorcinol units (6.10, 6.29, 6.94, 7.04 ppm) and two singlets for the hydrogen 
atoms at the methine bridges at 5.46 and 5.58 ppm (Figure 39). The structure 
of 154a is also supported by mass spectrometry analysis. The spectrum gave 
molecular ion at m/z 1386.5188 that corresponds to (M+2NH4)
2+. (Expected: 
m/z 1386.5179) (Appendix 9).  
The minor isomer was obtained in 5% yield after column chromatography, the 
1H NMR showed single doublet resonance for the bridging hydrogens at 5.37 
ppm and single peaks for each pair of the aromatic hydrogens of resorcinol 
units (5.97, 6.29, 6.89, 6.92 ppm) and a pair of doubles for pendant aromatic 
substituents (Figure 40). The structure of 154b is also supported by mass 
spectrometry analysis. The spectrum gave molecular ion at m/z 1386.5188 that 
corresponds to (M+2NH4)
2+. (Expected: m/z 1386.5179) (Appendix 10).  
As expected the 1H and the 13C NMR spectra of both calix[4]resorcinarenes 
functionalised with glucoside or galactoside residues were similar in case the 
protons and carbon signals for the resorcinol and the aromatic groups for both 
isomers, except the appearance of resonances for the carbohydrate residues 
were different. Each pair of octabutyrates showed almost corresponding 
infrared and mass spectra, but their Rf values on TLC, melting points and the 
1H 











Figure 39: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 












Figure 40: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 
calix[4]resorcinarene galactoside octabutyrate 154b (minor isomer) in CDCl3 
After success in preparing a series of calix[4]resorcinarenes bearing 
monosaccharide- containing fragments in the lower rim, we transferred our 
attention to the synthesis of corresponding glycocalix[4]resorcinarenes in which 
disaccharide units are linked to the lower rim of the macrocycle.  
The synthesis of these glycoclusters was based on our previous experience of 
the condensation of resorcinol with glycosylated benzaldehydes in the presence 
of a Lewis acid, in which the hydroxyl units of the carbohydrates are protected 




Amongst the methods described in the literature for the synthesis of 
glycosylated benzaldehydes include reaction of the corresponding 
acetobromodisaccharide with hydroxyl-benzaldehydes in the presence of NaOH 
in acetone. A low yield was obtained using this procedure, even when using 
prolonged reaction times (Driaf et al., 1996).  
Other methods to prepare these compounds are also commonly used in which 
4-(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-lactosyloxy)benzaldehyde was prepared 
by reaction of peracetylated lactosyl bromide with hydroxy benzaldehydes using 
phase transfer catalysis. This reaction proceeded either by using a two phase 
system of (1:1) water-chloroform in the presence of aqueous Na2CO3 or NaOH 
and using tetrabutyl- or tetraoctylammonium bromide as catalyst, or by using 
DCM as solvent instead partitioned with a saturated aqueous solution of K2CO3. 
These methods required heating in some cases or stirring from 3 h to overnight 
to give the required compound (Wen et al., 2008).  
4-(2’,3’,6’,2’’,3’’,4’’,6’’-Heptaacetyl-β-D-cellobiosyloxy)benzaldehyde has been 
reported as being prepared by treatment of 4-hydroxybenzaldehyde with 
2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-cellobiosyl bromide in DCM using 5% 
aqueous solution of NaOH and tetrabutylammonium bromide as catalyst. The 
required compound was obtained after 3 days of stirring at room temperature 
(Griesbeck et al., 2011).  
In our study we wanted to prepare per-acetylated disaccharides conjugated 
with benzaldehydes at the anomeric position using the Koenigs-Knorr method. 
The linker preparation began with the bromination of per-acetylated 
carbohydrates according to a procedure described in the literature (Mitchell et 
al., 2001). In the presence of silver(I) oxide and MeCN as solvent, 
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2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-lactosyl bromide 156 reacted with 4-
hydroxybenzaldehyde in 1:1 molar ratio. The reaction was complete as shown 
by TLC monitoring and the mixture was subsequently subjected to purification 
using flash chromatography to give the corresponding glycoside 157 as white 
crystals in a reasonable yield of 60% (Figure 41).  
 
Figure 41: 1H NMR spectrum of heptaacetoxylactoside of 4-
hydroxybenzaldehyde 157 in CDCl3 
 
2.4 Synthesis of calix[4]resorcinarene lactoside 158 
Preparation of tetra(4-lactophenyl)calix[4]resorcinarene through Lewis acid 
catalysed condensation using an equimolar ratio of resorcinol to 4-
(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-lactosyl)benzaldehyde was carried out in a 
15:10 mixture of Et2O and THF at r.t. in a similar manner to that described for 
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compound 153 (Scheme 40). The product was characterised using usual 
methods, including 1H NMR, 13C NMR, DEPT135 and HSQCDEPT.  
The 1H NMR spectrum in d6-acetone shows, as previously noticed for large 
pendant fragments, characteristic multiplet signals for aromatic groups between 
6.51-7.20 ppm, characteristic signals for protons in the resorcinol units between 
5.88-6.43; 7.28-7.70 ppm, doublet peaks for the methine bridge hydrogens 5.74 
ppm, characteristic signals for lactose residues between 3.97-5.45 ppm and the 
acetyl groups between 1.88-2.22 ppm (Figure 42).  
The 13C NMR spectrum in d6-acetone showed a significant signal at 41.9 ppm 
which confirmed the existence of methine bridge residues between the aromatic 
rings, and the aromatic carbons of resorcinol units appeared at 153.3, 153.1, 
132.0, 102.4 and 102.2 ppm. Signals at 130.0, 129.7, 115.6 and 115.3 ppm 








Reagents and conditions: (i) HBr/AcOH, DCM, (ii) Ag2O, MeCN, 5 h (iii) 















Figure 42: (a) 1H NMR, (b) 13C NMR and (c) DEPT135 spectra of 
calix[4]resorcinarene lactoside 158 in d6-acetone 
The lactose-functionalised glycocluster 158 was subjected to an acylation 
reaction utilising a mixture of butyric anhydride and pyridine, producing the 
octabutyrate- of tetra(4-lactophenyl)calix[4]resorcinarene 159. TLC analysis of 
the crude mixture suggested the presence of two isomers by the presence of 
two spots (major and minor), the same result was estimated from the 1H NMR 
spectrum which showed three non-equivalent signals in the region in the 
spectrum 5.83-6.02 ppm that contains resonances for the aromatic core protons 
as usually observed from the crude mixture of calix[4]resorcinarene precursors 
with 4-substituent aromatic rings at the methine bridges. However, upon 
purification by column chromatography using EtOAc: Pet. ether (3:1) as eluent 
and identification of the recovered compounds after column, the result was 
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expected: one major isomer was obtained as indicated by the presence of two 
resonances for protons at methine bridges 5.38 and 5.49 ppm, four signals with 
chemical shift 5.82, 5.90, 6.01 and 6.22 ppm with three singlet resonances 
between 6.88-6.91 ppm for the aromatic hydrogens of resorcinol units, together 
with the expected multiplet and doublet for the pendant aromatic units 6.41-6.75 
and 6.98 ppm (Figure 43). The structure of 159 is also supported by mass 
spectrometry analysis. The spectrum gave molecular ion at m/z 1962.6890 that 
corresponds to (M+2NH4)













Figure 43: (a) 1H NMR, (b) 13C NMR, (c) DEPT135 and (d) HSQCDEPT spectra 
of calix[4]resorcinarene lactoside octabutyrate 159 in CDCl3 
 
2.5 Synthesis of calix[4]resorcinarene cellobioside 163  
The synthesis of a macrocyclic carbohydrate cluster which displays four 
cellobiose residues on the lower rim was conducted by applying our previous 
synthetic methods, which have already been described.  
The synthetic route consists of three steps (Scheme 41) beginning with 
bromination of peracetylated 1,2,3,6,2’,3’,4’,6’-octa-O-acetyl-cellobiose 160, 




Reagents and conditions: (i) HBr/AcOH, DCM, (ii) Ag2O, MeCN, 5h (iii) 
BF3.Et2O, 24 h, DCM 
Scheme 41: Synthesis of calix[4]resorcinarene cellobioside 
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The glycosidation was conducted under Koenigs-Knorr conditions by 
condensation of an equimolar ratio of acetylated cellobiosyl bromide with 4-
hydroxybenzaldehyde in MeCN and Ag2O as a catalyst to produce glycoside 
162. The reaction was monitored by TLC and was completed in 5 h. The 
required compound was obtained in 62% yield after purification by column 
chromatography using EtOAc: Pet. ether (1.5:1) as eluent (Figure 44).  
 
Figure 44: 1H NMR spectrum of heptaacetoxycellobioside of 4-hydroxy 
benzaldehyde 162 in CDCl3 
Finally, the protected tetracellobiosyl calix[4]resorcinarene was synthesised 
according to the method reported in the literature (Kumar and Venkatakrishnan 
2018). By condensation of 4-(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-
cellobiosyl)benzaldehyde with resorcinol in 1:1 molar ratio and (2 eq.) of the 
Lewis acid boron trifluoride as catalyst. The reaction was worked up after 24 h 
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of stirring at r.t, affording a low yield of the corresponding compound. However, 
upon changing the solvent system to (Et2O: THF) and using the same reaction 
conditions, no macrocyclisation was observed even after stirring for 4 days. 
TLC showed the presence of the aldehyde starting material before and after 
work-up, and this was also confirmed by 1H NMR spectroscopy.   
The structure of calix[4]resorcinarene cellobioside 163 was confirmed by 1H 
NMR, 13C NMR, DEPT135 and HSQCDEPT spectroscopy experiments and 
mass spectrometry. The protons of phenyl substituents gave a pair of doublets 
at 6.61 and 6.53 ppm, protons for resorcinol units appeared as singlet at 6.13 
ppm and as a broad signal at 6.00 ppm, one singlet at 5.56 ppm, assigned to 
the methine hydrogens at the calix[4]resorcinarene bridges, while that related to 
cellobiose unit protons appeared with a chemical shift between 4.71-5.29 ppm 
and 3.84-4.49 ppm. The acetyl protons were observed as a multiplet between 
1.79-1.97 ppm. The appearance of a single resonance for the bridging 
hydrogens and for each of the aromatic resorcinol protons (H endo and H exo) 
confirms that this compound has the rccc crown conformation (Moore et al., 
2008) (Figure 45).  
13C NMR spectrum in d6-acetone displayed three signals for the aromatic 
carbon atoms at 138.9, 129.7 and 115.0 ppm, a weak signal at 130.9 ppm as 
well as sharp signals at 153.3, 121.7, 120.8 and 102.5 ppm confirmed the 
presence of resorcinol units, and the presence of methine bridge carbons 
between the aromatic rings was confirmed at 42.2 ppm (Figure 45). The 
structure of 163 is also supported by mass spectrometry analysis. The 
spectrum gave molecular ion at m/z 1682.5200 that corresponds to (M+2NH4)
2+. 



















Figure 45: (a) 1H NMR, (b) 13C NMR, (c) DEPT135 and (d) HSQCDEPT spectra 
of calix[4]resorcinarene cellobioside 163 in d6-acetone 
 
2.6 Conclusion 
Functionalisation of calix[4]resorcinarenes can be investigated from the starting 
substrates. By altering the position of the substituent residue on the aldehyde, 
the arrangement of the substituents on the lower rim of the scaffold can be 
influenced. A suitable select of reaction conditions via either prolonged 
treatment or the catalyst conferred condensation of resorcinol with a varied 
series of aldehydes bearing carbohydrate residue to form tetravalent 
calix[4]resorcinarene glucosides according to previously reported protocol. 
These cyclic tetramers display general scaffold for the design of conformational 
isomer and offer the binding of groups in a specific spatial orientation.   
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Despite the drawbacks associated with using Lewis acid for the synthesis of 
these calix[4]resorcinarenes, of low outcome yield, long reaction time and 
fatigued isolation of the calix[4]resorcinarene glucoside products, successful 
attempts had been made using flash column chromatography, preparative thin 
layer chromatography and the chromatotron chromatography to separate the 
conformational isomers resulted during these syntheses from the crude mixture 
before acylation.  
All of the calix[4]resorcinarene glucosides was derivatised in the upper rim as 
their octabutyrates, two previously known isomeric compounds (major and 
minor isomers) 137a and 137b of calix[4]resorcinarenes based 
tetraacetoxyglucoside of 4-position of pendant aromatic unit were isolated. One 
isomer of each calix[4]resorcinarene based tetraacetoxyglucoside of 3- or 2-
position on the aromatic group, were also isolated as their octabutyrates 147 
and 149.  
Another analogue compound of calix[4]resorcinarene bearing galactoside 
glycocluster was introduced to this family of macrocycles and synthesised using 
different Lewis acid (BF3.Et2O). It was found that this Lewis acid which 
catalysed such reactions was facile and valuable procedure of gaining 
macrocycles in a shorter reaction time. This reaction generated two isomers 
which were separated as their octaester into major 154a and minor 154b 
isomers.   
Two new tetravalent lactose and cellobiose functionalised 
calix[4]resorcinarenes were synthesised using the reaction of substituted 
benzaldehyde glycosides in a stepwise synthetic route. Using a mixture of Et2O 
and THF as reaction solvent and a Lewis acid catalyst (BF3.Et2O), conditions 
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previously used for the synthesis of the calix[4]resorcinarene galactoside, the 
lactose calix[4]resorcinarene was accessed, but this was not effective for the 
synthesis of the corresponding tetracellobiosyloxy compound. Alternative 
conditions, previously reported by Kumar and Venkatakrishnan for the 
synthesis of tetramethoxy calix[4]resorcinarenes, allowed us to synthesise the 
tetracellobiosyl glycocluster 163 in a low yield.  
Interestingly, characterisation of calix[4]resorcinarene lactoside using 
spectroscopic methods showed the presence of one conformation, isolated as 
the octabutyrate which was also delivered as one configuration as confirmed by 
NMR analysis. The synthesis of tetracellobiosyl calix[4]resorcinarene produced 
one configuration also which can be tentatively assigned to be in the rccc crown 
configuration. 
The formation of one isomer of both compounds 158 and 163 with 4-substituted 
phenyl glycosides could be due to the size of the 4-glycosylated benzaldehydes 
which cannot adopt alternative configurations upon condensation with 





























The aim of this present work was to synthesise of new calix[4]resorcinarenes 
based on a 4-glucosylated derivatives of 4-hydroxyphenyl propanal 164 and 4-
hydroxyphenyl acetaldehyde 165 (Figure 46). 
In order to synthesise glucosylated calix[4]resorcinarenes 164 and 165, a seven 
step synthesis was designed for both strategies. Starting from 3-(4’-
hydroxyphenyl)propionic acid 166 (Scheme 42), the aldehyde 167 was 
envisaged to be readily prepared in six steps. The second sequence started 
from 2-(4’-hydroxyphenyl)acetic acid 168 (Scheme 47) to prepare the aldehyde 
169 (Figure 46).  
 







The strategy was to prepare aldehydes 170 (Scheme 42) and 171 (Scheme 47) 
and conjugate each one of them with various carbohydrates to prepare a series 
of homologated glycosyloxybenzaldehydes for use in the synthesis of 
glycosylated calix[4]resorcinarenes, with the glycosylated aryl residues being 
separated from the calix[4]resorcinarene core by an alkyl spacers. The 
synthesis of tetravalent calix[4]resorcinarene glycosides would be possible by a 
condensation reaction between the glycosylated aldehydes with resorcinol and 
its derivatives (2-methylresorcinol and pyrogallol), using the same 
methodologies used previously to prepare glycosylated calix[4]resorcinarenes 
by Lewis acid catalysis.  
The novel homologous glycosylated calix[4]resorcinarenes would be butyrated 
before purification of any conformational isomers yielded was attempted.  
Unfortunately, the aldehyde fragments in 170 and 171 were unable to withstand 
reaction conditions commonly required for the synthesis of the corresponding 
glycosides. Therefore, it was decided to prepare aryl substituted 




Reagents and conditions: (i) conc. H2SO4, MeOH, reflux 24 h (ii) KI, K2CO3, 
PhCH2Cl, acetone, reflux 24 h (iii) LiAlH4, THF, 0 
0C to r.t, 2 h (iv) PCC, DCM, 0 
0C to r.t, 3 h (v) H2, Pd/C, MeOH, r.t (vi) conc. HCl, EtOH, reflux 4 h 
Scheme 42: Synthesis of tetra(4-hydroxyphenylethyl)calix[4]resorcinarenes 
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3.1 Esterification of 4-hydroxyphenylpropionic acid towards 
ester 172 
Starting from the commercially available 4-hydroxyphenylpropionic acid 166 
(Scheme 42), the corresponding ester was prepared by a Fisher esterification, 
a nucleophilic acyl substitution reaction between the acid 166 and MeOH as 
reactant and solvent. Addition of a few drops of concentrated sulfuric acid 
catalyst were required to protonate the carboxylic acid and convert it into a 
stronger electrophile to be attacked by the nucleophilic alcohol at the C=O 
bond. The mechanism is shown in (Scheme 43). Work up of this reaction gave 
the corresponding methyl ester as white crystals in a quantitative yield (Tung et 
al., 2016). The structure of the product 172 was confirmed by 1H NMR 
spectroscopy and showed appearance of methyl ester group at 3.72 ppm and 





Scheme 43: Ester production via nucleophilic acyl substitution reaction between 










3.2 Protection of methyl 3-(4’-hydroxyphenyl)propanoate 172 
Protecting the hydroxyl group on the aromatic ring is required for preparing 
compound 172 for the next step, since the subsequent nucleophilic substitution 
reactions of the phenol require basic conditions (Scheme 44). Compound 172 
was benzylated by direct reaction with benzyl chloride in the presence of 
potassium carbonate and potassium iodide, using acetone as a solvent at 56 0C 
overnight, in a similar manner to that described in the literature (Herbert and 
Kattah 1990). The reaction was monitored by TLC which showed 
disappearance of the starting material and appearance of one spot for the 
product with a higher Rf value than the starting ester. After filtration and 
evaporation the filtrate, the solid product was purified by recrystallisation from 
n-hexane to afford monobenzyl ether 173 as yellow crystals in  
83% yield.  
The 1H NMR spectrum showed peaks for the benzyl methylene protons at 5.08 
ppm and for the benzyl aromatic protons at 7.35-7.49 ppm, which agreed with 
the reference data (Herbert and Kattah 1990).  
 
Scheme 44: Nucleophilic attack on benzyl chloride 
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3.3 Reduction of methyl 3-(4’-benzyloxyphenyl)propionate 173 
Following benzylation, the ester 173 underwent reduction using LiAlH4 as 
reducing agent to furnish the protected alcohol 174 in a quantitative yield. 
Reaction completion was indicated by TLC analysis after 2 h stirring at room 
temperature, which gave one spot for the product with lower Rf value than the 
protected ester. The mechanism of such a reaction involves formation of an 
aldehyde. The aldehyde formed is a strong electrophile and cannot be isolated 
therefore it reacts with another equivalent of LiAlH4 (Scheme 45). 
1H NMR 
spectrum displayed three signals at 3.65, 2.64 and 1.85 ppm for the methylene 
protons which were matched with those previously characterised (Kantee et al., 
2016).  
 




3.4 Oxidation of 3-(4’-benzyloxyphenyI)propan-1-ol to carbonyl  
Treatment of alcohol 174 with 1.5 eq. of pyridinium chlorochromate (PCC) in 
dry dichloromethane was conducted at 0 0C (Kashanna et al., 2012). After 
stirring for 3 h at room temperature, the TLC showed disappearance of the 
starting alcohol and appearance the product spot with higher Rf value than the 
starting alcohol. After evaporation of the solvent and extraction of the black gum 
with diethyl ether, the crude aldehyde was purified by chromatography on silica 
gel using EtOAc: Pet. ether (1:4) as eluent, affording the corresponding 
aldehyde 175 as a colourless oil in a moderate yield of 58%.  
The structure of 175 was determined by spectroscopic analysis, especially the 
1H NMR spectrum which contained signals at 2.79 and 2.95 ppm for the two 
methylene groups and at 9.85 ppm for the aldehyde moiety, identical to that 
previously reported (Tadiparthi et al., 2017).  
Among various oxidizing agents, PCC was preferred because it is mild, 
commercially available and soluble in organic solvent (DCM). It is used to 
convert primary alcohols exclusively to the corresponding aldehyde with high 
efficacy and on a large scale. The only drawback associated with this reagent is 
the formation of Cr(III) complexes and pyridinium chloride as by-products which 




Scheme 46: Alcohol oxidation mechanism by PCC  
 
3.5 Hydrogenolysis of 3-(4’-benzyloxyphenyl)propanal 
The protecting benzyl ether of 3-(4’-benzyloxyphenyl)propanal 175 was 
removed under catalytic hydrogenation conditions using 5% palladium on 
charcoal as a catalyst in methanol, as shown in (Scheme 42). Reaction 
progress was monitored by TLC, which showed the protected aldehyde 
disappearing completely to give just the target compound with lower Rf value 
after stirring for 2 h at room temperature. The unprotected aldehyde 170 was 
obtained as a colourless oil in a yield of 72% after purification by column 
chromatography. The 1H NMR spectrum of 170 was identical to reference data 
(Herbert and Kattah 1990) (Figure 47).   
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Notably, the first attempt to synthesise the unprotected aldehyde using catalytic 
hydrogenation failed since it appeared that the aldehyde group had also been 
reduced along with removal of the benzyl ether moiety. This indicated that 







Figure 47: (a) 1H NMR and (b) 13C NMR spectra of 3-(4’-
hydroxyphenyl)propanal 170 in CDCl3 
Once the pure 4-hydroxyphenyl propanal had been prepared, it was then 
envisaged that it could be reacted with a variety of suitably protected 
carbohydrate moieties to give the corresponding glycosylated aldehydes. 
In an attempt to synthesise the novel tetraacetoxyglucoside of 4-hydroxyphenyl 
propanal 167, compound 170 was initially reacted with acetobromoglucose 138 
in the presence of silver(I) oxide in dry MeCN, using similar conditions to those 
employed for the glycosylation of hydroxybenzaldehydes 139-141 (Stavila et 
al., 2008). However, after stirring for 6 h at r.t, TLC analysis of the crude 
mixture suggested the presence of several new compounds. After column 
chromatography using EtOAc: Pet. ether (1:1) as eluent, the 1H NMR spectra 
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obtained of combined fractions displayed the presence of unreacted 
acetobromoglucose and a mixture of unidentifiable species. The reaction was 
repeated with the starting aldehyde in excess and a prolonged reaction time of 
24 h. Unfortunately, a similar result was obtained after column chromatography 
and analysing each component by 1H NMR spectroscopy. The reaction was 
repeated many times using different combinations of conditions but with the 
same results.  
In all cases, it is believed that the aldehyde 170 was oxidised under the reaction 
conditions to yield the corresponding acid (Tu et al., 1995). 
The literature suggests that conversion of hydroxyaryl aldehydes to their 
corresponding β-glucosides can be achieved in a short reaction time under 
Koenigs-Knorr conditions using quinoline as a solvent. Therefore, it was 
decided to attempt this protocol in which compound 170 was reacted with 
acetobromoglucose in the presence of Ag2O in quinoline for 25 min at r.t 
(Belyanin et al., 2012). The reaction mixture was then suspended in a mixture 
of EtOAc and 1 M HCl. Work up this experiment afforded a mixture of many 
compounds as suggested by TLC analysis. After flash chromatographic 
separation using EtOAc: Pet. ether (1.5:1) as eluent and analysing the fractions 
by 1H NMR spectroscopy, one fraction was suggested to contain the desired 
product but mixed with another compound, potentially being the glycosylated 
alcohol. However, we were unable to separate this mixture further, even by 
preparative TLC. This experiment was repeated twice with substrate 170 in 
excess and for 2 h reaction time but similar results was obtained after 
separation by column chromatography as evidenced by 1H NMR spectroscopy.  
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Another attempt at the Koenigs-Knorr reaction using a different substrate was 
attempted. Bromoacetylated lactose 156 and 4-hydroxyphenyl propanal 170 
were subjected to the reaction conditions using MeCN as a solvent, but again 
the desired aldehyde was not obtained using this protocol.  
As a result of the obvious problems associated with employing the Koenigs-
Knorr method in our hands, various other processes were considered to 
prepare compound 167. It was decided to attempt synthesis of this glycoside 
using Hunig’s base (Sultana et al., 2006). Compound 170 was treated with an 
equimolar amount of acetobromoglucose and 10 eq. of diisopropylethylamine 
(Hunig’s base) in dry MeCN. After 48 h stirring at r.t, the excess solvent was 
removed azetropically with toluene. No reaction was observed, again as 
indicated by 1H NMR spectroscopy of the crude material. 
It was then decided to attempt the synthesis of the aromatic glycoside 167 
using phase transfer catalysis. In this way, compound 170 was reacted with 
acetobromoglucose 138 in the presence of a vigorously stirred aqueous 
solution of NaOH and tetrabutylammonium bromide (TBAB) in CHCl3 (Mohri et 
al., 2003). After being stirred for 5 h at r.t., TLC analysis showed the presence 
of three different new spots with lower Rf value than the starting aldehyde, It 
was believed that the reaction has proceeded to yield the desired compound, 
but after column chromatography and 1H NMR analysis of each group of 
fractions separated, a complex mixture of glycosides and aromatic compounds 
was obtained, with several different aldehydes being isolated in small amounts 
from the group of fractions obtained. Similar results were afforded upon 
repeating the reaction several times using DCM as a solvent with stirring for 3 
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days at r.t. (Chen et al., 2012) or using K2CO3 instead of NaOH in DCM (Wang 
et al., 2007).  
Further attempts at the glycosylation of 170 with acetobromoglucose using 
different reported procedures were unsuccessful, including using a 4% aqueous 
solution of KOH and 4-dimethylaminopyridine (DMAP) in DCM (Xiang et al., 
2006) or reaction in the presence of K2CO3 in dry acetone and dry DMF 
(Olsufyeva et al., 2003).  
 
3.6 Synthesis of tetra(4-
hydroxyphenylethyl)calix[4]resorcinarenes 
In order to explore the reactivity and stability of 4-hydroxyphenyl propanal 170 
under cyclooligomerisation reaction conditions, we decided to subject 
compound 170 to cyclisation with resorcinol utilising two different experimental 
methods: 
Firstly, a mixture of equimolar amounts of the initial substrates was heated 
under reflux in the presence of concentrated HCl in EtOH, in a manner similar 
to that reported by Pfeiffer et al. (Pfeiffer et al., 2016). The product was 
precipitated from the reaction mixture using ice cold water to give the 
calix[4]resorcinarene 176 in 21% yield.  
Analysis of the product by 1H NMR spectroscopy showed two broad peaks at 
8.57 and 8.19 ppm, corresponding to two kinds of phenolic hydroxyl groups in 
the upper and the lower rim. The characteristic signals of the ethyl link protons 
at 2.51-2.60 ppm and a one triplet at 4.38 ppm attributed to the hydrogen atoms 
at the methine bridges were also observed (Figure 48). This spectral pattern 
confirmed the structure was in the rccc (crown conformation), similarly to that 
previously synthesised and reported by other authors from different aldehydes 
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(Tunstad et al., 1989; Victorovna-Lijanova et al., 2008; Serkova et al., 2018). 
The structure of 176 is also supported by mass spectrometry analysis. The 
spectrum gave molecular ion at m/z 967.3693 that corresponds to (M-H)-. 
(Expected: m/z 967.3693) (Appendix 12).  
The second method used AlCl3 solution in nitrobenzene as Lewis acid catalyst 
in dry Et2O, conditions identical to those used for the synthesis of compound 
145 under our standard conditions. Similarly to the above mentioned data, the 
1H NMR spectrum indicated one triplet at 4.38 ppm assigned to the methine 







Figure 48: (a) 1H NMR and (b) 13C NMR spectra of tetra(4-
hydroxyphenylethyl)calix[4]resorcinarene 176 in d6-acetone 
Reaction of compound 170 with 2-methylresorcinol and pyrogallol under protic 
acid-catalysed conditions also gave only the rccc isomer in the crown 
conformer, as indicated by 1H and 13C NMR spectroscopy. Each group of 
signals for compounds 177 and 178 in their NMR spectra appear as a single 
resonance, this is an indicative of highly symmetric structures in the cone 
conformation (Figure 49 and 50). The structure of 177 is also supported by 
mass spectrometry analysis. The spectrum gave molecular ion at m/z 
1023.4313 that corresponds to (M-H)-. (Expected: m/z 1023.4319) (Appendix 
13). A satisfactory mass spectrum could not be obtained for 178 due to 













Figure 49: (a) 1H NMR and (b) 13C NMR spectra of tetra(4-














Figure 50: (a) 1H NMR and (b) 13C NMR spectra of tetra(4-
hydroxyphenylethyl)calix[4]pyrogallolarene 178 in d6-acetone 
 
3.7 Preparation of 4-hydroxyphenyl acetaldehyde  
4-Hydroxyphenyl acetaldehyde was prepared as described in (Scheme 47). 
The synthetic sequence started from the commercially available  
4-hydroxyphenylacetic acid 168, by adopting analogous experimental 
conditions described for the esterification of 166. Thus, compound 168 was 
treated with MeOH and sulfuric acid at 70 0C to give the known methyl ester 





Reagents and conditions: (i) H2SO4, MeOH, reflux 24 h (ii) KI, K2CO3, PhCH2Cl, 
acetone, reflux 24 h (iii) LiAlH4, THF, 0 
0C to r.t, 2 h (iv) Dess-Martin 
periodinane, DCM, 0 0C to r.t, 24 h (v) H2, Pd/C, MeOH, r.t, 24 h (vi) SO3-
Pyridine, DMSO, TEA, r.t, 1 h 







The phenolic hydroxyl group of methyl 2-(4’-hydroxyphenyl)acetate 179 was 
subsequently protected by benzylation. Such protecting group has been 
previously used in the context of methyl 3-(4’-benzyloxyphenyl)propionate 
synthesis. Treatment of 179 with benzyl chloride and anhydrous potassium 
carbonate in acetone under reflux conditions gave the protected 2-(4’-
benzyloxyphenyl)acetate 180. Compound 180 was obtained as yellow crystals 
in 64% yield after recrystallisation from n-hexane.   
Reduction of 180 was accomplished in the same manner as for compound 173, 
with LiAlH4 in THF to obtain 2-(4’-benzyloxyphenyl)ethanol 181 as an off-white 
solid in 93% yield.    
In our previous synthetic strategy, we demonstrated that oxidation of alcohol 
174 to aldehyde 175 by a PCC oxidation proceeded smoothly. Here, we 
expected that reaction of 2-(4’-benzyloxyphenyl)ethanol with 1.5 eq. of PCC 
would produce the expected aldehyde 182. Surprisingly, the Corey-Suggs 
oxidation did not convert the alcohol 181 completely to the aldehyde 182 even 
after stirring for 24 h at r.t. as shown by TLC analysis. We were unable to 
separate the components of the reaction mixture by recrystallisation or by 
column chromatography. It appeared that the cleavage of a C-C bond had 
occurred (Scheme 48), as reported possible in the literature (Fernandes and 
Kumar 2003). The product mixture was proved by 1H NMR analysis where two 






Scheme 48: Synthetic endeavour by PCC oxidation (Fernandes and Kumar 
2003)  
Previously reported synthetic methods have shown that alcohols with a similar 
structure to the alcohol 181 could be oxidised selectivity to the aldehyde 182 
using the Dess-Martin periodinane (DMP) as mild oxidant (Tilley et al., 2012). 
Compound 181 treated with DMP in DCM from 0 0C to r.t. for 24 h. The reaction 
mixture was quenched by washing with saturated aqueous solutions of 
NaHCO3 and Na2S2O3 to yield the corresponding aldehyde 182 as a pale yellow 
oil in 71% yield (Scheme 49).   
 
Scheme 49: Alcohol oxidation mechanism by Dess-Martin Periodinane (DMP) 
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The structure of the product was confirmed by 1H NMR spectroscopy where the 
benzylic methylene protons were characteristic at 5.11 ppm and the aldehyde 
proton appeared as triplet at 9.76 ppm (Nadkarni et al., 2013).   
An initial attempt to synthesise the target compound 171 by debenzylation of 
182 using 5% Pd/C and H2 gas in MeOH, failed to cleave the C-O bond after 48 
h stirring at r.t. It was noticed that the majority of literature syntheses of the 
target compound 171 and analogues was by oxidising 4-hydroxyphenyl ethanol 
183. Therefore, it was decided to reattempt deprotection of 4-benzyloxyphenyl 
ethanol 181 using conditions previously reported by Fernandez-Pastor et al. 
(Fernandez-Pastor et al., 2016) Under these conditions, debenzylation of 181 
was performed under catalytic hydrogenation again using 5% Pd/C in MeOH, 
with the derivative 4-hydroxyphenyl ethanol 183 being produced with a very 
good yield of 97%.  
As a result of being this alcohol 183 being insoluble or slightly soluble in DCM, 
PCC or Dess-Martin oxidation were excluded in this state. The previously 
reported Parikh-Doering oxidation of 4-hydroxyphenyl ethanol 183 
(Pyridine.SO3, DMSO, Et3N) (Vece and Vuocolo 2015) (Scheme 50) eventually 
afforded, after flash chromatography, the target aldehyde 171 as a colourless 
oil in low yield 33% (Figure 51).  
The attractive feature of this reaction is that it proceeds rapidly and reaches 
completion after 30 min at r.t. The corresponding 4-hydroxyphenyl 
acetaldehyde 171 and 4-hydroxybenzaldehyde 139 were obtained after the 
reaction was left stirring for more than an hour. It is important to note that 
aldehyde 171 is also highly unstable and cannot be stored; therefore, it should 
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be used directly after synthesis. A similar finding was observed by Zhao et al. 
(Zhao et al., 2016). 
 








Figure 51: (a) 1H NMR and (b) 13C NMR spectra of 4-hydroxyphenyl 
acetaldehyde 171 in CDCl3 
An endeavour to prepare the glycoside of aldehyde 169 was unsuccessful and 
has not been reported here. 
  
3.8 Conclusion 
The two different synthetic approaches chosen to prepare glycosylated 
calix[4]resorcinarenes containing alkyl chains separating the aromatic residues 
from the lower rim of the molecule (Figure 46), failed to achieve this goal and 
several problems were encountered.  
Despite various protocols at the synthesis of glucosylated aldehyde 167 derived 
from 4-hydroxyphenyl propanal had to be applied to synthesise the novel 
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aldehyde, but these were unsuccessful as 1H NMR spectroscopy of different 
attempts of this synthesis suggesting the existence of either starting materials 
or producing different species.  
Nevertheless, the synthesis of new substituted calix[4]resorcinarenes 176-178 
from 4-hydroxyphenyl propanal was largely successful and leads to the 
formation of intentionally desired rccc isomer.  
The second synthetic sequence (Scheme 47) followed to prepare the novel 
aldehyde 169 faced lots of problems which arose during the transformation 
between compounds and consequently, led to an aldehyde 171 was found to 


































In 1989 Cram and co-workers reported the cyclisation of aliphatic aldehydes 
functionalised with a benzene ring: this was conducted using equimolar 
quantities of resorcinol and the aldehyde catalysed by concentrated aqueous 
HCl in an ethanolic aqueous solution at 25 0C with for 24 h or longer. Only the 
C4 symmetric isomer was isolated from reaction with dihydrocinnamaldehyde, 
phenylethanal, 4-nitrodihydrocinnamaldehyde and 4-
bromodihydrocinnamaldehyde (Figure 52) (Tunstad et al., 1989).  
 
Figure 52: Calix[4]resorcinarenes functionalised with alkyl bridges containing 






Calix[4]resorcinarenes bearing bromine substituents at the 2-position 191 have 
been synthesised by bromination of calix[4]resorcinarenes and have been used 
extensively as building blocks for the construction of molecules with an 
enforced closed shell such as cavitands and carcerands (Bryant et al., 1991; 
Ugono et al., 2008). Morikawa et al. reported the direct synthesis of these 
compounds by cyclocondensation of an equimolar ratio of 2-bromoresorcinol 
189 and phenylpropionaldehyde 190 in MeCN catalysed by trifluoromethane 
sulfonic acid (CF3SO3H) (9:1 v/v) (Scheme 51). The product that precipitated 
under standard conditions was the rccc isomer exclusively. The 
stereochemistry of the alkyl substituents was confirmed by comparison of its 1H 
NMR spectra with that of an authentic sample. The cyclic tetramer showed one 
signal for the methine bridges and one signal for the intraannular aromatic 
proton, thus confirming that it existed in the rccc cone conformation (Morikawa 
et al., 2002).      
 




Thankar et al. reported the synthesis of tetramethoxy calix[4]resorcinarene by 
the interaction of 3-alkoxyphenol 45 with dihydrocinnamaldehyde 190 using 
BF3.Et2O as a Lewis acid catalyst (Scheme 52). In this case, the asymmetry is 
derived from the stereogenic axis and not from the stereogenic center. By using 
the process as previously reported by McIldowie et al. they obtained a racemic 
mixture in a good yield, and the predominate isomer possessed the C4 
symmetry or rccc configuration (Thakar et al., 2014). 
 
Scheme 52: Synthesis of tetramethoxy calix[4]resorcinarene as a racemic 








The development of vehicles to aid in the solubilisation of hydrophobic drugs in 
aqueous media depends not only on the interaction between the water-hating 
cavity of calix[4]resorcinarenes (host) and the drug molecules (guest), but also 
on the groups attached at the rims of the host and the size of the drug 
molecules. In some cases the starting aldehyde used or the addition of 
particular groups to the calix[4]resorcinarene can cause the host molecules to 
aggregate in solution and form large capsule-like structures. In this case, the 
drug molecule can become encapsulated inside the capsule or associate in 
some other, unexpected way.  
The aim of the work described in this chapter is to determine the effect of using 
an glycosidic aliphatic aldehyde on the isomer ratios and conformation of the 
product calix[4]resorcinarene. In particular, by using substituted 
phenylpropanal, products which are similar to those exploited by Cram et al. 
may be obtained. The five-step strategy for the synthesis of 
tetra(glucosyloxyphenylethyl)calix[4]resorcinarene octabutyrate 196 is shown in 
(Scheme 53): 2,3,4,6-tetra-O-acetyl-β-D-glucosylated 4-hydroxybenzaldehyde 
142 was prepared from 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl bromide 138 
and 4-hydroxybenzaldehyde 139 according to procedure stated beforehand 
(page 100, Scheme 34) (Stavila et al., 2008).  
Compound 142 was used as the starting material in the synthesis of 3-[4’-
(2’’,3’’,4’’,6’’-tetra-O-acetyl-β-D-glucopyranosyloxy)phenyl]propanal 167 for the 
synthesis of compound 164. The process for the synthesis of glycosidic 
aldehyde with alkyl chain 167 was carried out according to the general 
procedure for hydrogenation. Subsequent reaction with resorcinol delivered the 




Reagents and conditions: (i) phosphonium salt 193, KOtBu, THF, reflux, 24 h (ii) 
Br2, CCl4, HOAc, H2O, 0 
0C to r.t (iii) H2, Pd/C 5%, MeOH (iv) anhyd AlCl3, 
Et2O, THF, 48 h, r.t (v) butyric anhydride, pyridine, 80 
0C, 24 h  




4.2 Synthesis of 2-{2’-[4’’-(2’’’,3’’’,4’’’,6’’’-tetra-O-acetyl-β-D-
glucopyranosyloxy)-phenyl]ethenyl}-1,3-dioxolane 194 
Vinylogation of tetra-O-acetyl glucoside of 4-hydroxybenzaldehyde 142 using 
1,3-dioxolane-2-ylmethyltriphenylphosphonium salt 193 was conducted using 
two different methods. The first method employed followed the literature 
method described by Daubresse (Daubresse et al., 1998) under phase transfer 
conditions by mixing the aldehyde (1 eq) with TDA-1 {tris[2-(2-
methoxyethoxy)ethyl]amine} (1 eq) and the phosphonium salt (1.22 eq) 193 in a 
refluxing emulsion of saturated aqueous K2CO3 solution and DCM. This 
reaction was worked up by quenching with water and extraction with DCM, the 
organic layer was then washed with aqueous hydrochloric acid led to deliver 
α,β-unsaturated 1,3-dioxolane 194 in 5% yield.  
The Wittig reaction following the method of Daubresse et al. led to the formation 
of compound 194 in a low yield which was not sufficient to complete the 
planned strategy for the synthesis of calix[4]resorcinarene glycocluster. 
Therefore, following other literature precedent, it was decided to select different 
conditions for the Wittig reaction. Compound 194 was produced by treatment of 
4-glucosylated benzaldehyde 142 with phosphonium salt 193 and potassium 
tert-butoxide in THF (Ka et al., 2016). After refluxing the mixture at 70 0C for 24 
h, styryl-1,3-dioxolane glucoside 194 was obtained with a slightly improved 
yield of 25%.  
Unfortunately, the yield obtained from a single reaction under these conditions 
was also inadequate to complete four more steps. Therefore, the reaction was 
repeated 26 times in order to obtain a sufficient amount.  
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The structure of the crude dioxolane 194 was confirmed by 1H NMR spectra 
which indicated a Z/E ratio of approximately 66:34 (first method) and 55:45 
(second method). In all cases the TLC of the crude reaction mixture showed 
two spots in close proximity to each other indicating two isomers with nearly the 
same Rf as for the starting glucosylated aldehyde. The purification was 
conducted on flash column chromatography using EtOAc: Pet. ether (1.5:1) as 
eluent. The 1H NMR after purification contained signals at 3.93-4.00 and 4.07-
4.12 ppm assigned to the methylene protons O-CH2-CH2-O. Two signals at 
5.43, 5.51 ppm appeared as two doublets due to dioxolane methine proton. The 
vinylic protons were seen as double doublets each at 5.71, 6.09 and 6.77 ppm 
for E−Z isomers (cis and trans). The triplet and double doublet for the aromatic 
protons were observed at 6.96-7.00, 6.34-7.39 ppm (Figure 53).  
 




One of the most important methods for the synthesis of alkenes is the Wittig 
reaction, which is the reaction of an aldehyde or ketone with phosphonium 
ylides. An ylide is a species with a positive charge on the phosphorus atom and 
negative charge on the adjacent carbon atom. Phosphonium ylides are 
prepared from phosphonium salts by treatment with a strong base (Scheme 
54).  
 
Scheme 54: Phosphonium ylide formation 
The mechanism of the Witting reaction involves the nucleophilic attack of the 
carbanion of the phosphonium ylide on the carbonyl group of the aldehyde to 
form a betaine as a zwitterionic intermediate. The betaine then closes by 
reaction of the negatively charged oxygen with the positively charged 
phosphorous to give an unstable four-membered cyclic intermediate called an 
oxaphosphetane. Finally, the oxaphosphetane ring cleaves to form an alkene 
along with triphenylphosphine oxide as a by-product. The phosphorous-oxygen 
double bond is very strong and it is the driving force for the forward reaction 









Some Wittig reactions are Z-selective and some show E-selectivity on the 
products. The stereoselectivity is due to the nature of the substituent group in 
the ylide. Generally, there are two types of ylides, stabilised and unstabilised: 
Stabilised ylides refer to stabilising of the negative charge not only by the 
positively charged phosphorus atom but also by conjugation with substituents 
on the anionic carbon atom. Unstabilised ylides have no such interaction with 
substituents on the anionic carbon atom. The Wittig reaction is E-selective with 
stabilised ylides whereas it is Z-selective with non-stabilised ylides (Figure 54).  
 
Figure 54: Stabilised and unstabilised ylides 
To explain how the Z/E-selectivity in the Wittig reaction arises, consideration 
must be made to the fact that there may be two separate steps: formation of the 
oxaphosphetane and subsequent decomposition and elimination to give an 
alkene; the decomposition step can be used to explain the stereospecificity. In 
principle, addition of the ylide to the aldehyde can produce two diastereomers 
of the intermediate oxaphosphetane and then the stereospecific elimination 
step means that the geometrical isomer of the final alkene will reflect the 
stereoselectivity of this addition step.  
With unstabilised ylides the syn oxaphosphetane is the favoured product, this is 
reflected by the formation of the corresponding Z alkene predominately. The 
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mechanism by which the syn oxaphosphetane produced has not been clearly 
established, one possible explanation depends on rules of orbital symmetry. By 
approaching the carbonyl compound and the ylide at right angles, they will react 
to form an oxaphosphetane ring in the transition state in one step. Keeping the 
large substituents away from each other leads to the formation of transition 
state which leads to the syn stereochemistry of oxaphosphetane (Scheme 56).  
 
Scheme 56: Mechanism of syn oxaphosphetane formation and Z alkene (cis) 
With stabilised ylides the stereoselectivity is opposite and gives the E isomer. 
Again, the mechanism is not entirely clear and there are different potential 
explanations. One which has been evidenced is that the stereoselectivity of the 
alkene product again relies upon the stereochemistry of the oxaphosphetane, 




Scheme 57: Mechanism of anti oxaphosphetane formation and E alkene (trans)  
It was believed that the anti oxaphosphetane is formed under thermodynamic 
control, but research suggests that it is likely that is produced under kinetic 
control. The difference with unstabilised ylides is that the electronegative 
stabilising group of the ylide and the polarised C=O bond of the aldehyde repel 
each another. As the ring become flattens out, the anion stabilising substituents 
of the ylide and the phenyl group of the aldehyde end up on opposite faces of 








4.3 Acetal hydrolysis for preparing trans 4-
glucophenylpropionaldehyde 195 
Acetals are important protecting groups for aldehydes because acetals are 
stable to bases, basic nucleophiles and redox reagents. In addition, their 
formation is reversible because acetals can be hydrolysed in dilute acid and the 
original functional group is revealed following this hydrolysis. In our study, the 
cyclic acetal was formed by reaction of an aldehyde 142 with a phosphonium 
ylide in the Wittig reaction. To convert the dioxolane acetal back into an 
aldehyde required hydrolysis by aqueous acid to produce (E)-α,β-unsaturated 
aldehyde 195.  
The process involved treatment of both Z/E isomers with catalytic amounts of 
bromine in carbon tetrachloride at 0 0C for 1 h, followed by addition of dilute 
AcOH at r.t. After leaving the reaction for 24 h, followed by work-up, which 
included washings using KOH, Na2S2O3 and NaHCO3, syrup was obtained. 
Crystallisation from Et2O led to the formation of a white powder. The glycosidic 
cinnamaldehyde 195 was purified using column chromatography using EtOAc: 
Pet. ether (1:1) as eluent to give the desired product in a yield of 74%.  
The structure of compound 195 was confirmed by 1H NMR, 13C NMR and 
DEPT135 spectroscopy experiments. The 1H NMR displayed signal resonances 
were consistent with the values supplied by the author (Daubresse et al., 1998), 
in which, the vinylic protons give two resonances at 6.66 ppm appeared as 
double doublets and at 7.46 ppm as a doublet, and the peaks of aromatic 
protons were observed at 7.06 ppm and 7.55 ppm as two doublets. The doublet 
signal at 9.70 ppm assigned to the aldehyde group with a couplet constant J= 
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7.7 Hz (Figure 55). The (E)-configuration was proved by the high value of the 
coupling constant (ca. 15.9 Hz) for the vinylic protons.  
The mechanism involves, in the first step, the Z dioxolane substituted alkene is 
isomerised to the thermodynamically more stable E isomer using bromine via a 
radical mechanism. In the next step, the hydrolysis of dioxolane acetal proceed 
by protonation one of the oxygens, then the other oxygen attacks to liberate the 
activated one to form the oxonium ion. Thus, water will attack the carbonyl 
carbon to give the hemiacetal intermediate after deprotonating the attacking 
group and regeneration of the acid catalyst. Repeating these steps produces 









Figure 55: (a) 1H NMR and (b) 13C NMR spectra of (E)-α,β-unsaturated 





Scheme 58: Dioxolane hydrolysis mechanism 
 
4.4 Hydrogenation of trans-cinnamaldehyde derivative 195 to 
give hydrocinnamaldehyde derivative 167 
Trans-cinnamaldehyde is extensively used as an important substrate because 
its hydrogenation products are widely used in organic chemistry, biochemistry 
and pharmaceutical chemistry (Pritchard et al., 2015; Chen et al., 2017). The 
selective hydrogenation differs due to the potential of reduction of either the 
alkene unit, to form hydrocinnamaldehyde, or the carbonyl unit to give cinnamyl 
alcohol. The selectivity to give cinnamyl alcohol is commonly poor due to 
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thermodynamically preferable reduction of the C=C bond over the C=O bond 
(Szumelda et al., 2014).  
In α,β-unsaturated carbonyl compounds the selective reduction of the alkene 
C=C bond can be achieved easily by reduction using hydrogen gas in the 
presence of a Pd/C catalyst (Choi et al., 2017). However, the situation with α,β-
unsaturated aldehydes is challenging and mixtures of products often result (Li 
et al., 2018).  
Hydrogenation selectivity is affected by the organic ligand, metal center, 
texture, structure and catalyst composition (shape, particle size, support and 
molar ratio of components), reaction conditions (solvent, temperature and 
pressure) and functional groups on the substrates (Shi et al., 2016; Li et al., 
2016; Zhang et al., 2018).  
In the field of metal transfer hydrogenation, metal hydride species produced 
from iridium (Chen et al., 2015), ruthenium (Azua et al., 2017), palladium (Ding 
et al., 2013) and nickel (Castellanos-Blanco et al., 2012) preferentially lead to 
hydrogenation of the C=C bond. By comparison, metal-ligand bifunctional H-M-
NH catalysis selectivity leads to hydrogenation of the C=O bond in α,β-
unsaturated carbonyl compounds (Baldino et al., 2016). 
The commercially available palladium catalyst supported on carbon is well 
known as a selective catalyst for alkene C=C hydrogenation. However, its 
effective catalytic activity probably causes poor selectivity between alkene 
reduction and total reduction of all double bonds.  
The catalyst makes the hydrogen react with double bonds with catalytic 
hydrogenation taking place on the metal surface. Therefore, the metal must be 
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finely divided and scattered on an inert support surface. This is the case for 
commercially available Pd/C catalyst, finely divided palladium on a carbon 
support.  
In this study the hydrogenation of (E)-3-[4’-(2’’,3’’,4’’,6’’-tetra-O-acetyl-β-D-
glucopyranosyloxy)phenyl]prop-2-enal 195 in methanol was achieved using 
Pd/C as catalyst. 
Compound 167 was prepared using a modified method reported by Lee et al. 
(Lee et al., 2017). Treatment of trans-α,β-unsaturated aldehyde 195 with 
hydrogen gas in the presence of a catalytic amount of 5% Pd/C in MeOH as 
solvent at room temperature led to the selective hydrogenation of the olefinic 
C=C unit and formation of the saturated carbonyl compound 167 in 19% yield 
after 2 h.  
The suggested mechanism involves the chemisorption of hydrogen onto the 
catalyst surface, a process that leads to cleavage of the H-H bonds and 
disperses hydrogen atoms on the surface to make them able to react with the 
organic substrate. The alkene can also coordinate to the metal, thereby 




Scheme 59: Suggested hydrogenation mechanism 
However, in some cases and under varied conditions it is difficult to control the 
selectivity of this reaction and a product mixture was obtained, consisting 
mainly of the saturated aldehyde together with the undesired saturated alcohol 
(Scheme 60) (Jahjah et al., 2011). The α,β-unsaturated alcohol was not 
observed on the 1H NMR data as indicated by disappearing of the olefin moiety. 
Careful monitoring of the reaction until TLC indicated complete conversion of 
the starting material 195 led to the hydrocinnamaldehyde 167 being obtained as 
white crystals (Figure 56) following purification using column chromatography 
EtOAc: Pet. ether (2:1) as eluent. The 1H NMR displayed two triplets at 2.76 




Scheme 60: Potential reaction pathways for cinnamaldehyde hydrogenation 









Figure 56: (a) 1H NMR and (b) 13C NMR spectra of tetraacetoxyglucoside of 4-
phenylpropionaldehyde 167 in CDCl3 
 
4.5 Synthesis of tetra(4-glucophenylethyl)calix[4]resorcinarene 
The preparation of lower-rim glucosylated calix[4]resorcinarene with ethyl 
bridges between the hydrophobic core and the aromatic residues was based 
upon a one-step cyclooligomerisation reaction according to scheme 53. We 
investigated the catalytic properties of a number of Lewis acids in the reaction 
of different aromatic aldehydes and resorcinol in dry Et2O. Among them, 
anhydrous AlCl3 shown high catalytic efficiency and promoted the cyclisation in 
a short reaction time. This result prompted us to apply these reaction conditions 
to the condensation reaction of 3-[4’-(2’’,3’’,4’’,6’’-tetra-O-acetyl-β-D-
glucopyranosyloxy)phenyl]propanal 167 with resorcinol.  
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When we used an equimolar quantity of resorcinol and 167 with 1.5 equivalent 
of aluminium(III) chloride in an anhydrous solvent mixture of Et2O and THF, the 
reaction was complete after 48 h stirring under N2 at r.t. After work up of this 
experiment in the usual way we obtained 20% of a crude mixture of the desired 
compound. However, some signals expected to be present in the 1H NMR and 
13C NMR spectra were absent, though the spectra were very clean. The 
structure of compound 164 was confirmed utilising a diversity of analytical 
techniques.  
The important 1H NMR, 13C NMR and DEPT135 spectrum could be accurately 
assigned by heteronuclear single quantum correlation (HSQC). In the 1H NMR 
spectrum of the crude mixture in (d6-acetone), signal of the methine bridges 
was absent, while ethyl chain residues appeared as multiplet with chemical 
shifts of 2.37-2.76 ppm. Signals for glucose units were completely exhibited in 
the spectrum with a chemical shift between 4.00-4.46, 5.06-5.48 ppm and the 
acetyl protons were observed at 1.91-2.14 ppm. The δ values for the broad 
signals that referred to the resorcinol fragments were between 6.19-6.55 ppm. 
Multiplet signals are also observed at 6.68-7.42 ppm attributed to the aromatic 
protons. In DEPT135 four important signals associated with ethyl phenyl 
chains, resorcinol units and the aromatic groups were observed at 33.5, 102.9, 
116.7 and 129.5 ppm. In the HSQCDEPT spectrum, the signal of the methine 
bridges showed a correlation with glucose protons.  
The presence of multiplet for the ethyl chains, together with disappearance of 
signals for the methine groups that link the aromatic rings in the 1H NMR or may 
be hidden since they overlap with signals assigned to the glucosyl residues, 
while the chemical shifts of those diagnostic protons which could be observed 
were to a large extent consistent with 1H NMR data published by Cram, 
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(Tunstad et al., 1989) and correspond to the C4v symmetry or rccc conformation 







Figure 57: (a) 1H NMR and (b) DEPT135 spectra of calix[4]resorcinarene 
glucoside 164 in d6-acetone 
In order to fully characterise the calix[4]resorcinarene obtained from the 
reaction of glucosylated aldehyde 167 with resorcinol 35d, the crude mixture of 
protected tetra(4-glucophenylethyl)calix[4]resorcinarene was reacted with 
butyric anhydride in pyridine in a similar manner to that described for butyration 
of 145. The crude reaction mixture was separated by means of silica column 
chromatography employing EtOAc: Pet. ether (2:1) as eluent which afforded the 
principal product as an off-white powder in a low yield of 12%.  
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The molecular structure of this derivative was confirmed by 1H, 13C NMR, 
DEPT135, 2D-NMR spectroscopy experiments and mass spectrometry. The 1H 
NMR spectrum of 196 showed multiplet signals at 2.37-2.67 ppm for ethyl chain 
protons though these overlapped with signals characteristic of the acyl 
protecting groups. The signal at 4.23 ppm was attributed to the methine protons 
at the calix[4]resorcinarene bridges. In the aromatic region, the 2- and 5- 
protons of the tetrasubstituted resorcinol units appeared at 6.46-7.20 ppm and 
were overlapped with the aromatic ring hydrogens of the glucosylated phenyl 
residues. In order to emphasise the above assignments, the carbon signals in 
13C NMR spectrum were assigned using 1D- and 2D-NMR techniques, 
including DEPT135 and HSQCDEPT. The 13C NMR spectrum showed a weak 
signal at 32.6 ppm, this signal showed correlation with the ethyl chain attached 
to the lower rim in the 13C DEPT-1H HSQC. While signals could be clearly 
assigned to the methine groups or the 2- and 5- protons of the tetrasubstituted 
resorcinol units in 13C NMR, two weak signals were assigned in DEPT135 at 
117.7 and 127.8 ppm as being due to calix[4]resorcinarene protons, and the 
protons at the methine bridges were observed in the 13C DEPT-1H HSQC 
correlation spectrum (Figure 58). The structure of the final compound is also 
supported by mass spectrometry analysis. The spectrum gave molecular ion at 
m/z 2872.0863 that corresponds to the mass of the desired 
calix[4]resorcinarene bound to one sodium ion (M+Na)+. (Expected: m/z 
2872.0822) (Appendix 14).  
It is worth noting, that the signal for the methine hydrogens at the 
calix[4]resorcinarene bridges appeared as multiplet in the 1H NMR amongst the 
characteristic resonances related to the protons attached to the glucose 
moieties, which hence affected on their resolution. However, overall, these 
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results gave us an indication that the calix[4]resorcinarene glycocluster 
obtained had an rccc conformation. These results also showed the important 
















Figure 58: (a) 1H NMR, (b) 13C NMR, (c) DEPT135 and (d) HSQCDEPT spectra 
of tetra(4-glucophenylethyl)calix[4]resorcinarene octabutyrate 196 in CDCl3 
 
4.6 Conclusion 
The results reported here highlight a route to prepare calix[4]resorcinarene 
glucoside with an alkyl chain at the lower rim, and derivative with eight 
functional groups on the upper rim, key for delivery of highly functionalised 
calix[4]resorcinarene. We demonstrated that anhydrous AlCl3 is an efficient 
catalyst for the reaction of resorcinol with glucose-4-phenylpropionaldehyde 
and the convenient reaction procedure led to formation of calix[4]resorcinarene 
glucoside 164. The condensation reaction under these conditions selectivity 
produced the rccc configuration and the macrocyclic ring is expected to adopt 
the crown conformer as observed by 1H NMR, 13C NMR and 2D-NMR analysis. 
We also noticed that aluminium(III) chloride powder is a more efficient catalyst 
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for the preparation of calix[4]resorcinarene glucoside than a solution of AlCl3 in 
nitrobenzene, simply because it gave us the desired products without 
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With the aim to synthesise aryl-substituted calix[4]resorcinarenes, the 
condensation of resorcinol, 2-methylresorcinol and pyrogallol with 4-(1-benzyl-
1H-[1,2,3]-triazole-4-ylmethoxy)-benzaldehyde 197 was carried out in 
chloroform in the presence of trifluoroacetic acid (Scheme 61). It was noticed 
that the synthetic outcome of this reaction depended on the structure of the 
substrate resorcinol, for example the reaction of compound 197 with resorcinol 
afforded calix[4]resorcinarene as the rccc isomer 198a in 53% yield. The 
condensation of aldehyde 197 with 2-methylresorcinol under the same reaction 
conditions gave a mixture of rccc (cone) 199a and rctt (chair) 199b isomers, in 
a 1:2.3 ratio, respectively, with a total yield of 66%. Only the rccc isomer in the 
crown conformer 200a was isolated from the reaction of aldehyde 197 with 
pyrogallol (Knyazeva et al., 2018). 
 
Scheme 61: Synthesis of calix[4]resorcinarenes containing triazole fragments 
(Knyazeva et al., 2018) 
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Parulekar and co-workers reported the synthesis of 
calix[4]methylresorcinarenes by condensation of 2-methylresorcinol 95 with 
benzaldehyde or 4-bromobenzaldehyde 201 in 1:1 refluxed mixture of ethanol 
and concentrated aqueous hydrochloric acid. The corresponding 
calix[4]methylresorcinarenes 202 and 203 as the rctt (chair) isomers after 
characterisation using 1H NMR and mass spectroscopy (Scheme 62) (Parulekar 
et al., 2015).  
 
Scheme 62: Synthesis of calix[4]methylresorcinarenes (Parulekar et al., 2015) 
The first representative of calix[4]resorcinarenes with four thiophosphoryl-
containing residues on the lower rim were synthesised by the reaction of 
thiophosphorylated aldehydes 204 or 205 (thiophosphoryl unit located in 3 or 4 
position on the aromatic ring relative to the aldehyde group) with resorcinol, 2-
methylresorcinol and pyrogallol in alcoholic acidic media (Scheme 63). The 1H 
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and 13C NMR spectral data of compounds 206a-c and 207a-c were in 
agreement with the results obtained from single-crystal X-ray diffraction 
analysis and display double signals of protons and carbon atoms of resorcinol 
units. This attests to the opposite orientation of two resorcinol rings from other 
resorcinol groups (vertical and horizontal arrangements). This refers to that the 
molecules exist in rctt isomer (chair conformation) (Knyazeva et al., 2011).  
 
Scheme 63: Synthesis of calix[4]resorcinarenes bearing thiophosphorylated 
fragments on the lower rim (Knyazeva et al., 2011)  
Different findings have been observed by Knyazeva et al.: condensation of 
equimolar quantities of the aldehyde 2-(4-formylphenoxy)-2-thioxa-5,5-dimethyl-
1,3,2-dioxaphosphorinane 208 with resorcinol in chloroform and in the presence 
of trifluoroacetic acid, led to the formation calix[4]resorcinarene 209a as the 
rccc isomer exclusively in 96% yield (Scheme 64). Reaction of 2-
methylresorcinol with aldehyde 208 under the same conditions resulted in the 
formation of a mixture of rccc- and rctt-isomers 210a and 210b in a 5:1 ratio in 
a total yield of 89%. Finally, an analogous reaction of pyrogallol with compound 
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208, gave also a mixture of rccc- and rctt-isomers 211a and 211b, respectively, 
in 1:2 ratio and a combined yield of 93%. The effect of the nature of catalysts 
and solvents utilised on the isomeric ratios of the calix[4]resorcinarenes was 
also noted. Substitution of the mixture of trifluroacetic acid and chloroform with 
a mixture of ethanol, water and concentrated HCl gave only the rctt isomers of 
210b and 211b stereoselectivly in moderate yield of 56% (Knyazeva et al., 
2013).  
 
Scheme 64: Synthesis of thiophosphorylated calix[4]resorcinarenes 






C-4-acetamidophenylcalix[4]methylresorcinarene 213 has been synthesised by 
using one-pot cyclocondensation reaction of 2-methylresorcinol and 4-
acetamidobenzaldehyde 212 in refluxing ethanolic concentrated hydrochloric 
acid afforded calix[4]methylresorcinarene product in 83% yield after refluxing 
the reaction mixture for 24 h (Scheme 65). It was noted that the X-ray structure 
was in agreement with the 1H NMR data and the calix[4]methylresorcinarene 
molecule adopted the chair conformation. It was also noted that the stability of 
this molecule in the crystalline state was influenced by the C-H…O and O-H…O 
intermolecular hydrogen-bonding between the hydroxyl groups and also the 
intermolecular hydrogen-bonding involving DMSO and water molecules with the 
phenolic moieties of the calix[4]methylresorcinarene molecules (Abosadiya et 
al., 2015).  
 
Scheme 65: Synthesis of C-4-acetamidophenylcalix[4]methylresorcinarene 




Although various crystalline forms, cocrystals and solvates of 
calix[4]resorcinarenes and calix[4]pyrogallolarenes are reported, hydrates are 
uncommon due to low water solubility. Applications of these macrocycles in 
pharmaceutical and biological systems is also restricted as a consequence of 
their low water solubility and, hence, poor bioavailability. 
Patil et al. reported the ethanolic protic-acid-catalysed synthesis of 
calix[4]pyrogallolarenes with 4-hydroxyphenyl groups attached at the methine 
bridge groups to improve the solubility of the calix[4]pyrogallolarenes in 
aqueous media. The crude product was found to contain a mixture of the chair 
and boat/cone conformers. The purification of the boat/cone conformer was 
carried out by solvent extraction, and the crystalline hydrate of the boat 
conformer of 4-hydroxyphenyl calix[4]pyrogallolarene 214 (Figure 59) was 
obtained by heating this compound in deionized water at 80 0C, subsequent 
gradual cooling to r.t. produced single crystals suitable for characterisation by 
single-crystal X-ray diffraction analysis. It was noted that the hydrate formed 3D 
arrangements supported by O-H…O hydrogen bonding between water 































This chapter describes the formation of calix[4]resorcinarenes with varied 
groups on the upper and the lower rim of the macrocyclic system as part of our 
investigation into the formation of calix[4]methylresorcinarenes and 
calix[4]pyrogallolarenes with different conformations. The predominating 
conformation and configuration of calix[4]resorcinarenes is determined by many 
factors, including: the nature of the substituents on the calix[4]resorcinarene 
framework, functional groups present on the calix[4]resorcinarene and reaction 
conditions. The conformation of the product calix[4]resorcinarene is one of the 
essential factors in determining the role of these macrocycles in supramolecular 
chemistry.  
Reinhoudt et al. reported the synthesis of substituted 
calix[4]methylresorcinarenes by condensation of 2-methylresorcinol with 
various aromatic aldehydes under protic acid-catalysed conditions and found 
that the chair conformer was formed exclusively in these reactions (Middel et 
al., 1998). Similarly, Cram et al. also found that the condensation of 
benzaldehyde with substituted resorcinol gave calix[4]methylresorcinarene in 
the chair conformer (>97%), referring to the potential influence of the methyl 
group on the calix[4]methylresorcinarene conformation (Tunstad et al., 1989).   
We aimed to explore the synthesis of calix[4]resorcinarenes having an 
increased number of possible hydrogen-bonding functionalities in order to 
investigate expanded self-assembled structures and for more understanding 
the structural conformations of symmetry substituted calix[4]resorcinarenes.  
Herein, we present the synthesis and characterisation of novel substituted 
calix[4]methylresorcinarenes and calix[4]pyrogallolarene containing four 
glycoside fragments on the lower rim of the macrocycles via condensation 
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resorcinol derivatives like 2-methylresorcinol and pyrogallol with carbohydrates 
functionalised benzaldehydes (Scheme 66), different conformations of these 
compounds are also expected, it is therefore expected to increase the study of 

















Reagents and conditions: (i) AlCl3 in nitrobenzene, AlCl3 anhyd. or BF3.Et2O, 
Et2O: THF, 48-92 h, r.t (ii) butyric anhydride, pyridine, 80 
0C, 24 h 




5.2 Synthesis of glycosylated ligand based on the 
calix[4]methylresorcinarene matrix  
In order to design glucosylated calix[4]methylresorcinarene 215 as 
functionalised partner calix[4]resorcinarene glucoside, we used 
tetracetoxyglucoside of 4-hydroxybenzaldehyde 142 (page 100, Scheme 34), 
which was prepared according to a known method (Stavila et al., 2008). 
The first attempt to synthesise calix[4]methylresorcinarene 215 using AlCl3 in 
nitrobenzene as catalyst failed to yield the desired product. However, reaction 
of 2-methylresorcinol and aldehyde 142 in a 1:1 mixture of Et2O and THF 
containing 2 eq. of anhydrous aluminium chloride (AlCl3) as Lewis acid catalyst 
afforded 22% yield of the calix[4]methylresorcinarene 215.   
The conformation of the macrocycle 215 was confirmed according to 1H- and 
DEPT135 and HSQC NMR, the 1H NMR spectra of the compound in d6-acetone 
solution showed mutiplet signals for the lower rim aryl substituents at 6.50-7.13 
ppm, the aromatic resorcinol protons appeared in the spectrum as three 
singlets with chemical shift between 5.70-6.44 ppm, protons assigned to the 
glucose residues appeared between 5.01-5.53 and 4.13-4.65 ppm, the acetyl 
protecting groups appeared between 1.86-2.17 ppm. The signals for protons 
attached to the methyl groups of the resorcinol units were observed at 2.04-
2.30 ppm and methine protons appeared as two singlets 5.68 and 5.76 ppm. 
The DEPT135 spectrum showed significant signals for the methylresorcinol 
units at 8.6, 8.7 and 8.8 ppm, and the signal for the methine bridges at 43.3 
ppm.  
In order to make the calix[4]methylresorcinarene product sufficiently soluble in a 
wide range of polar and a polar organic solvents the eight phenolic hydroxyl 
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groups were acylated. Butyration of the crude product was performed by 
treatment of 215 with butyric anhydride in the presence of pyridine for 24 h at 
80 0C. TLC analysis of the resulting reaction mixture contained many spots 
which could correspond to the desired compound, though this could also have 
indicated decomposition of the product at this temperature or due to 
uncompleted cyclisation. Purification by silica gel column chromatography using 
EtOAc: Pet. ether (1.5:1) as eluent afforded the crystalline product 216 in 24 
yield %.  
The major acylation product 216, was identified by 1H NMR and 13C NMR 
spectroscopy experiments, the protons of the aromatic substituent are 
represented by two sets of signals, two doublets are not well resolved at 6.62 
ppm with integrated intensity 16 H. The signals for methyl group protons and 
the aromatic protons at 5- position of resorcinol residues. They give three sets 
of signals each, the signals of methyl groups at 1.72 (3H), 1.81 (3H) and 1.85 
(6H) ppm and the expected three signals for resorcinol units protons at 5.80 
(1H), 6.1 (2H) and 6.76 (1H) ppm. While, featuring signals for the methine 
protons, we were unable to determine them precisely, as a result of their 
chemical shifts in the range of glucose fragments. In the 13C NMR spectrum 
methine bridge carbons showed a weak signal at 44.3 ppm (Figure 60). The 
structure of 216 is also supported by mass spectrometry analysis. The 
spectrum gave molecular ion at m/z 1414.5493 that corresponds to (M+2NH4)
2+. 













Figure 60: (a) 1H NMR and (b) 13C NMR spectra of tetra(4-
glucophenyl)calix[4]methylresorcinarene octabutyrate 216 in CDCl3 
Similarly, condensation of equimolar amounts of 3-glucosylated benzaldehyde 
143 (page 100, Scheme 34) with 2-methylresorcinol under similar conditions to 
those used for the 4-substituted counterpart resulted in the formation of novel 
glucosylated calix[4]methylresorcinarene 217 in 19% yield after stirring for 92 h 
under nitrogen and subsequent purification. 
Characterisation of compound 217 was predominantly achieved by means of 
1H, 13C and HSQC NMR spectroscopy experiments. In d6-acetone solution the 
1H NMR spectrum of compound 217, contained multiplet signals for the protons 
of the aromatic and resorcinol fragments at chemical shift 6.14-7.26 ppm, three 
signals appeared at 5.63-5.75 ppm related to the protons at the methine 
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bridges. The signals between 4.93-5.50 ppm and 4.02-4.41 ppm were assigned 
to the protons at glucose units; in addition, to the acetyl protecting groups were 
observed at 1.83-2.10 ppm. Finally, the assignment of signals for the methyl 
groups of resorcinol rings in the macrocycle system was done with the HSQC 
spectrum. In the HSQC spectrum, the signals at 8.3, 8.7 and 8.8 ppm showed a 
correlation with the methyl protons 2.03-2.28 ppm and confirm that these 
signals match with the methyl groups of resorcinol units.  
To aid further understanding of the nature of the calix[4]methylresorcinarene 
product and to determine the expected conformers of compound 217, 
butyration of the crude mixture 217 was undertaken using similar conditions to 
those descried previously for the butyration of analogous 
calix[4]resorcinarenes. The acylated product 218 possessed an enhanced 
solubility in non-polar organic solvents and analysis of the product by TLC 
revealed a complex mixture. The mixture was purified using silica gel column 
chromatographed using EtOAc: Pet. ether (1.5:1) as eluent to give 
calix[4]methylresorcinarene 218.  
The analytical data from 1H, 13C, and HSQC NMR spectroscopy experiments 
confirmed the proposed structure. Unexpected broad peaks were noticed in the 
1H NMR spectra in CDCl3. The 
13C NMR spectrum in CDCl3 showed signals for 
the ester groups, methyl groups of resorcinol units and for the aromatic system, 
which agree with structure of compound 218, and assignments were 
unambiguously established through 2D-NMR (HSQC). However, a weak signal 
was observed for the bridging methine with no correlation in the HSQC 
spectrum, and also a weak signal at 124.6 ppm showed correlation with 
aromatic protons is expected it is for resorcinol protons at 5-position (Figure 
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61). The structure of 218 is also supported by mass spectrometry analysis. The 
spectrum gave molecular ion at m/z 1414.5499 that corresponds to (M+2NH4)
2+. 







Figure 61: (a) 1H NMR and (b) HSQCDEPT spectra of tetra(3-
glucophenyl)calix[4]methylresorcinarene octabutyrate 218 in CDCl3 
The aldehyde 152 (page 125, Scheme 38) which possesses a galactose 
residue was also included in this study in order to demonstrate that other 
monosaccharides can be attached to the lower rim using this present strategy. 
Condensation of aldehyde 152 with 2-methylresorcinol was undertaken in dry 







Formation of the corresponding calix[4]methylresorcinarene 219 was confirmed 
by acquiring the 1H NMR spectrum in d6-acetone: the spectrum showed similar 
features to data obtained for the analogous calix[4]methylresorcinarene 215 
obtained from 4-glucosylated benzaldehyde, with some variations obviously 
due to the presence of the galactosyl residues. The 1H NMR spectra displayed 
two resonances for the methine protons at 5.70 and 5.79 ppm and the methine 
carbon appeared as strong signal at 43.1 ppm in the 13C NMR spectrum. The 
methyl groups of the tetrasubstitued resorcinol units appeared at 8.8, 8.7 and 
8.6 ppm in the 13C NMR.   
The octabutyrate of macrocycle 220 was isolated after chromatographic 
separation using EtOAc: Pet. ether (1.5:1) as eluent. The structure of the 
product was established by 1H NMR spectroscopy: a single resonance for the 
aromatic protons appeared as a doublet at 6.65 ppm. Three signals for the 
methyl substituted resorcinol were present at 1.76, 1.82 and 1.86 ppm. The 
three broad signals with different integrated intensity at 5.88, 6.13 and 6.76 
ppm are expected for the internal aromatic ring protons. The signals for the 
methine links were present as a weak signal at 44.2 ppm in the 13C NMR 
(Figure 62). The structure of 220 is also supported by mass spectrometry 
analysis. The spectrum gave molecular ion at m/z 1414.5494 that corresponds 
to (M+2NH4)













Figure 62: (a) 1H NMR and (b) HSQCDEPT spectra of tetra(4-
galactophenyl)calix[4]methylresorcinarene octabutyrate 220 in CDCl3  
 
5.3 Synthesis of calix[4]pyrogallolarene glucoside 221 
In order to further develop the synthesis of calix[4]resorcinarenes that can act 
as templates for glycocluster formation, the glucosylated calix[4]pyrogallolarene 
221 was prepared from the reaction of pyrogallol with tetraacetoxyglucoside of 
4-hydroxybenzaldehyde in the presence of a solution of AlCl3 in nitrobenzene 
under N2 for 72 h. The general procedure of the reaction is outlined in scheme 
63. 
The reaction mixture took on a black colour directly after the addition of 
pyrogallol to the aldehyde-Lewis acid mixture in dry Et2O/THF. Work-up of the 
reaction mixture gave compound 221 as a black solid of 16% yield. TLC 
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analysis of the reaction mixture showed that the starting material was no longer 
present in the mixture and just an intense spot was observed on the base line. 
Perhaps because of the 12 hydroxyl groups on the upper rim this aryl 
calix[4]pyrogallolarene 221 had limited solubility in organic solvents. Hence, it 
was very difficult to obtain reasonable characterisation data for this compound, 
despite CDCl3, d6-acetone and d6-DMSO as solvents for NMR spectroscopy. 
The 1H NMR showed broadened signals for each group of protons. Therefore, it 
was decided to butyrate the material to facilitate confirmation of the structure.  
TLC of the corresponding butyrated calix[4]pyrogallolarene 222 showed an 
intense black spot on the base line, a very light spot with Rf value 0.41 and lots 
of contaminants. After subjecting that mixture to column chromatography 
eluting EtOAc: Pet. ether (2:1) a yellow powder was obtained in a very low yield 
of 7%. In the 1H NMR spectrum of 222 a pair of doublets for the methine 
protons was observed at 5.46 and 5.61 ppm. Protons at the 5 position of the 
pyrogallol residues resonated as two signals integrating 1:1 at 6.08 and 6.30 
ppm, which indicates the presence two matched pairs of pyrogallol residues in 
the matrix in concordance with C2h symmetry (Figure 63). The structure of 222 
is also supported by mass spectrometry analysis. The spectrum gave molecular 
ion at m/z 1558.5918 that corresponds to (M+2NH4)
2+. (Expected: m/z 










Figure 63: (a) 1H NMR and (b) 13C NMR spectra of tetra(4-
glucophenyl)calix[4]pyrogallolarene octabutyrate 222 in CDCl3 
The glucosides derivatived from 3- and 2-hydroxybenzaldehydes 143 and 144 
were also reacted with pyrogallol under Lewis acid-catalysed conditions in 
attempts to make the corresponding cyclic oligomers. Condensation of 3-
glucosylated aldehyde 143 (page 100, Scheme 34) with pyrogallol under the 
same conditions employed for it is 4-substituted counterpart 142 (page 100, 
Scheme 34) did not yield the corresponding cyclic tetramer. TLC analysis 
showed starting material and few new products, this was further confirmed by 
the 1H NMR spectrum. A similar result was obtained on changing the catalyst to 




Also, no macrocyclisation occurred in the attempted condensation of 2-
glucosylated benzaldehyde 144 (page 100, Scheme 34) with pyrogallol using 
AlCl3 solution in nitrobenzene as catalyst, even after prolonged reaction times. 
The poor reactivity of both aldehydes 143 and 144 in reaction with pyrogallol 
may be influenced by the more prevalent steric hindrance associated with these 
aldehydes, though interaction of the Lewis acid with the additional hydroxyl 
group on pyrogallol cannot be ruled out since this may have given a stable 
complex which was also poorly reactive. 
In previous experiments we attempted to prepare calix[4]resorcinarenes which 
possessed disaccharide residues on the lower rim.  
In this present study, lactoside and cellobioside derived from 4-
hydroxybenzaldehyde 157 (page 139, Scheme 40) and 162 (page 145, Scheme 
41) were reacted with 2-methylresorcinol and pyrogallol under Lewis acid 
catalysis, using similar protocols as had been employed for the reaction of 
these aldehydes with resorcinol and subsequent butyration of macrocycles 223-




Reagents and conditions: (i) BF3.Et2O, DCM, 24 h, r.t (ii) butyric anhydride, 
pyridine, 80 0C, 24 h 




The pattern observed in the 1H NMR data of the acylated 
calix[4]methylresorcinarene lactoside 227 and calix[4]methylresorcinarene 
cellobioside 228, isolated after column chromatography using EtOAc: Pet. ether 
(gradient ratio) was analogous, both calix structures showed the appearance of 
single set of signals for the four methyl groups of the resorcinol fragments at 
chemical shifts of 1.80-1.95 ppm, Weak signals for the protons in the 
macrocyclic core were observed and were not matched with expected number 
of protons, as well as, the proton and carbon signals of the methine linkage 
were absent from 1H NMR and 13C NMR. While two doublet signals of equal 
integrated intensity belonging to the 4-glycosylated benzene rings appeared at 
about 6.84-7.00 ppm.  
In the 1H NMR spectra of the octabutyrated calix[4]pyrogallolarene lactoside 
229, the aromatic protons of pyrogallol rings were observed at 5.89 and 6.15 
ppm, but, the 13C NMR was not well resolved, therefore, we could not use it to 
assign the signals related to the CH-bridges, these resonances were only 
assigned using 2D-NMR. Similarly, the 1H NMR spectra of the 
calix[4]pyrogallolarene-based cellobiosyl benzaldehyde 230, revealed unclean 
signals of the protons at 5-position of pyrogallol units and for the methine 
protons, In the 13C NMR spectrum, also these resonances were not observed. 
A satisfactory mass spectrum could not be obtained for compounds 227, 228, 






5.4 Conclusion  
The first representative of calix[4]methylresorcinarene and 
calix[4]pyrogallolarene with four glucose fragments on the aromatic substituents 
located on the methine bridges of the macrocycles was realised by the 
condensation of 2-methylresorcinol or pyrogallol with 4-glucosylated 
benzaldehyde in the presence of Lewis acids.  
The suggested synthetic methods are single-step process led to the target 
compounds and provided single isomer relying on the experimental conditions 
used. 
Modification of calix[4]methylresorcinarene on the lower rim was done by 
changing either the position of the glucose group or the kind of the 
carbohydrate included in the aromatic substituents. In this case, the reactivity of 
3-glucosylated benzaldehyde or 4-galactosylated benzaldehyde for 
condensation with 2-methylresorcinol was experienced using two different 
Lewis acids. While, attempted to vary the nature of glucosylated derivatives of 
the hydroxybenzaldehydes on the calix[4]pyrogallolarene scaffold did not 
investigate, despite using different Lewis acids. 
Finally, we demonstrated the spectral similarities of the conformational isomer 
of the acquired 216 and 220. With 4-substituted benzaldehyde and 2-
methylresorcinol, the expected conformational products are either in ccc-boat 
with C2v symmetry or more likely in rctt-chair with C2h symmetry, the ccc-crown 
with C4v symmetry is excluded in this case. It is clear to elucidate that methyl or 
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Saccharide derivatives bearing ‘spacers’ able to form neoglycoconjugates have 
been observed to be beneficial in biological studies, and in the last few years a 
large number of neoglycoproteins have been synthesised for immunological 
research (Abronina et al., 2018). Several calix[4]resorcinarenes-spacer-
carbohydrate conjugates with carbohydrates on the upper rim have been 
prepared by various approaches, for example by glycosylation of 
calix[4]resorcinarene-cavitand tetrathiol 124 with glycosyl bromides (page 93, 
Scheme 31) (Hayashida et al., 1999), or by reacting octa-2-
hydroxyethoxytetraalkyl calix[4]resorcinarene 60d-f and 84a-c (page 68, 
Scheme 21) with a perbenzoylated glycosyl bromide (Hussain et al., 2017).  
Following our research into the conformer-selective synthesis of 
calix[4]resorcinarenes bearing carbohydrate pendants on the lower-rim, we 
investigated a new strategy for the formation of calix[4]resorcinarene-based 
glycoclusters. In this strategy, the monosaccharide residues are conjugated 
with the calix[4]resorcinarene core through different spacer linkages (Scheme 
68).  
In order to generate the glycosidic spacer linkages, the spacers must contain 
two functional end groups. The carbohydrate residue can be facilely connected 
to the spacer molecule using a glucoside donor and the other terminal group 
can be converted to the necessary carbonyl group for calix[4]resorcinarene 
synthesis.  
In this study, we aimed to expand our tetramerisation strategy to include 
calix[4]resorcinarene glucosides using aromatic free glucosylated aldehydes. 
This strategy was expected to deliver single conformational isomers with 
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selectivity towards the rccc cone and which may possess different self-
assembling behaviours in water.  
Furthermore, it may be possible to introduce other functional groups into the 
spacer on the bottom rim, a polar polyether for example, which could be 







Reagents and conditions: (i) HgBr2, DCM, 24 h (ii) Dess-Martin periodinane, 
DCM, 3 h r.t. (iii) Et2O: THF, BF3.Et2O, 48 h (iv) butyric anhydride, pyridine, 24 
h, 80 0C 




6.1 Synthesis of calix[4]resorcinarene based on glucoside 
bearing alkyl bridges  
The glucosylated calix[4]resorcinarene derivatives 243 and 244 were prepared 
as described in (Scheme 68). The first step included the synthesis of glucosides 
234, 235 and 236, obtained by the method of Wang et al. from the reaction of 
the glycosyl donor 138 with ethylene glycol 231, diethylene glycol 232 and 1, 3-
propanediol 233, respectively, in the presence of mercuric bromide as catalyst 
in dry dichloromethane under Helferich conditions. The expected glucoside 
derivatives 234-236, were isolated in an analytically pure form after 
chromatography.  
Then, each separated anomer was oxidised into an aldehyde using Dess-
Martin periodinane oxidation in dry DCM at r.t. The glucosides 237 and 238, 
were recovered as white solids following flash column chromatography in 
acceptable yields 45-63% (Figure 64 and 65). The glucoside 239 was obtained 
in a high yield of 93% and used without further purification (Figure 66) since the 




Figure 64: 1H NMR spectrum of 2-oxoethyl(2’,3’,4’,6’-tetra-O-acetyl-β-D-





Figure 65: 1H NMR spectrum of 2-((2’,3’,4’,6’-tetra-O-acetyl-β-D-






Figure 66: 1H NMR spectrum of 3-oxopropyl(2’,3’,4’,6’-tetra-O-acetyl-β-D-
glucopyranoside) 239 in CDCl3 
The synthesis of tetrasubstituted calix[4]resorcinarenes 240-242 was achieved 
by stirring of the appropriate aldehyde and resorcinol in a mixture of Et2O: THF 
under catalysis by BF3.Et2O under nitrogen at r.t. for 48 h. Corresponding 
glycoconjugated calix[4]resorcinarenes 240-242 were obtained in poor yields.   
The conformations of the glycoconjugates 240-242 afforded under these 
conditions could not be determined or estimated by NMR spectroscopy, the 1H 
NMR spectrum just contained broadened signals for the glucose epitopes but 
the resorcinol unit protons were characteristic. The glycocluster mixtures were 
acylated according to the previously used method with butyric anhydride and 
pyridine, and after evaporation of the excess reagents under high vacuum, 
248 
 
unexpected results were noticed on TLC: dark spots were observed on the 
baseline with lighter spots having higher Rf values. 
Purification of the crude butyrated mixture obtained from the reaction of 
resorcinol with the glucosylated acetaldehyde 237, using column 
chromatography afforded one isomer of this derivative in a low yield. To prove 
the structure of 243, several NMR experiments were undertaken, including a 
HSQC experiment. 
In the 1H NMR spectra, the most interesting aspect is the position of the signals 
of the methine bridges, the alkyl chains attached to the methine linkages and 
the aromatic resonances. As mentioned above the assignment of these signals 
was aided by the HSQC analysis. In the HSQC spectrum, a signal at 37.1 ppm 
showed correlation with the signals at 4.37-4.42 ppm. Hence the signal should 
be related to the protons at the bridged methine. The signal at 68.7 ppm has a 
correlation with the signal at 3.79 ppm; this signal is expected due to the 
methylene chain fragments. The signal at 117.0 ppm displayed correlation with 
the signals at 5.87-7.14 ppm. Hence the signal must be for the 
calix[4]resorcinarene cage protons (Figure 67). The structure of 243 is also 
supported by mass spectrometry analysis. The spectrum gave molecular ion at 
m/z 1262.4869 that corresponds to (M+2NH4)
2+. (Expected: m/z 1262.4867) 












Figure 67: (a) 1H NMR and (b) HSQCDEPT spectra of 
tetra(glucomethyl)calix[4]resorcinarene octabutyrate 243 in CDCl3 
Fractions obtained from column chromatography of the crude butyration 
product obtained from 3-oxopropyl glucose 239, gave 1H NMR data was broad, 
although all the resonances for the protons and carbons of the glucose, 
aliphatic chain and resorcinol moieties were assigned with the assistance of 
2D-1H NMR, but the signals that correspond to the bridging carbons were 
absent (Figure 68). However, the mass spectrometry indicated the presence of 
the compound 244. The spectrum gave molecular ion at m/z 1290.5192 that 
corresponds to (M+2NH4)









Figure 68: (a) 1H NMR and (b) HSQCDEPT spectra of 
tetra(glucoethyl)calix[4]resorcinarene octabutyrate 244 in CDCl3 
 
6.2 Conclusion 
The preparation of calix[4]resorcinarene glucoconjugates bearing an aliphatic 
spacer linking the carbohydrate residue to the calix[4]resorcinarene lower rim 
has been investigated. Aldehydes functionalised bridge molecules showed 
lower reactivity in condensation reaction with resorcinol than those 
functionalised aromatic spacer. In spite of this, the three aldehydes with 
different aliphatic spacers 237-239 were reacted with resorcinol but only the 
calix[4]resorcinarenes derived from the glucosylated acetaldehyde 243 and the 





The reactivity of these aldehydes was dependent on the features of the 
aliphatic arms that linked the glucose fragment to the aldehyde group. Never 
the less, this work paves the route for using various types of bridge aldehyde 




















































7.1 Hydrolysis of rctt calix[4]resorcinarene glucoside 137a 
Amongst the goals for our research in this area of calix[4]resorcinarene 
chemistry is the use of glycosylated calix[4]resorcinarenes as targeted agents 
in nanopharmaceutics and nanomedicine. To that end, the carbohydrate 
residues and phenolic hydroxyl groups must be deprotected to make the 
calix[4]resorcinarenes soluble in water. Various methods have been reported 
for deacylation of carbohydrates but our choice is limited by the requirement to 
leave any sensitive carbohydrate residues intact.  
Acylated calix[4]resorcinarene glucoside 137a was chosen as a model 
compound because we had a significant quantity of this compound in hand. 
Firstly, acylated substrate 137a was reacted in the presence of a mixture of 
methanol, triethylamine and water (8:1:1) to afford the deprotected glycocluster 
245 (Dondoni et al., 1997). However, this proved to be unsuccessful as 
manifested in the 1H NMR spectrum, most likely because the amount of water 
used in the reaction mixture was insufficient to break all the butyrate groups. 
The mixture was subsequently subjected to similar reaction conditions, but this 
time using an excess of water and for an elongated reaction time (48 h). This 
reaction delivered a more complex mixture of products as evidenced again by 
1H NMR analysis.  
Upon applying another commonly used method, compound 137a was reacted 
with a catalytic amount of sodium methoxide in a mixture of MeOH and DCM 
(4:1, v/v). The novel polyhydroxylated glycocluster based on a 
calix[4]resorcinarene core 245 was produced as a red solid in 83% yield 






Scheme 69: Ester hydrolysis 
Compound 245 was characterised using standard methods, especially 1H NMR 
spectroscopy and mass spectrometry. The compound is stable in aqueous 
media and in polar solvents but is insoluble in CDCl3 and other organic 
solvents. 
In deuterated water, calix[4]resorcinarene glycocluster 245 showed broad 
signals, suggesting persistent intermolecular aggregates as a consequence of 
hydrogen bonds in solution. In spite of broadening of signals, the broad 
resonances accounting for the glucose and aromatic hydrogen atoms disclosed 
the nature of structure 245 (Figure 69b).  
In an endeavour to further characterise the nature of configuration, we tested 
the 1H NMR in deuterated DMSO, analogous trend was noticed for the 
(chemical shift values δ) of the glucose proton signals 3.01-3.80; 4.71-4.89 
ppm, doublet signals for all the protons of the bridging methine residues 5.44-
5.61 ppm and muliplet signals for the pendant aromatic units 6.58-7.25 ppm. 
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The remaining hydrogen signals for resorcinol fragments were almost 
corresponded (Figure 69a).  
The structure of 245 is also supported by mass spectrometry analysis. The 
spectrum gave molecular ion at m/z 751.2244 that corresponds to (M-2H)2-. 








Figure 69: 1H NMR spectra of hydroxylated glycocluster 245 in (a) d6-DMSO 
and (b) D2O 
 
7.2 Dynamic light scattering measurements (DLS) 
Dynamic light scattering (DLS) or also known as photon correlation 
spectroscopy (PCS) has emerged as one of the most important techniques to 
investigate the particle size and surface charge of nanoparticles created for 
drug delivery purposes, such as (macromolecules and peptides). Thus, these 
parameters play a great role for a range of biological affects of nanodrug 
delivery systems including cellular uptake, safety, toxicity, stability and 
dissolution performance. The principle of DLS is based on light scattering 
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intensity by particles in the solution which follow the principle of Brownian 
motion and produced from the random movement of particles present in the 
suspension depending on their size. Polydispersity index (PDI) is an option 
exists on the DLS software use to express the sorts of particles population or 
particle size distribution of nanosuspensions. A PDI value ranges between 0.1 
to 0.25 indicates small size distribution in contrast with a PDI value of more 
than 0.5 shows a very wide size distribution. These values give the stability and 
the aggregation rate of nanosuspention (Bhattacharjee 2016).  
Zeta potential measurement (ZP) is one of the important features that indicate 
to the stability of nanoparticle dispersions by measuring the properties of 
surface charge or voltage of nanoparticles and compared with the charge of the 
surrounded solution. The zeta potential value is affected by the size of 
nanoparticles, especially; particles of very small size that promote noticeable 
electrostatic repulsion and very stable zeta potential of ±30 mV. With zeta 
potential value a minimum of ±20 mV, the aggregation will not be resisted with 
poorly dispersed particles (Patel and Agrawal 2011; Bhattacharjee 2016).  
One of the crucial factors that effect on DLS measurements is sample 
preparation, which should be done in water. Hydroxylated calix[4]resorcinarene 
glucoside 245 was highly soluble in aqueous media (~15 mg/mL) and DLS 
measurements were carried out in distilled water by using Zetasizer nano ZS 
(Malvern Instruments, UK). The particle size, zeta potential and size distribution 
were measured at four concentrations (1 mg/mL, 3 mg/mL, 6 mg/mL and 10 
mg/mL). The measurements were performed in triplicate at room temperature. 
As shown in figure 70, particle size values at each of the concentrations used (1 
mg/mL, 3 mg/mL, 6 mg/mL and 10 mg/mL) were 150.3 nm ±1.02 nm, 160.16 
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nm ±15.43 nm, 189.66 nm ±5.25 nm and 168.13 nm ±37.25 nm, respectively. 
There was no significant increase in particle size noticed with increasing 
concentration. This indicated that particle or cluster formation within the 
aqueous environment was independent of concentration.   
 
       (A)                                                                (B) 
 
(C) 
Figure 70: Representation (A) size, (B) zeta potential and (C) PDI of optimal 
formulation nanoaggregate of hydroxylated calix[4]resorcinarene glucoside with 


























Zeta potential values of the fully hydroxylated calix[4]resorcinarene glucoside 
with all concentrations were high and negatively charged which indicates the 
presence of polar hydroxyl groups that ionize in water (Scheme 70). The values 
were found to be -16.43 mV ±0.49 mV, -17.06 mV ±1.30 mV, -17.06 mV ±0.46 
mV and -17.16 mV ±0.81 mV, respectively. As before, there was not any 
significant change of charge with an increase in concentration. 
 
Scheme 70: Deprotonation and stabilisation of phenoxide ion by resonance 
The polydispersity index (PDI) was measured at each of the increasing 
concentrations. The size of self-assembled species may vary in water at 
different concentrations, thus affecting particle size distribution dependent on 
concentration. The highest PDI were noticed of 3 mg/mL and 10 mg/mL 
concentration with a value of 0.56±0.08 and 0.63±0.06, respectively. However, 
the value for the 6 mg/mL solution was 0.39±0.02, lower than that of 3 mg/mL 
concentration, but higher than the value of 0.26±0.01 for the 1 mg/mL solution. 
The high polydispersity index values may be associated with the aggregation of 
molecules of unprotected calix[4]resorcinarene glucoside into different particle 







We have further characterised the first model of a calix[4]resorcinarene 
glucoside bearing four monosaccharide substituents at the lower rim that is 
soluble in aqueous media. The properties of a hydroxylated 
calix[4]resorcinarene glucoside were studied, which showed good water 
solubility and stability. This opens the scope for using such molecules in 
molecular recognition approaches. The preliminary data obtained from particle 
size, zeta potential and size distribution measurements, evidence the promising 
use of glycocalix[4]resorcinarenes to interact with biologically relevant 
molecules, specifically hydrophobic drugs. This compound and the successful 
solvolysis conditions used in here could result in focusing investigations into the 
synthesis of further water soluble calix[4]resorcinarene glycosides, especially 
that derived from the corresponding rccc conformational isomer in order to 
increase their potential use as drug delivery systems or in other biological 
events such as, anti-adhesion or inhibition pathogens attack (virus and 
bacteria) to the cell, antifungal activity, targeted drug delivery systems for 
cancer treatments, immune response and cell trafficking. All occour as a result 
of interaction of glycocalix[4]resorcinarene with carbohydrates untis existent on 



































In continuation of our efforts to investigate other methods for the synthesis of 
complex calix[4]resorcinarenes, we wished to further demonstrate the utility of a 
range of Lewis acids as catalysts for the reaction of structurally complex 
aldehydes with resorcinols. 
Many of the calix[4]resorcinarenes we investigated were already reported in the 
literature as being prepared by conventional mineral acid catalysed 
condensation reaction, with some other reports highlighting protocols which 
used Lewis acids for the synthesis of calix[4]resorcinarenes.  
The principal reason for preparing these octols during our studies was not to 
isolate each compound or isomer in a pure form. Rather, it was to assess the 
reactivity and selectivity of each Lewis acid on the reaction and diastereoisomer 
distribution. 
8.1 Synthesis of alkyl- and aryl-substituted 
calix[4]resorcinarenes 
The general procedure employed involved reacting equal molar quantities of 
aliphatic or aromatic aldehydes with resorcinol, 2-methylresorcinol and 
pyrogallol in the presence of a Lewis acid. The reactions were conducted at 
room temperature in dry Et2O and the reaction was monitored over various time 
periods (Scheme 71). Generally, products precipitated from solution and the 
reaction mixtures were worked up by diluting the mixture with a further 50 mL 
portion of Et2O, suspending the precipitated calix[4]resorcinarenes in water and 
the solid products were collected by filtration.   
With aliphatic aldehydes only the rccc configuration was isolated when R= H 
and R’= CH3(CH2)3 using anhydrous AlCl3. Other attempts at condensation of 
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resorcinol or analogues substituted at the 2-position with valeraldehyde or 
octanal using different Lewis acids were conducted but failed to give solid 
precipitate from the reaction mixture. The 1H NMR spectrum of macrocycle 246 
(Table 1) was analogous to that reported for the same calix[4]resorcinarene 
obtained by hydrochloric acid catalysed condensation (Tunstad et al., 1989). 
 
Scheme 71: Synthesis of alkyl and aryl substituted calix[4]resorcinarenes 
The reaction of resorcinol with aromatic aldehydes was also studied and the 
structures are reported in table 1. With benzaldehyde, a mixture of two 
diastereoisomers was obtained upon running three separate reactions with 
three different catalysts, the all-cis (rccc, C4v) isomer and the cis-trans-trans 
(rctt, C2h) isomer. The exact isomer ratio was not investigated, but based on 
1H 
NMR data of benzaldehyde-derived calix[4]resorcinarene displayed three 
singlets at δ 5.74, 5.78 and 5.88 ppm, in addition, six single resonances in the 
range 6.33-6.64 ppm for benzylic hydrogens and for each set of aromatic 
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protons at 2- and at 5-position of resorcinol rings. This was well correlated with 
the data observed for the same compound produced by Lewis acid catalysts 
(Barrett et al., 1999; Deleersnyder et al., 2007; Darvish and Khazraee 2014) but 
was not consistent with acid-catalysis (Senthan and Alexander 2015).   
Table 1: Octols produced from the reaction of resorcinol, 2-methylresorcinol 
































































































































































































































































































































In the condensation of resorcinol with 2-methoxybenzaldehyde, only one isomer 
was detected by the 1H NMR of the crude that precipitated from the reactions, 
runs 5-9 (Table 1). The chair conformation product was expected to produce 
from these reactions, accordingly to previous reported finding from acid induce 
synthesis (Pfeiffer et al., 2016) or similar to our synthesised 
calix[4]resorcinarene from 2-glucosylated benzaldehyde by Lewis acid.  
For the calix[4]resorcinarenes derived from 4-substituted benzaldehydes, the 
tetrameric nature of the macrocycles was diversified relying on the type of 
substituent on the benzaldehyde. When R’= 4-CH3OC6H4, of the characterised 
products, runs 10-14 (Table 1), two isomers (rccc and rctt) were identified by 
the 1H NMR data. It was important to note that each group of these compounds 
featured as a couple of signals with differences in the chemical shifts of the 
methine signals and resorcinol hydrogens for the two configurations. This fact is 
concordant with the detections of previous workers, used acid condition 
(Sarjono et al., 2007), and was not agreeable with Pfeiffer et al. suggestion, that 
was only of (rctt, C2h) symmetry.   
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Other aromatic aldehydes such as 4-methylbenzaldehyde and 4-acetoxy 
benzaldehyde were also tested. In the synthesis of 248 and the products from 
runs 16-20, the corresponding calix[4]resorcinarenes were characterised as the 
rccc (boat conformation). The 1H NMR spectra of these compounds in d6-
acetone display double resonances for the protons for the resorcinol 
constituents, as previously reported values (Funck et al., 2010). The possibility 
of presence traces of rctt isomer in the crude mixture of macrocycles 52h is 
also existed.  
In case of 4-methylbenzaldehyde, a big difference was noticed in the 1H NMR 
spectra in d6-DMSO, the observed 
1H NMR of macrocycles 52h was 
characteristic of the rccc (cone conformation); where each group of protons 
match with a single resonance. One singlet at 5.63 ppm of the bridging methine 
and characteristic resonances for each of the four protons at 2- and of the four 
protons at 5-position of resorcinol fragments at δ 6.16 and 6.27 ppm indicated 
to the presence of rccc isomer.  
Reaction of 2-substituted resorcinols with a series of substituted benzaldehydes 
was accomplished using a range of Lewis acids. Compared to the yields 
obtained from substituted resorcinol and analogous reactions with unsubstituted 
resorcinol, the yields of runs 21-51 are lower. Despite the existence of higher 
electron density in substituted resorcinol than that in resorcinol and 
consequently the electrophilic attack by the benzaldehyde lead to faster 
tetramerisation, but different findings were observed from the corresponding 
reactions. These are required longer reaction time than that of runs 1-20 and 
some catalysts did not give cyclisation or partial interaction occurred.  
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When R= CH3 and R’= C6H5, compounds from runs 21 and 23 were isolated as 
the rctt isomers as indicated by the existence two signals at δ 2.10 and 2.27 
ppm for the methyl groups of resorcinol fragments, beside two signals attributed 
to the intra annular resorcinol protons (Parulekar et al., 2015). Whereas, that 
from 22 of the same substrates but using different catalyst (anhydrous AlCl3) 
came out as a mixture, probably rccc and the rctt isomers. Four sets of signals 
appeared for the methylresorcinol units and two resonances for the methine 
linkage referred to chair and boat conformation.  
With R= CH3 and R’= 2-OCH3C6H4, the products from runs 24 and 26 showed 
the presence of starting material and the cyclisation was not completed within 
48 h reaction time. Similar reactions, runs 25 and 27, used different catalysts 
and for longer reaction time (up to week), afforded the corresponding 
calix[4]resorcinarenes and were not precipitated in a pure status. However, they 
clearly show formation of a single isomer of rctt configuration by the 1H NMR 
spectra. No solid product precipitated from run 28 on using ZnCl2 as a catalyst.  
The calix[4]methylresorcinarenes 250, resulting upon reaction of 4-
methoxybenzaldehyde with 2-methylresorcinol were observed in two isomers, 
probably (rccc and rctt) as indicated by the appearance two signals for the 
methine bridges and double resonances for the aromatic protons for each 
isomer were characteristics. This was not in agreement with the previous 
reported finding by Reinhoudt et al. (Middel et al., 1998). From run 31 (TiCl4 
catalyst), slightly condensed product was isolated. Again, no precipitate 
obtained from the run 30 catalysed by ZnCl2. 
Prosvirkin et al. have previously described the isomeric composition of 
calix[4]methylresorcinarene derived from 4-tolualdehyde and determined two 
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main products correspond to that tetramer (rccc and rctt) (Prosvirkin et al., 
2005). Different investigation has been determined by Miao et al. that the 
corresponding compound produces in the chair conformation (Miao et al., 
2003). The results obtained by our hand were differentiated based on the sort 
of catalyst used. Only single isomer as the rctt configuration was detected in 
synthesis of 251, runs 34 and 37. In runs 35 and 36, two isomeric forms (rccc 
and rctt) were distinguished on the 1H NMR spectra.   
On applying a wide range of various Lewis acids in the condensation reaction of 
2-hydroxyresorcinol with aromatic aldehydes, runs 38-51, the 1H NMR chemical 
shifts in d6-acetone for macrocycles 94, showed well resolved mixture of 
conformations, potentially correspond to (rccc and rctt). Two single peaks at 
5.30 and 5.78 ppm, additionally, two characteristic signals at 6.17 and 6.48 ppm 
for pyrogallol units were comparable with the literature estimation for the 
isolated isomers prepared by conventional method (Casas-Hinestroza and 
Maldonado 2018).  
The reaction also worked well with R= OH and R’= 4-CH3OC6H4, run 44, the 
1H 
NMR displayed two sets of signals for bridging methylene at 5.67 and 5.80 
ppm, here also, possibly a mixture of diastereoisomers being presented. 
However, from runs 45-47, or when R’= 2-CH3OC6H4, runs 40-43 or 4-
CH3C6H4, runs 48-51, partially condensed products were isolated.  
In runs 40 and 48, pyrogallol condensed with 2-methoxybenzaldehyde and 4-
toulaldehyde, respectively. Apparently, the products show single isomer as 
elucidated by the appearance of three resonances singlet for the methine 






We have provided alternative methods for the synthesis of aryl substituted 
calix[4]resorcinarenes in the presence of varied Lewis acids as catalysts. The 
benefits of these methods include the use of simple available catalysts, easy 
workup and in some cases rational reaction time periods in comparison with 
other Lewis acids synthesised and reported in the synthesis of 
calix[4]resorcinarenes.    
Comparisons were made between the syntheses of macrocycles presented in 
table 1 and other reported methods. The results sometimes showed similarity 
and others were contradicted to the earlier reported procedures in terms of 
reactivity, stereoselectivity and yield products.  
In this study we demonstrated that with aliphatic aldehydes and resorcinol or 2-
substituted resorcinols, Lewis acids showed low reactivity and only one 
compound 246 of rccc isomer was produced. With benzaldehyde or substituted 
benzaldehydes and resorcinol or 2-substiuted resorcinols, the molecules 
possessed either all-cis (boat-like conformer) or cis-trans-trans (chair-like 
conformer) or mixtures of both were produced. Moreover, in the reaction of 
substituted benzaldehydes with pyrogallol, the amount of condensed products 
was very low for unknown reasons or could be associated with the low acidity 

























It is known that carbohydrates play key roles in a number of essential biological 
phenomena, especially events triggered by receptor-mediated intermolecular 
interactions. For this reason, the initial milestones of this present study were to 
synthesise glycoconjugated compounds bearing monosaccharide epitopes at 
the lower rim of cyclic tetramer calix[4]resorcinarenes, in order to isolate 
different topologies of calix[4]resorcinarene glycosides with enhanced aqueous 
solubility. Each calix[4]resorcinarene conformation isolated may have different 
potential as a biomimetic structure. In this context, varying the nature of the 
aromatic aldehydes, which bear the carbohydrate residues, that take part in the 
Lewis acid catalysed condensation reaction with resorcinol provided 
glycosylated calix[4]resorcinarenes 145, 146, 148 and 153. Conformers of 
these compounds were isolated as the octabutyrates after derivatisation the 
initial phenolic products from the condensation reaction: in general, the 
products of the condensation reactions starting from 4-substituted 
benzaldehyde glycosides were isolated as a mixture of conformers of each 
glycocluster. However, only one conformation of glycocluster was isolated from 
reactions starting with glucosylated derivatives of 2- and 3-
hydroxybenzaldehydes.  
Following the effective syntheses of glycoclusters bearing monosaccharide 
residues, the subsequent aim was to introduce disaccharide ligands at the 
lower rim of the calix[4]resorcinarene scaffold in an attempt to provide 
molecules with a significant increase in solubility in aqueous media. Here, 
compounds 158 and 163 were successfully synthesised by reacting lactosyl 
and cellobiosyl derivatives of 4-hydroxy benzaldehyde with resorcinol. 
Remarkably, the reactions delivered only one conformer in each case, 
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delivering the pure ester of compound 159 and the octaphenol of 
calix[4]resorcinarene 163.    
Carbohydrates confer important physico-chemical properties on the 
glycocluster compounds, particularly related to solubility in aqueous media and 
the potential ability to recognise lectins and cells. At the same time, however, 
the significant hydrophobicity of calix[4]resorcinarene matrices and the 
presence of a modest number of hydrophilic sugar motifs limits their aqueous 
solubility and potentially hinder their biological applications. To overcome these 
limitations and to explore isolation of different conformations of 
calix[4]resorcinarene glycosides, we aimed to prepare glycosidic aldehydes 
with various spacer units of various length and flexibility. It was anticipated that 
the spacers may influence the conditions required to prepare the corresponding 
calix[4]resorcinarenes and the increased hydrophobic region on the lower rim of 
these calix[4]resorcinarenes may have a significant effect upon the ability of 
these compounds to act as drug solubilising agents.  
Unfortunately, attempts to prepare the glucosylated derivatives of 4-
hydroxyphenyl propanal 167 and 4-hydroxyphenyl acetaldehyde 169, required 
for the calix[4]resorcinarene synthesis, from their acid derivatives was 
unsuccessful. The principal issue was the instability of the aldehydes 170 and 
171 under the numerous glycosylation conditions employed. As a 
consequence, the parent aryl substituted calix[4]resorcinarenes were prepared 
from the substrate 4-hydroxyphenyl propanal by acid catalysis and the three 
calix[4]resorcinarenes were isolated in the all-cis (rccc) configuration.   
The successful synthesis of the novel glycosidic aldehyde 167 was 
accomplished via Wittig reaction and the synthesis of the corresponding 
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calix[4]resorcinarene glucoside 164 was investigated by using anhydrous AlCl3 
as a catalyst. The stereoselective formation of the glycocluster 164 in rccc 
configuration was one of the advantages of using the aldehyde 167 in the 
reaction with resorcinol. This strategy could provide an entry point for further 
development on the calix[4]resorcinarene framework. 
Addition of functional groups to calix[4]resorcinarene glycosides on the upper 
rim was undertaken using resorcinol derivatives 2-methylresorcinol and 
pyrogallol in condensation with glycosylated aldehydes. All of these reactions 
produced only one conformer as shown by NMR spectroscopy: The 
appearance of the spectra of the products 216, 218, 220 and 222 varied but 
showed similar resonances to those of conformational isomers obtained from 
the condensation reactions starting with resorcinol. This indicated to the 
influential role played by these groups on the isomeric composition of the 
macrocycles produced.  
An alternative strategy was used to obtain glucosylated aldehydes with an alkyl 
spacer between the carbonyl group and the carbohydrate residues. 2-Glucose 
acetaldehyde 237, 2-glucoseethoxy acetaldehyde 238 and 3-oxopropyl glucose 
239 were prepared according to established methodology. The successful 
synthesis of corresponding calix[4]resorcinarene glucosides was achieved from 
reaction of resorcinol with the glucosides 237 and 239. There is obvious 
potential here for developing the synthesis of glycoclusters bearing 
carbohydrate moieties linked through different spacers since the spacer arms 
could be further extended to include different ratios of hydrophilic and 
hydrophobic properties.  
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Finally, in order to be suitable for use as drug solubilising agents an essential 
requirement of any calix[4]resorcinarene is that it must be soluble in aqueous 
media. This was readily achieved by cleaving all of the protecting groups from 
the carbohydrate residue and calix[4]resorcinarene upper rim of rctt 
glycocluster 137a. Standard measurements of relative solubility, particle size, 
zeta potential and size distribution were made for the major conformational 
isomer. It would be highly desirable to make all the prepared compounds 
soluble in aqueous media, especially the minor conformational isomer of 
glycocluster 137b, anticipated to be the rccc conformer, and then any 
conformers deemed suitable would then be investigated for their ability to 
solubilise a range of hydrophobic drugs. This would be the best foundation for 































10.1 Synthesis and characterisation of compounds 
All chemicals and reagents were purchased from Alfa Aesar, Sigma-Aldrich, 
Fisher and ACROS and unless otherwise stated were used without further 
treatment. Most reactions were carried out under a nitrogen atmosphere. 
Solvents were either used as received or stored over molecular sieves (4 Å). 
Thin layer chromatography (TLC) was undertaken using aluminium plates pre-
coated with 60 F254 silica gel (Merck). TLC plates were visualised using UV 
light, 5% solution H2SO4 in MeOH or potassium permanganate solution. Rf 
values were calculated as the distance travelled by the spotting material over 
the distance travelled by the eluent system. Preparative TLC plates used were 
with thickness (1000 µm) and size (20x20 cm) (Material Harvest Ltd, 
Cambridge); PLC Silica gel 60 F254, (2 mm), (Merk). Chromatotron 
chromatography was undertaken using glass plates coated with silica gel 60 
PF254 containing gypsum (Merck) prepared in-house. Column chromatography 
was performed on silica gel (40-63 µm) (VWR) and all mixtures were dissolved 
in DCM and pre-absorbed on a small amount of silica gel before placing on top 
of the column and elution. 
Melting points of materials were measured using a Bibby Stuart Scientific 
Melting point apparatus and were uncorrected. Infrared spectra were obtained 
using a Thermo Nicolet Nexus FT-IR spectrophotometer. 
1H and 13C NMR spectra were recorded on a Bruker Avance instruments with 
frequencies (1H at 300 MHz, 13C at 75 MHz) and (1H at 400 MHz, 13C at 100 
MHz). NMR samples were prepared by dissolving the substance in deuterated 
solvents (CDCl3, d6-acetone, d6-DMSO or D2O). All chemical shifts (δ) are 
quoted in ppm using SiMe4 as an internal reference and coupling constant (J 
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values) are given in Hertz (Hz). Multiplicities of the NMR peaks are described 
as singlet (s), doublet (d), triplet (t), quartet (q), double-doublet (dd), double 
double doublet (ddd), multiplet (m) and broard signals are denoted as br.  
Mass spectrometry of the final compounds was carried out by the National 
Mass Spectrometry Facility at Swansea University on a Waters Xevo G2-S QT 
or a ThermoFisher LTQ Orbitrap XL ETD Hybrid Ion Trap-Orbitrap Mass 

















10.2 Synthesis of peracetylglycosyl bromides  
(General Procedure) 
The acetylated carbohydrates (1 eq) with a solution of HBr (33% in AcOH, 13 
eq) were mixed in a round flask containing DCM (50 mL) cooled to 0 0C for 1 hr. 
The reaction was left to stir overnight at r.t and the reaction progress was 
monitored by TLC. The mixture was subsequently diluted with DCM (100 mL) 
and the organic layer was washed with ice water (100 ml), saturated aq. 
solution NaHCO3 (100 mL x 2), brine (100 mL x 2) and dried (MgSO4). The 
mixture was filtered and solvent evaporated under reduced pressure to give the 
title compounds 151, 156 and 161 (Mitchell et al., 2001). 
 
10.2.1 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide 151 
 
Compound 151 was synthesised according to the general procedure from 
1,2,3,4,6-penta-O-acetyl-β-D-galactose 150 (5.85 g, 15 mmol). Sample was 
obtained as a colourless gum (5.46 g, 13.28 mmol, 89%), which was used 
without further purification.   




10.2.2 2,3,6,2’,3’,4’,6’-Hepta-O-acetyl-α-D-lactosyl bromide 156 
 
Compound 156 was synthesised according to the general procedure from 
1,2,3,6,2’,3’,4’,6’-octa-O-acetyl-lactose 155 (6.00 g, 115 mmol). Sample was 
recrystallised from Et2O to give the title compound as a white solid (3.25 g, 4.65 
mmol). 
Yield: 52% 
Rf of compound 156 (EtOAc: Pet. ether, 2:1): 0.63 
Vmax (cm-1): 1741 (C=O ester), 1369 (C-H bending), 1212, 1040 (C-O 
stretching), 904 (C-H bending), 599 (C-Br). 
1H NMR (400 MHz CDCl3): δ 6.53, (1H, d, J 4.2, H1-Lac), 5.56, (1H, t, J 9.7x(2), 
H3-Lac), 5.36, (1H, dd, J 3.4,0.9, H4’-Lac), 5.14, (1H, dd, J 10.4, 7.9, H2’-Lac), 
4.96, (1H, dd, J 10.5, 3.5, H3’-Lac), 4.77, (1H, dd, J 10, 4, H2-Lac), 4.49-4.53, 
(2H, m, H1’-, H6-Lac), 4.06-4.23, (4H, m, H5-, H6, H6’-Lac), 3.84-3.91, (2H, m, 
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H5’-, H4-Lac), 2.17, (3H, s, OAc), 2.14, (3H, s, OAc), 2.10, (3H, s, OAc), 2.08, 
(3H, s, OAc), 2.07, (3H, s, OAc), 2.06, (3H, s, OAc), 1.97, (3H, s, OAc). 
13C NMR (100 MHz CDCl3): δ 170.3, 170.2, 170.1, 170.1, 170.0, 169.2, 168.9 
(C=O); 100.8, 86.3, 75.0, 72.9, 71.0, 70.8, 70.7, 69.5, 69.0, 66.5, 61.0, 60.8 (C-
Lactose); 20.8, 20.8, 20.6, 20.5 (OAc-Lactose) (Bier et al., 2017). 
 
10.2.3 2,3,6,2’,3’,4’,6’-Hepta-O-acetyl-α-D-cellobiosyl bromide 161 
 
Compound 161 was synthesised according to the general procedure from 
1,2,3,6,2’,3’,4’,6’-octa-O-acetyl-cellobiose 160 (6.00 g, 115 mmol). Sample was 
recrystallised from Et2O to give the title compound as a white solid (4.55 g, 6.50 
mmol). 
Yield: 74% 
Rf of compound 161 (EtOAc: Pet. ether, 1.5:1): 0.43 
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Vmax (cm-1): 2957 (C-H stretching), 1737 (C=O ester), 1367 (C-H bending), 
1215, 1040 (C-O stretching), 907 (C-H bending), 596 (C-Br). 
1H NMR (400 MHz CDCl3): δ 6.53, (1H, d, J 4, H1-Cel), 5.54, (1H, t, J 9.7x(2), 
H3- Cel), 5.06-5.18, (2H, m, H4’-, H3’-Cel), 4.95, (1H, dd, J 9.2, 8.1, H2’-Cel), 
4.77, (1H, dd, J 10, 4, H2-Cel), 4.52-4.56, (2H, m, H6b-, H1’-Cel), 4.38, (1H, dd, 
J 12.5, 4.4, H6a’-Cel), 4.15-4.22, (2H, m, H6a-, H4-Cel), 4.05, (1H, dd, J 12.5, 
2.2, H6b’-Cel), 3.84, (1H, t, J 9.7x(2), H5-Cel), 3.66-3.70, (1H, m, H5’-Cel), 
2.15, (3H, s, OAc), 2.10, (6H, s, OAc), 2.05, (6H, s, OAc), 2.02, (3H, s, OAc), 
1.99, (3H, s, OAc) (Xu et al., 2008). 
13C NMR (100 MHz CDCl3): δ 170.5, 170.2, 170.1, 170.0, 169.3, 169.3, 168.9 
(C=O); 100.5, 86.4, 75.2, 72.9, 72.9, 72.0, 71.5, 70.7, 69.4, 67.7, 61.5, 60.9 (C-
Cellobiose); 20.8, 20.7, 20.6, 20.5 (OAc-Cellobiose). 
 
10.3 Glycosylation of Hydroxyarylaldehyde  
(General procedure) 
2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide (1 eq) and 
hydroxybenzaldehyde (1 eq) were dissolved in anhydrous MeCN (100 mL). 
Silver(I) oxide (freshly prepared) (4.2 eq) was added and the reaction was 
stirred for 4 h at r.t. The solvent was subsequently evaporated under reduced 
pressure and the resulting residue was taken up in EtOAc, filtered and the 
solvent was removed. The crude mixture was purified by silica gel column 
chromatography to afford the corresponding glycosylated aldehydes (Stavila et 








Compound 142 was synthesised according to the general procedure from 4-
hydroxybenzaldehyde (2.44 g, 20 mmol), 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl bromide (8.22 g, 20 mmol) and silver(I) oxide (freshly prepared) 
(20 g, 84 mmol) in anhydrous MeCN (200 mL). The reaction was stirred for 16 h 
at r.t. The crude mixture was purified by silica gel column chromatography 
using EtOAc: Pet. ether (1:1.5) as eluent to afford white crystals of compound 
142 (6.23 g, 13.77 mmol). 
Yield: 69% 
Rf of compound 142 (EtOAc: Pet. ether, 1:1.5): 0.12 
Mp: 134-136 0C 
Vmax (cm-1): 2962 (C-H stretching), 1733 (C=O ester), 1690 (C=O aldehyde), 
1599, 1504 (C=C arene), 1365 (C-H bending), 1217, 1034 (C-O stretching). 
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1H NMR (400 MHz CDCl3): δ 9.95, (1H, s, CHO), 7.88, (2H, d, J 7.8, H2,6-Ar), 
7.13, (2H, d, J 7.9, H3,5-Ar), 5.19-5.36, (4H, m, H3’,4’,2’,1’-Glu), 4.32, (1H, dd, 
J 5.4, 5.5, H6b’-Glu), 4.21, (1H, dd, J 2.3, H6a’-Glu), 3.94-3.98, (1H, m, H5’-
Glu), 2.07-2.10, (12H, OAc) (Wang et al., 2007). 
13C NMR (100 MHz CDCl3): δ 190.6 (CHO); 170.4, 170.1, 169.3, 169.1 (C=O); 
161.2, 131.9, 131.8, 116.8 (aromatic carbons); 98.1, 72.5, 72.3, 71.0, 68.1, 61.9 
(C-Glucose); 20.6, 20.5 (OAc-Glucose). 
 
10.3.2 3-(2’,3’,4’,6’-Tetra-O-acetyl-β-D-
glucopyranosyloxy)benzaldehyde 143  
 
Compound 143 was synthesised similarly to compound 142 from 3-
hydroxybenzaldehyde (1.22 g, 10 mmol), 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl bromide (4.11 g, 10 mmol) and silver(I) oxide (freshly prepared) 
(10 g, 42 mmol) in anhydrous MeCN (100 mL). The crude mixture was purified 
by silica gel column chromatography using EtOAc: Pet. ether (1:1.5) as eluent 




Rf of compound 143 (EtOAc: Pet. ether, 1:1.5): 0.10 
Mp: 99-102 0C 
Vmax (cm-1): 2940, 2863 (C-H stretching), 1745, 1731 (C=O ester), 1696 (C=O 
aldehyde), 1592, 1482 (C=C arene), 1365 (C-H bending), 1205, 1031 (C-O 
stretching). 
1H NMR (400 MHz CDCl3): δ 9.98, (1H, s, CHO), 7.59, (1H, m, H5-Ar), 7.50, 
(2H, m, H2,6-Ar), 7.27, (1H, m, H4-Ar), 5.31-5.33, (2H, m, H3’,4’-Glu), 5.14-
5.20 (2H, m, H2’,1’-Glu), 4.18-4.29, (2H, m, H6’-Glu), 3.93-3.97 (1H, m, H5’-
Glu), 2.10, (3H, s, OAc), 2.08, (3H, s, OAc), 2.07, (3H, s, OAc), 2.05, (3H, s, 
OAc) (Laville et al., 2004).  
13C NMR (100 MHz CDCl3): δ 191.5 (CHO); 170.7, 170.2, 170.1, 169.6, 169.4, 
169.3 (C=O); 157.2, 137.8, 130.3, 126.0, 123.7, 115.0 (aromatic carbons); 98.5, 











glucopyranosyloxy)benzaldehyde 144  
 
Compound 144 was synthesised similarly to compound 142 from 2-
hydroxybenzaldehyde (2.44 g, 20 mmol), 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl bromide (8.22 g, 20 mmol) and silver(I) oxide (freshly prepared) 
(20 g, 42 mmol) in anhydrous MeCN (200 mL). The crude mixture was purified 
by silica gel column chromatography using EtOAc: Pet. ether (1:1) as eluent to 
afford white crystals of compound 144 (2.40 g, 5.30 mmol).  
Yield: 27% 
Rf of compound 144 (EtOAc: Pet. ether, 1:1): 0.65 
Mp: 126-128 0C 
Vmax (cm-1): 2961 (C-H stretching), 1745 (C=O ester), 1682 (C=O aldehyde), 
1600, 1483 (C=C arene), 1364 (C-H bending), 1203, 1036 (C-O stretching). 
1H NMR (300 MHz CDCl3): δ 10.36, (1H, d, J 0.8, CHO), 7.88, (1H, dd, J 7.7, 
H6-Ar), 7.56-7.61, (1H, m, H4-Ar), 7.12-7.24 (2H, m, H3,5-Ar), 5.32-5.43, (2H, 
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m, H3’,4’-Glu), 5.19-5.25, (2H, m, H1’,2’-Glu), 4.32, (1H, dd, J 5.1, 5.3, H6’-
Glu), 4.2, (1H, dd, J 2.4, 2.6, H6’-Glu), 3.90-3.95, (1H, m, H5’-Glu), 2.10, (3H, s, 
OAc), 2.08, (6H, d, OAc), 2.07, (3H, s, OAc) (Chen et al., 2012). 
13C NMR (100 MHz CDCl3): δ 189.1 (CHO); 170.5, 170.1, 169.3, 169.2 (C=O); 
158.7, 135.7, 128.3, 126.1, 123.6, 115.9 (aromatic carbons); 99.0, 72.4, 72.2, 





Compound 152 was synthesised similarly to compound 143 from 4-
hydroxybenzaldehyde (1.22 g, 10 mmol), 2,3,4,6-tetra-O-acetyl-α-bromo-D-
galactopyranose (4.11 g, 10 mmol) and silver(I) oxide (freshly prepared) (10 g, 
42 mmol) in anhydrous MeCN (100 mL). The crude mixture was purified by 
silica gel column chromatography using EtOAc: Pet. ether (1:1) as eluent to 




Rf of compound 152 (EtOAc: Pet. ether, 1:1): 0.32 
Vmax (cm-1): 1744 (C=O ester), 1692 (C=O aldehyde), 1600, 1583, 1507 (C=C 
arene), 1367 (C-H bending), 1209, 1042 (C-O stretching), 752 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 9.93, (1H, s, CHO), 7.86, (2H, d, J 8.2, H2,6-Ar), 
7.12, (2H, d, J 8.7, H3,5-Ar), 5.53, (1H, dd, J 10.5, 7.9, H4’-Gal), 5.48, (1H, d, J 
3.4, H2’-Gal), 5.18, (1H, d, J 7.9, H1’-Gal), 5.14, (1H, dd, J 10.4, 3.4, H3’-Gal), 
4.11-4.26, (3H, m, H5’, H6’-Gal), 2.19, (3H, s, OAc), 2.07, (6H, s, OAc), 2.03, 
(3H, s, OAc) (Wen et al., 2008). 
13C NMR (100 MHz CDCl3): 190.7 (CHO); 170.3, 170.1, 170.0, 169.3 (C=O); 
161.3, 131.8, 116.7 (aromatic carbons); 98.6, 71.3, 70.6, 68.4, 66.7, 61.3 (C-













Compound 157 was synthesised similarly to compound 142 from 4-
hydroxybenzaldehyde (0.73 g, 6 mmol), 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-
lactosyl bromide (4.19 g, 6 mmol) and silver(I) oxide (freshly prepared) (5.83 g, 
25.20 mmol) in anhydrous MeCN (60 mL). The reaction was stirred for 5 h at r.t. 
The crude mixture was purified by silica gel column chromatography using 
EtOAc: Pet. ether (1:1) as eluent to afford white crystals of compound 157 (2.74 
g, 3.70 mmol). 
Yield: 60%  
Rf of compound 157 (EtOAc: Pet. ether, 1:1): 0.26 
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Mp: 75-76 0C 
Vmax (cm-1): 3024 (C-H stretching), 1742 (C=O ester), 1693 (C=O aldehyde), 
1601, 1583, 1508 (C=C arene), 1367 (C-H bending), 1211, 1165, 1043 (C-O 
stretching), 750 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 9.93, (1H, s, CHO), 7.85, (2H, d, J 4.8, H2,6-Ar), 
7.08, (2H, d, J 5, H3,5-Ar), 5.37, (1H, d, J 2.6, H3’-Lac), 5.18-5.33, (3H, m, 
H1’,3’’,4’’-Lac), 5.14, (1H, dd, J 10.5, 7.9, H2’’-Lac), 4.98, (1H, dd, J 10.4, 3.4, 
H2’-Lac), 4.50-4.53, (2H, m, H1’’,6’-Lac), 4.07-4.18, (3H, m, H6’,6’’-Lac), 3.83-
3.94, (3H, m, H4’,5’,5’’-Lac), 2.16, (3H, s, OAc), 2.09, (3H, s, OAc), 2.08, (3H, s, 
OAc), 2.07, (9H, s, OAc), 1.98, (3H, s, OAc) (Wen et al., 2008). 
13C NMR (100 MHz CDCl3): δ 190.6 (CHO); 170.4, 170.3, 170.2, 170.1, 170.0, 
169.6, 169.5, 169.1 (C=O); 161.2, 131.8, 116.7 (aromatic carbons); 101.1, 97.7, 
76.0, 73.0, 72.6, 71.2, 70.9, 70.7, 69.0, 66.5, 61.9, 60.8 (C-Lactose); 20.7, 20.7, 












Compound 162 was synthesised similarly to compound 157 from 4-
hydroxybenzaldehyde (0.73 g, 6 mmol), 2,3,6,2’,3’,4’,6’-hepta-O-acetyl-α-D-
cellobiosyl bromide (4.19 g, 6 mmol) and silver(I) oxide (freshly prepared) (5.83 
g, 25.20 mmol) in anhydrous MeCN (60 mL). The reaction was stirred for 5 h at 
r.t. The crude mixture was purified by silica gel column chromatography using 
EtOAc: Pet. ether (1.5:1) as eluent to afford white crystals of compound 162 
(2.77 g, 3.74 mmol). 
Yield: 62% 
Rf of compound 162 (EtOAc: Pet. ether, 1.5:1): 0.44 
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Mp: 192-194 0C 
Vmax (cm-1): 2962 (C-H stretching), 1743 (C=O ester), 1699 (C=O aldehyde), 
1602, 1508 (C=C arene), 1366 (C-H bending), 1216, 1165, 1034 (C-O 
stretching).  
1H NMR (400 MHz CDCl3): δ 9.93, (1H, s, CHO), 7.85, (2H, d, J 5, H2,6-Ar), 
7.08, (2H, d, J 8.7, H3,5-Ar), 5.06-5.32, (5H, m, H1’,3’,2’’,3’’,4’’-Cel), 4.96, (1H, 
dd, J 9.2, 8, H2’-Cel), 4.53-4.56, (2H, m, H1’’,6’-Cel), 4.39, (1H, dd, J 12.5, 4.3, 
H6’’-Cel), 4.14, (1H, dd, J 11.9, 5.6, H6’-Cel), 4.06, (1H, dd, J 12.5, 2.1, H6’’-
Cel), 3.80-3.91, (2H, m, H4’,5’-Cel), 3.66-3.71, (1H, m, H5’’-Cel), 2.11, (3H, s, 
OAc), 2.09, (3H, s, OAc), 2.06, (9H, m, OAc), 2.02, (3H, s, OAc), 2, (3H, s, 
OAc) (Griesbeck et al., 2011). 
13C NMR (100 MHz CDCl3): δ 190.7 (CHO); 170.5, 170.2, 170.1, 169.7, 169.5, 
169.3, 169.0 (C=O); 161.2, 131.8, 131.7, 116.7 (aromatic carbons); 100.8, 97.8, 
76.2, 73.0, 72.8, 72.3, 72.0, 71.5, 71.1, 67.6, 61.8, 61.5 (C-Cellobiose); 20.7, 
20.6, 20.6, 20.5, 20.5 (OAc-Cellobiose). 
 
10.4 Synthesis of calix[4]resorcinarene glycosides  
(General procedure) 
To a stirred solution of aldehyde (1 eq) in a mixture of Et2O and THF (1:1 ratio, 
40 mL) was added a solution of AlCl3.PhNO2 (4 eq) and the mixture was stirred 
under nitrogen for 15 min. Subsequently, resorcinol (1 eq) was added and the 
mixture was stirred at r.t for a further 48 h. A precipitate was obtained by adding 
the reaction mixture to Et2O (200 mL). The precipitate was filtered and washed 
many times with Et2O. The solid was then dissolved in EtOAc and the organic 
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layer was washed with water (100 mL x 2) then dried (MgSO4). The solvent was 
evaporated under reduced pressure to give the desired compounds as crude 
solid (Curtis 1997). 
 
10.4.1 Calix[4]resorcinarene glucoside 145 
 
Compound 145 was synthesised according to the general procedure from 4-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)benzaldehyde (4.88 g, 10.79 
mmol), resorcinol (1.18 g, 10.79 mmol) and AlCl3.PhNO2 (4.60 mL, 43.14 mmol) 
in a mixture of Et2O and THF (1:1 ratio, 50 mL) gave a red precipitate of the 
desired compound (4.46 g, 2.04 mmol, 19%). A portion of the crude mixture 
was purified by preparative TLC using DCM: MeOH (4.5:0.5) as eluent to afford 
a red precipitate of compound 145. 
Rf of compound 145 (DCM: MeOH, 4.5:0.5): 0.31 
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Vmax (cm-1): 3445 (O-H stretching), 1742 (C=O ester), 1604, 1505 (C=C 
arene), 1431, 1367 (C-H bending), 1212, 1033 (C-O stretching). 
1H NMR (400 MHz d6-acetone): δ 7.19-8.22, (8H, m, ArOH), 6.67-7.19, (16H, 
m, H2’,3’,5’,6’-Ar), 6.57, (2H, d, H2-Ar), 6.48, (2H, s, H2-Ar), 6.24-6.45, (2H, m, 
H5-Ar), 5.93, (2H, s, H5-Ar), 5.84, (2H, s, ArCH), 5.72, (2H, s, ArCH), 5.03-
5.63, (16H, m, H1’’,2’’,3’’,4’’-Glu), 4.47, (2H, dd, J 11.5; 6.4, H6’’-Glu), 4.08-
4.38, (10H, m, H5’’,6’’-Glu), 1.94-2.12, (48H, m, OAc). 
13C NMR (100 MHz d6-acetone): δ 170.1, 170.0, 169.9, 169.4, 169.4, 169.4, 
169.3, 169.1, 169.1, 169.0, 169.0 (C=O); 155.3, 155.2, 153.5, 153.2, 153.0, 
139.5, 138.1, 131.9, 131.5, 130.3, 130.0, 129.7, 115.9, 115.5, 106.5 (aromatic 
carbons); 99.7, 72.7, 71.7, 71.4, 68.7, 62.1 (C-Glucose); 41.9 (ArCH); 20.0, 
19.9, 19.9, 19.8, 19.8, 19.7, 19.7 (OAc-Glucose).  
Mass Spectrum: Expected: m/z 1106.3506 (M+2NH4)













10.4.2 Calix[4]resorcinarene glucoside 146 
 
Compound 146 was synthesised according to the general procedure from 3-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)benzaldehyde (2.26 g, 5 
mmol), resorcinol (0.55 g, 5 mmol) and AlCl3.PhNO2 (2.13 mL, 20 mmol) in a 
mixture of Et2O and THF (1:1 ratio, 40 mL) gave a red precipitate of the desired 
compound (1.94 g, 0.89 mmol, 18%). A portion of the crude mixture was 
purified by chromatotron chromatography using DCM: MeOH: EtOAc (4:0.4:0.6) 
as eluent to afford a red precipitate of compound 146. 
Rf of compound 146 (DCM: MeOH: EtOAc, 4:0.4:0.6): 0.37 
Mp: 190-194 0C 
Vmax (cm-1): 3463 (O-H stretching), 1739 (C=O ester), 1606, 1486 (C=C 




1H NMR (400 MHz d6-acetone): δ 7.23-8.17, (8H, m, ArOH), 6.28-7.19, (20H, 
m, H2,2’,4’,5’,6’-Ar), 5.86-6.21, (4H, m, H5-Ar), 5.50-5.63, (4H, s, ArCH), 4.84-
5.38, (16H, m, H1’’,2’’,3’’,4’’-Glu), 3.82-4.39, (12H, m, H5’’,6’’-Glu), 1.79-1.96, 
(48H, m, OAc). 
Mass Spectrum: Expected: m/z 1106.3506 (M+2NH4)
2+. Observed: m/z 
1106.3500 
 
10.4.3 Calix[4]resorcinarene glucoside 148 
 
Compound 148 was synthesised according to the general procedure from 2-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)benzaldehyde (2.26 g, 5 
mmol), resorcinol (0.55 g, 5 mmol) and AlCl3.PhNO2 (2.13 mL, 20 mmol) in a 
mixture of Et2O and THF (1:1 ratio, 40 mL) gave a red precipitate of the desired 
compound (2.40 g, 1.10 mmol, 22%). A portion of the crude mixture was 
purified by preparative TLC using DCM: MeOH (4.5:0.5) as eluent to afford a 
red precipitate of compound 148. 
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Rf of compound 148 (DCM: MeOH, 4.5:0.5): 0.27 
1H NMR (300 MHz d6-acetone): δ 7.55-7.82, (8H, brs, ArOH), 7.28, (2H, d, J 
7.7, ArH), 6.95-7.12, (4H, q, ArH), 6.86, (4H, d, J 8.1, ArH), 6.66-6.79, (4H, m, 
ArH), 6.48-6.61, (2H, d, ArH), 6.3, (4H, s, H2,5-Ar), 6.17, (2H, s, H2-Ar), 5.89, 
(4H, d, J 20, ArCH), 5.46, (2H, s, H5-Ar), 5.10-5.39, (10H, m, H1’’,3’’,4’’-Glu), 
5.03, (4H, t, J 9.2ₓ(2), H2’’-Glu), 4.72, (2H, d, H1’’-Glu), 4.41-4.57, (2H, dd, H6’’-
Glu), 4.19-4.38, (4H, m, H6’’-Glu), 4.06-4.17, (4H, m, H5’’,6’’-Glu), 3.39-4.04, 
(2H, m, H5’’-Glu), 1.84-2.27, (48H, m, OAc).  
Mass Spectrum: Expected: m/z 1106.3506 (M+2NH4)
2+. Observed: m/z 
1106.3497 
 
10.4.4 Calix[4]resorcinarene galactoside 153 
 
To a stirred solution of 4-(2’,3’,4’,6’-tetra-O-acetyl-β-D-
galactopyranosyloxy)benzaldehyde (1.50 g, 3.31 mmol) in Et2O (20 mL) was 
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added BF3.Et2O (0.40 mL, 3.31 mmol) and the mixture was stirred under 
nitrogen for 15 min. Subsequently, resorcinol (0.36 g, 3.31 mmol) was added 
and the mixture was stirred at r.t for a further 24 h. A precipitate was obtained 
by adding the reaction mixture to Et2O (200 mL). The precipitate was filtered 
and washed many times with Et2O. The solid was then dissolved in EtOAc and 
the organic layer was washed with water (100 mL x 2) then dried (MgSO4). The 
solvent was evaporated under reduced pressure to give the desired compound 
as yellow crystals. 
 
10.4.5 Calix[4]resorcinarene lactoside 158 
 
Compound 158 was synthesised similarly to compound 153 from 4-
(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-lactosyl)benzaldehyde (2.00 g, 2.70 mmol), 
resorcinol (0.29 g, 2.70 mmol) and BF3.Et2O (0.66 mL, 5.40 mmol) in a mixture 
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of Et2O: THF (1.5:1 ratio, 25 mL). The reaction was stirred for 48 h at r.t. The 
crude mixture was obtained as a red powder (1.97 g, 0.59 mmol, 22%).  
 
10.4.6 Calix[4]resorcinarene cellobioside 163 
 
To a stirred solution of 4-(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-
cellobiosyl)benzaldehyde (0.53 g, 0.71 mmol) and resorcinol (0.07 g, 0.71 
mmol) in anhydrous DCM (15 mL) was added BF3.Et2O (0.17 mL, 1.43 mmol) 
and stirring was continued overnight under N2 atmosphere. The reaction 
mixture was then diluted with water (20 mL) and DCM (40 mL); the organic 
layer was washed with brine (50 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the title compound as a yellow solid (0.23 g, 0.07 
mmol, 10%) (Kumar and Venkatakrishnan 2018). 
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Mass Spectrum: Expected: m/z 1682.5195 (M+2NH4)
2+. Observed: m/z 
1682.5200 
 
10.5 Esterfication of calix[4]resorcinarene glycosides and 
analogues (General procedure) 
To a suspension of the crude calix[4]resorcinarene glycoside in pyridine (5 mL), 
butyric anhydride (30 mL) was added and the mixture was stirred overnight at 
80 0C. The solvents were removed using vacuum distillation giving a brown oily 
mixture, that was separated by silica gel column chromatography to yield the 
butyrated calix[4]resorcinare glycosides (Curtis 1997). 
 
10.5.1 Acylated calix[4]resorcinarene glucoside 137 
 
Compound 137 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene glucoside 145 (4.46 g, 2.04 mmol) was reacted 
with butyric anhydride (60 mL) and pyridine (10 mL), the crude product was 
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separated by silica gel column chromatography using EtOAc: Pet. ether (2:1) as 
eluent to yield the major (2.24 g, 0.82 mmol) and the minor (0.28 g, 0.10 mmol) 
isomers of the butyrated calix[4]resorcinarene glucosides. 
Major isomer 137a 
Yield: 40% 
Rf of compound 137a (EtOAc: Pet. ether, 2:1): 0.26 
Mp: 230-233 0C 
Vmax (cm-1): 2968 (C-H stretching), 1746 (C=O ester), 1608, 1507, 1490 (C=C 
arene), 1366 (C-H bending), 1216, 1130, 1033 (C-O stretching), 907 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 7.06, (2H, s, H2-Ar), 6.95, (2H, s, H2-Ar), 6.85, 
(2H, s, ArH), 6.75, (4H, d, J 8.8, ArH), 6.54-6.67, (10H, m, ArH), 6.28, (2H, d, J 
3.2, H5-Ar), 6.03, (2H, s, H5-Ar), 5.56, (2H, s, ArCH), 5.47, (2H, s, ArCH), 5.22-
5.45, (12H, m, H2’’,3’’,4’’-Glu), 4.87-5.00, (4H, m, H1’’-Glu), 4.41-4.55, (4H, m, 
H6’’-Glu), 4.13-4.22, (4H, m, H6’’-Glu), 4.06, (2H, ddd, J 6.2x(2); 3.5, H5’’-Glu), 
3.98, (2H, ddd, J 6.5x(2); 3.1, H5’’-Glu), 2.16-2.42, (16H, m, COCH2), 1.99-
2.14, (48H, m, OAc-Glu), 1.42-1.60, (16H, m, CH2), 0.79-0.94, (24H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 171.2, 171.1, 170.4, 170.1, 170.0, 169.6, 169.4, 
169.2 (C=O); 156.2, 156.1, 147.0, 146.9, 146.8, 146.4, 134.9, 133.9, 132.5, 
132.2, 131.8, 131.6, 131.1, 130.2, 130.1, 129.8, 128.8, 117.5, 116.8, 116.1 
(aromatic carbons); 100.5, 100.2, 72.9, 72.7, 72.0, 71.9, 71.3, 71.2, 68.7, 68.5, 
62.3, 62.2 (C-Glucose); 43.5 (ArCH); 35.8, 35.7, 35.5 (COCH2); 20.6, 20.6, 
20.6, 20.5, 20.5, 20.4 (OAc-Glucose); 18.1, 18.0, 18.0 (CH2); 13.6, 13.5 (CH3). 
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Mass Spectrum: Expected: m/z 1386.5179 (M+2NH4)
2+. Observed: m/z 
1386.5177 
Minor isomer 137b 
Yield: 4% 
Rf of compound 137b (EtOAc: Pet. ether, 2:1): 0.11 
Mp: 139-142 0C 
Vmax (cm-1): 2967 (C-H stretching), 1747 (C=O ester), 1608, 1507 (C=C 
arene), 1366 (C-H bending), 1216, 1131, 1033 (C-O stretching), 907 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 6.95, (2H, s, H2-Ar), 6.90, (2H, s, H2-Ar), 6.78, 
(8H, d, J 8.2, ArH), 6.66, (8H, d, J 7.8, ArH), 6.15, (2H, s, H5-Ar), 5.91, (2H, s, 
H5-Ar), 5.53-5.57, (2H, t, H3’’-Glu), 5.20-5.47, (10H, m, H2’’,3’’,4’’-Glu), 5.37, 
(4H, d, J 8.7, ArCH), 5.15, (2H, d, J 7.9, H1’’-Glu), 5.02, (2H, d, J 7.9, H1’’-Glu), 
4.38-4.65, (4H, m, H6’’-Glu), 4.02-4.28, (8H, m, H5’’,6’’-Glu), 2.11-2.48, (16H, 
m, COCH2), 1.93-2.16, (48H, m, OAc-Glu), 1.36-1.76, (16H, m, CH2), 0.76-1.09, 
(24H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 171.6, 170.6, 170.6, 170.5, 170.5, 170.1, 169.9, 
169.7, 169.6, 169.3, 169.2 (C=O); 155.9, 147.2, 147.2, 147.1, 147.0, 136.7, 
134.3, 132.5, 131.7, 131.7, 131.1, 130.1, 128.7, 117.5, 116.8, 115.7 (aromatic 
carbons); 99.7, 99.2, 72.7, 72.7, 72.2, 71.8, 71.5, 71.3, 68.3, 68.3, 62.2 (C-
Glucose); 44.2, 43.3 (ArCH); 35.9, 35.7, 35.5, 35.4 (COCH2); 20.7, 20.6, 20.6, 
20.6, 20.5 (OAc-Glucose); 18.3, 18.1, 17.9, 17.8 (CH2); 13.7, 13.6, 13.5 (CH3). 
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Mass Spectrum: Expected: m/z 1386.5179 (M+2NH4)
2+. Observed: m/z 
1386.5170 
 
10.5.2 Acylated calix[4]resorcinarene glucoside 147 
 
Compound 147 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene glucoside 146 (1.61 g, 0.74 mmol) was reacted 
with butyric anhydride (30 mL) and pyridine (5 mL), the crude product was 
separated by silica gel column chromatography using EtOAc: Pet. ether (2:1) as 
eluent to yield one product of the butyrated calix[4]resorcinarene glucoside 
(0.32 g, 0.12 mmol). 
Yield: 16% 
Rf of compound 147 (EtOAc: Pet. ether, 2:1): 0.41 
Mp: 130-133 0C 
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Vmax (cm-1): 2967 (C-H stretching), 1746 (C=O ester), 1588, 1487 (C=C 
arene), 1365 (C-H bending), 1214, 1129, 1034 (C-O stretching), 906 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 6.92-7.14, (6H, m, H2,5’-Ar), 6.9, (2H, d, J 3.5, 
H5’-Ar), 6.60-6.76, (4H, m, H4’-Ar), 6.36-6.66, (4H, m, H2’-Ar), 6.25-6.33, (4H, 
m, H6’-Ar), 6.24, (2H, d, J 5.6, H5-Ar), 5.82, (2H, s, H5-Ar), 5.48, (4H, d, J 13, 
ArCH), 5.15-5.38, (12H, m, H2’’,3’’,4’’-Glu), 4.89, (2H, d, J 7.7, H1’’-Glu), 4.67-
4.81, (2H, brs, H1’’-Glu), 4.27-4.47, (4H, m, H6’’-Glu), 4.03-4.22, (4H, m, H6’’-
Glu), 3.81-3.98, (4H, m, H5’’-Glu), 2.18-2.50, (16H, m, COCH2), 1.94-2.13, 
(48H, m, OAc-Glu), 1.40-1.58, (16H, m, CH2), 0.78-0.97, (24H, m, CH3) 
13C NMR (100 MHz CDCl3): δ171.1, 171.1, 170.5, 170.4, 170.4, 170.1, 170.1, 
169.5, 169.4, 169.3, 169.2 (C=O); 156.9, 147.1, 141.5, 132.0, 129.4, 123.8, 
117.4, 116.9, 116.5 (aromatic carbons); 99.1, 72.8, 71.9, 71.2, 68.4, 62.1 (C-
Glucose); 44.3 (ArCH); 35.8, 35.7, 35.5 (COCH2); 20.6, 20.6, 20.5, 20.4 (OAc-
Glucose); 18.1, 18.0, 17.9 (CH2); 13.5, 13.5, 13.4 (CH3). 
Mass Spectrum: Expected: m/z 1386.5179 (M+2NH4)








10.5.3 Acylated calix[4]resorcinarene glucoside 149 
 
Compound 149 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene glucoside 148 (2.40 g, 1.10 mmol) was reacted 
with butyric anhydride (30 mL) and pyridine (5 mL), the crude product was 
separated by silica gel column chromatography using EtOAc: Pet. ether (2:1) as 
eluent to yield one product of the butyrated calix[4]resorcinarene glucoside (0.6 
g, 0.23 mmol). 
Yield: 20% 
Rf of compound 149 (EtOAc: Pet. ether, 2:1): 0.36 
Mp: 244-247 0C 
Vmax (cm-1): 2966 (C-H stretching), 1747 (C=O ester), 1588, 1489 (C=C 




1H NMR (400 MHz CDCl3): δ 7.35, (2H, s, H2-Ar), 7.05-7.15, (2H, m, H4’-Ar), 
6.91-7.02, (4H, m, H4’,5’-Ar), 6.85, (2H, s, H2-Ar), 6.77, (2H, d, J 8.1, H3’-Ar), 
6.67, (2H, d, J 8.2, H3’-Ar), 6.52-6.62, (4H, m, H5’,6’-Ar), 6.24, (2H, dd, J 7.6; 
1.3, H6’-Ar), 6.11, (2H, s, H5-Ar), 5.92, (2H, s, H5-Ar), 5.80, (4H, d, J 18.7, 
ArCH), 5.4, (2H, t, J 9.5x(2), H3’’-Glu), 5.14-5.28, (4H, m, H1’’,3’’-Glu), 4.94-
5.10, (6H, m, H2’’,4’’-Glu), 4.79, (2H, dd, J 9.5; 8.1, H2’’-Glu), 4.56, (2H, d, J 
7.9, H1’’-Glu), 4.5, (2H, dd, J 12.3; 5.7, H6’’-Glu), 4.28, (2H, dd, J 12.2; 5.7, 
H6’’-Glu), 4.01-4.15, (4H, m, H6’’-Glu), 3.93, (2H, ddd, J 9.9; 5.7; 2.3, H5’’-Glu), 
3.85, (2H, ddd, J 10; 5.7; 2.2, H5’’-Glu), 2.12-2.68, (16H, m, COCH2), 1.91-2.10, 
1.24 (48H, m, OAc-Glu), 1.39-1.70, (16H, m, CH2), 0.70-1.03, (24H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 171.2, 170.8, 170.4, 170.4, 170.2, 169.9, 169.6, 
169.6, 169.5, 169.2, 168.9 (C=O); 153.5, 153.4, 147.6, 147.5, 146.7, 146.3, 
132.8, 131.5, 131.1, 130.8, 129.4, 129.2, 128.7, 127.6, 126.9, 126.8, 122.0, 
117.7, 116.4, 113.0 (aromatic carbons); 98.4, 97.6, 73.0, 72.7, 72.1, 71.4, 69.4, 
68.7, 68.2, 62.2 (C-Glucose); 37.2, 37.0 (ArCH); 36.1, 35.9, 35.6, 34.8 
(COCH2); 20.8, 20.8, 20.6, 20.6, 20.4 (OAc-Glucose); 18.1, 18.0, 17.8, 17.6 
(CH2); 13.7, 13.6, 13.6, 13.5 (CH3). 
Mass Spectrum: Expected: m/z 1386.5179 (M+2NH4)








10.5.4 Acylated calix[4]resorcinarene galactoside 154 
 
Compound 154 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene galactoside 153 (1.10 g, 0.50 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(1.5:1) as eluent to yield the major (0.19 g, 0.07 mmol) and the minor (0.07 g, 
0.02 mmol) isomers of the butyrated calix[4]resorcinarene galactosides. 
Major isomer 154a 
Yield: 14% 
Rf of compound 154a (EtOAc: Pet. ether, 1.5:1): 0.33 
Mp: 121-125 0C 
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Vmax (cm-1): 2968 (C-H stretching), 1745 (C=O ester), 1607, 1507 (C=C 
arene), 1367 (C-H bending), 1216, 1129, 1072 (C-O stretching), 916 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 7.04, (2H, s, H2-Ar), 6.94, (2H, s, H2-Ar), 6.85, 
(2H, s, ArH), 6.75, (4H, d, J 8.8, ArH) 6.58-6.68, (10H, m, ArH), 6.29, (2H, d, J 
8.7, H5-Ar), 6.10, (2H, s, H5-Ar), 5.58, (2H, s, ArCH), 5.48-5.57, (8H, m, 
H2’’,4’’-Gal), 5.46, (2H, s, ArCH), 5.21, (4H, ddd, J 19.6; 10.4; 3.5, H3’’-Gal), 
4.88, (4H, dd, J 12.2; 8, H1’’-Gal), 4.15-4.34, (12H, m, H5’’,6’’-Gal), 2.11-2.37, 
(16H, m, COCH2), 2.00-2.08, 2.22-2.23, (48H, m, OAc-Gal), 1.44-1.59, (16H, m, 
CH2), 0.82-0.93, (24H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 171.2, 171.1, 170.7, 170.6, 170.5, 170.5, 170.3, 
170.2, 170.0, 169.8, 169.5, 169.1 (C=O); 156.1, 147.0, 147.0, 146.8, 146.3, 
135.3, 133.8, 132.7, 132.2, 131.8, 131.5, 131.0, 130.2, 130.2, 130.0, 117.1, 
116.4 (aromatic carbons); 101.1, 100.9, 71.1, 70.9, 68.9, 68.9, 67.1, 67.0, 61.3, 
61.1 (C-Galactose); 43.5 (ArCH); 35.8, 35.6, 35.5, 35.5 (COCH2); 20.6, 20.6, 
20.6, 20.6 (OAc-Galactose); 18.1, 18.0, 18.0, 18.0, 17.8 (CH2); 13.6, 13.5, 13.5 
(CH3). 
Mass Spectrum: Expected: m/z 1386.5179 (M+2NH4)








Minor isomer 154b 
Yield: 5% 
Rf of compound 154b (EtOAc: Pet. ether, 1.5:1): 0.24 
Mp: 116-120 0C 
Vmax (cm-1): 2968 (C-H stretching), 1754 (C=O ester), 1609, 1508, 1492 (C=C 
arene), 1367 (C-H bending), 1216, 1131, 1073 (C-O stretching), 917 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 6.92, (2H, s, H2-Ar), 6.89, (2H, s, H2-Ar), 6.82, 
(8H, d, J 8.4, ArH), 6.67, (8H, d, J 8.2, ArH), 6.29, (2H, s, H5-Ar), 5.97, (2H, s, 
H5-Ar), 5.66, (2H, d, J 2, H4’’-Gal), 5.57, (2H, d, J 3.4, H4’’-Gal), 5.45-5.51, 
(6H, m, H2’’,3’’-Gal), 5.37, (4H, d, J 5.1, ArCH), 5.24, (2H, dd, J 10.4; 3.4, H3’’-
Gal), 5.16, (2H, d, J 7.6, H1’’-Gal), 4.99, (2H, d, J 8.1, H1’’-Gal), 4.44-4.47, (2H, 
t, H5’’-Gal), 4.17-4.31, (10H, m, H5’’,6’’-Gal), 2.08-2.51, (16H, m, COCH2), 
1.94-2.06, 2.23, (48H, m, OAc-Gal), 1.23-1.76, (16H, m, CH2), 0.78-1.03, (24H, 
m, CH3). 
13C NMR (100 MHz CDCl3): δ 171.8, 170.6, 170.6, 170.5, 170.5, 170.4, 170.3, 
170.0, 169.8, 169.5, 169.4 (C=O); 156.0, 155.7, 147.1, 147.1, 147.0, 146.9, 
137.3, 134.3, 131.8, 131.6, 130.9, 129.9, 129.1, 117.5, 117.0, 115.9, 115.7 
(aromatic carbons); 100.0, 99.9, 71.2, 71.2, 70.8, 70.6, 69.4, 68.7, 67.5, 67.1, 
61.7, 61.3 (C-Galactose); 44.1, 43.1 (ArCH); 35.9, 35.8, 35.4, 35.3 (COCH2); 
20.8, 20.8, 20.7, 20.6, 20.6, 20.6, 20.5 (OAc-Galactose); 18.3, 18.1, 17.8, 17.8, 
17.4 (CH2); 13.7, 13.6, 13.5, 13.5 (CH3). 
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Mass Spectrum: Expected: m/z 1386.5179 (M+2NH4)
2+. Observed: m/z 
1386.5188 
 
10.5.5 Acylated calix[4]resorcinarene lactoside 159 
 
Compound 159 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene lactoside 158 (1.50 g,  0.45 mmol) was reacted 
with butyric anhydride (30 mL) and pyridine (5 mL), the crude product was 
separated by silica gel column chromatography using EtOAc: Pet. ether (3:1) as 
eluent to yield one product of the butyrated calix[4]resorcinarene lactoside (0.16 
g, 0.04 mmol). 
Yield: 9%  
Rf of compound 159 (EtOAc: Pet. ether, 3:1): 0.46 
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Mp: 149-153 0C 
Vmax (cm-1): 2968 (C-H stretching), 1745 (C=O ester), 1507 (C=C arene), 1366 
(C-H bending), 1214, 1132, 1042 (C-O stretching), 901 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 6.98, (2H, d, ArH), 6.88-6.91, (3H, m, ArH), 6.41-
6.75, (14H, m, ArH), 6.22, (2H, d, J 4.3, ArH), 6.01, (1H, s, ArH), 5.90, (1H, s, 
ArH), 5.82, (1H, s, ArH), 5.49, (2H, d, J 3.7, ArCH), 5.34-5.43, (6H, m, ArCH+ 
H3’’-Lac), 5.17-5.31, (8H, m, H3’’’,4’’’-Lac), 5.01-5.15, (8H, m, H2’’,2’’’-Lac), 
4.85-4.99, (4H, m, H1’’-Lac), 4.39-4.78, (8H, m, H1’’’,6’’-Lac), 4.07-4.33, (16H, 
m, H5’’,6’’,6’’’-Lac), 3.79-4.04, (8H, m, H4’’,5’’’-Lac), 2.18-2.51, (16H, m, 
OCOCH2), 1.86-2.17, (84H, m, OAc-Lac), 1.35-1.73, (16H, m, CH2), 0.69-1.03, 
(24H, m, CH3). 
13C NMR (100 MHz CDCl3): 171.2, 171.1, 170.6, 170.5, 170.2, 170.2, 170.1, 
170.1, 170.1, 170.0, 169.9, 169.9, 169.8, 169.8, 169.3 (C=O); 155.7, 155.5, 
146.8, 146.7, 146.6, 131.8, 129.9, 129.8, 116.3 (aromatic carbons); 100.8, 70.9, 
69.1, 69.0, 66.8, 60.5 (C-Lactose); 43.96, 43.50 (ArCH); 35.7, 35.7, 35.5, 35.4 
(COCH2); 20.9, 20.8, 20.7, 20.7, 20.6, 20.6, 20.5, 18.2, 18.1 (OAc-Lactose); 
18.0, 18.0, 17.9, 17.9, 17.9, 17.4, 17.2 (CH2); 13.6, 13.6, 13.6, 13.5, 13.5, 13.4 
(CH3). 
Mass Spectrum: Expected: m/z 1962.6870 (M+2NH4)






10.6 Methyl 3-(4’-hydroxyphenyl)propanoate 172 
 
3-(4’-hydroxyphenyl)propanoic acid (16.60 g, 100 mmol) was dissolved in 
MeOH (100 mL), concentrated H2SO4 (2 drops) were added. The reaction 
mixture was refluxed for 24 h at 70 0C, the solvent was evaporated under 
reduced pressure and the residue was taken up in EtOAc (100 mL) then 
washed with saturated aqueous solution of NaHCO3 (100 mL x 2), brine (100 
mL x 2) and dried (MgSO4). The filtrate was concentrated under reduced 
pressure to yield the pure ester as white crystals (17.57 g, 97.50 mmol) (Tung 
et al., 2016).   
Yield: 97% 
Rf of compound 172 (EtOAc: Pet. ether, 1:1): 0.66 
Mp: 40-41 0C 
Vmax (cm-1): 3419 (O-H stretching), 3006, 2952 (C-H stretching), 1717 (C=O 
ester), 1614, 1593, 1515 (C=C arene), 1445, 1432, 1378 (C-H bending), 1266 
(O-H bending), 1193, 1172, 825. 
1H NMR (400 MHz CDCl3): δ 7.06, (2H, d, J 6.8, ArH), 6.83, (2H, d, J 6.6, ArH), 
3.72, (3H, s, COOCH3), 2.92, (2H, t, J 6.1, CH2), 2.66, (2H, t, J 5.6x (2), CH2). 
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13C NMR (75 MHz CDCl3): δ 174.2 (C=O); 154.2, 132.1, 129.3, 115.4, 114.9 
(aromatic carbons); 51.8, 36.1, 30.0 (aliphatic carbons).   
 
10.7 Methyl 3-(4’-benzyloxyphenyl)propionate 173 
 
To a solution of methyl 3-(4’-hydroxyphenyl)propanoate (16.2 g, 89.90 mmol) in 
acetone (250 mL) was added potassium iodide (20.83 g, 125.50 mmol), 
anhydrous potassium carbonate (73.56 g, 532.29 mmol) and benzyl chloride 
(16.04 mL, 139.34 mmol). The reaction mixture was refluxed overnight at 56 0C. 
The cooled mixture filtered and evaporated under reduced pressure. The 
residue was recrystallised from n-hexane to yield the title compound as yellow 
crystals (20.17 g, 74.61 mmol) (Herbert and Kattah 1990). 
Yield: 83% 
Rf of compound 173 (EtOAc: Pet. ether, 1:1): 0.84 
Mp: 77-78 0C 
Vmax (cm-1): 3029, 2954, 2911, 2864 (C-H stretching), 1723 (C=O ester), 1610, 
1581, 1510 (C=C arene), 1463, 1453, 1382 (C-H bending). 
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1H NMR (300 MHz CDCl3): δ 7.35-7.49, (5H, m, Ph), 7.17, (2H, d, J 8.7, ArH), 
6.96, (2H, d, J 8.7, ArH), 5.08, (2H, s, OCH2), 3.71, (3H, s, COOCH3), 2.95, 
(2H, t, J 7.7x(2), CH2), 2.65, (2H, t, CH2). 
13C NMR (75 MHz CDCl3): δ 173.4 (C=O); 157.3, 137.1, 132.9, 129.3, 128.6, 
128.4, 127.9, 127.5, 115.3, 114.9 (aromatic carbons); 70.0, 51.6, 36.0, 30.1 
(aliphatic carbons).  
 
10.8 3-(4’-BenzyloxyphenyI)propan-1-ol 174 
 
To a stirred suspension of lithium aluminium hydride (4.17 g, 110 mmol) in 
anhydrous THF (50 mL) was added a solution of methyl 3-(4-
benzyloxyphenyl)propionate (19.82 g, 73.31 mmol) in THF (150 mL) dropwise 
at 0 0C. The reaction mixture was stirred at r.t. under N2 for 2 h, then water was 
added dropwise to remove the excess reagent and acidified with concentrated 
HCl. The mixture was extracted with EtOAc (100 mL), washed with brine (100 
mL x 2) and dried (MgSO4). The solvent was removed under reduced pressure 
to give the pure alcohol as white crystals (17.62 g, 72.71 mmol) (Kantee et al., 
2016). 
Yield: 99% 
Rf of compound 174 (EtOAc: Pet. ether, 1:1): 0.22 
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Mp: 63-64 0C 
Vmax (cm-1): 3298 (O-H stretching), 3058, 3033, 2938, 2864 (C-H stretching), 
1608, 1581, 1509 (C=C arene), 1453, 1380 (C-H bending), 1239 (=C-O-C 
stretching). 
1H NMR (400 MHz CDCl3): δ 7.29-7.43, (5H, m, Ph), 7.11, (2H, d, J 7.7, ArH), 
6.9, (2H, d, J 7.7, ArH), 5.03, (2H, s, OCH2), 3.65, (2H, t, CH2OH), 2.64, (2H, t, 
J 7.5x(2), CH2), 1.85, (2H, p, J 6.8x(4), CH2), 1.44, (1H, brs, OH). 
13C NMR (100 MHz CDCl3): δ 157.1, 137.2, 134.2, 129.3, 128.5, 128.3, 128.0, 
127.9, 127.6, 127.4, 114.8 (aromatic carbons); 70.1, 62.2, 34.4, 31.2 (aliphatic 
carbons). 
 
10.9 3-(4’-Benzyloxyphenyl)propanal 175 
 
PCC (18.60 g, 86.66 mmol) was suspended in dry DCM (50 mL), a solution of 
3-(4’-benzyloxyphenyI)propan-1-ol (14.00 g, 57.77 mmol) in DCM (100 mL) was 
added at 0 0C. The reaction mixture was allowed to stir at r.t for 3 h, when TLC 
analyses showed that the reaction was complete. The reaction mixture was 
reduced under reduced pressure and was extracted with Et2O (100 mL x 3). 
The solvent was isolated by filtering the black solid and concentrated under 
reduced pressure.  
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The residue was purified by silica gel column chromatography using EtOAc: 
Pet. ether (1:4) as eluent to yield the aldehyde as a colourless oil (8.00 g, 33.29 
mmol) (Kashanna et al., 2012; Tadiparthi et al., 2017).   
Yield: 58% 
Rf of compound 175 (EtOAc: Pet. ether, 1:4): 0.35 
Mp: 36-38 0C 
Vmax (cm-1): 3033, 2928, 2733 (C-H stretching), 1716 (C=O aldehyde), 1609, 
1580, 1511 (C=C arene), 1452, 1381 (C-H bending), 1236 (=C-O-C stretching). 
1H NMR (400 MHz CDCl3): δ 9.85, (1H, s, CHO), 7.35-7.49, (5H, m, Ph), 7.16, 
(2H, d, J 7.8, ArH), 6.96, (2H, d, J 7.7, ArH), 5.09, (2H, s, OCH2), 2.95, (2H, t, 
CH2), 2.79, (2H, t, CH2CHO). 
13C NMR (100 MHz CDCl3): δ 201.7 (C=O); 157.3, 137.1, 132.6, 130.1, 129.2, 
128.6, 128.4, 127.9, 127.4, 115.0, 114.9, 114.8 (aromatic carbons); 70.1, 45.5, 












10.10 3-(4’-Hydroxyphenyl)propanal 170 
 
A solution of 3-(4’-benzyloxyphenyl)propanal (9.79 g, 40.74 mmol) in dry MeOH 
(100 mL) and Pd/C (5%, 1.20 g) was degassed with N2 for 5 min then stirred 
under an atmosphere of H2 at r.t. until TLC analyses showed the completion of 
the reaction. The reaction mixture was filtered off through celite and the filtrate 
was evaporated under reduced pressure. The residue was subjected to silica 
gel column chromatography using EtOAc: Pet. ether (1:2) as eluent to yield the 
title compound as a colourless oil (4.39 g, 29.23 mmol) (Herbert and Kattah 
1990). 
Yield: 72% 
Rf of compound 170 (EtOAc: Pet. ether, 1:2): 0.20 
Mp: 46-48 0C 
Vmax (cm-1): 3347 (O-H stretching), 3013, 2943, 2928, 2866 (C-H stretching), 
1691 (C=O aldehyde), 1608, 1591, 1512 (C=C arene), 1433 (C-H bending), 
1192. 
1H NMR (400 MHz CDCl3): δ 9.82, (1H, s, CHO), 7.07, (2H, d, J 7.8, H2’,6’-Ar), 
6.79, (2H, d, J 7.7, H3’,5’-Ar), 5.88, (1H, broad s, OH), 2.92, (2H, t, CH2), 2.78, 
(2H, t, CH2CHO). 
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13C NMR (100 MHz CDCl3): δ 202.8 (C=O); 154.2, 132.1, 129.6, 129.4, 115.5, 
115.1 (aromatic carbons); 45.4, 27.3 (aliphatic carbons). 
 
10.11 Synthesis of aryl substituted calix[4]resorcinarenes  
10.11.1 Tetra(4-hydroxyphenylethyl)calix[4]resorcinarene 176 
(General procedure) 
 
Resorcinol (0.54 g, 4.99 mmol) and 4-hydroxyphenyl propanal (0.75 g, 4.99 
mmol) were dissolved in EtOH (40 mL), then concentrated HCl (0.74 mL) was 
added dropwise with stirring. The reaction mixture was heated to reflux for 4 h 
at 105 0C, the mixture was allowed to cool down to r.t. A precipitate was formed 
by adding the reaction mixture to cold water. The precipitate was filtered and 
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dried in an oven to yield the title compound as a yellow precipitate (1.00 g, 1.03 
mmol). 
Yield: 21% 
Vmax (cm-1): 3251 (O-H stretching), 2933 (C-H stretching), 1611, 1511 (C=C 
arene), 1436 (C-H bending), 1217, 1167, 1085, 824. 
1H NMR (400 MHz d6-Acetone): δ 8.57, (8H, broad s, ArOH), 8.19, (4H, broad 
s, ArOH), 7.77, (4H, s, H5-Ar), 7.01, (8H, d, J 8.4, H2’’,6’’-Ar), 6.75, (8H, d, J 
8.4, H3’’,5’’-Ar), 6.30, (4H, s, H2-Ar), 4.38, (4H, t, J 7.3x(2), ArCH), 2.51-2.60, 
(16H, m, CH2-CH2). 
13C NMR (100 MHz d6-Acetone): δ 155.3, 151.9, 133.2, 129.4, 124.9, 124.4, 
115.1, 102.9 (aromatic carbons); 36.3, 33.8 (CH2-CH2); 33.6 (ArCH). 















10.11.2 Tetra(4-hydroxyphenylethyl)calix[4]methylresorcinarene 177 
 
Compound 177 was synthesised similarly to compound 176 from 4-
hydroxyphenyl propanal (0.70 g, 4.66 mmol), 2-methylresorcinol (0.58 g, 4.66 
mmol) gave the title compound as a red precipitate (1.19 g, 1.16 mmol). 
Yield: 25% 
Vmax (cm-1): 3334 (O-H stretching), 2939, 2864 (C-H stretching), 1613, 1513 
(C=C arene), 1476, 1444 (C-H bending), 1294 (O-H bending), 1233, 1169, 
1093, 824. 
1H NMR (400 MHz d6-Acetone): δ 8.17, (4H, s, ArOH), 8.05, (8H, s, ArOH), 
7.64, (4H, s, H5-Ar), 6.97, (8H, d, H2’’,6’’-Ar), 6.73, (8H, d, J 4.5, H3’’,5’’-Ar), 
4.44, (4H, t, ArCH), 2.46-2.59, (16H, m, CH2-CH2), 2.06, (12H, m, CH3). 
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13C NMR (100 MHz d6-Acetone): δ 155.3, 155.2, 149.6, 133.3, 129.4, 124.9, 
121.7, 115.0, 114.9, 111.2, 111.1 (aromatic carbons); 36.7 (CH2); 34.7 (ArCH); 
33.9 (CH2); 9.0 (CH3). 
Mass Spectrum: Expected: m/z 1023.4319 (M-H)-. Observed: m/z 1023.4313 
 
10.11.3 Tetra(4-hydroxyphenylethyl)calix[4]pyrogallolarene 178 
 
Compound 178 was synthesised similarly to compound 176 from 4-
hydroxyphenyl propanal (0.70 g, 4.66 mmol), pyrogallol (0.59 g, 4.66 mmol) 






10.12 Methyl 2-(4’-hydroxyphenyl)acetate 179  
 
Compound 179 was synthesised similarly to compound 172 from 4-
hydroxyphenylacetic acid (15.20 g, 100 mmol) to give the pure ester as a 
colourless oil (15.71 g, 94.54 mmol) (Hajji et al., 2006). 
Yield: 95% 
Rf of compound 179 (EtOAc: Pet. ether, 1:1): 0.75 
Vmax (cm-1): 3379 (O-H stretching), 3023, 2953 (C-H stretching), 1711 (C=O 
ester), 1614, 1596, 1514 (C=C arene), 1437 (C-H bending), 1219, 1159, 1009. 
1H NMR (400 MHz CDCl3): δ 7.13, (2H, d, J 8.4, ArH), 6.78, (2H, d, J 8.4, ArH), 
3.74, (3H, s, OCH3), 3.60, (2H, s, CH2CO). 
13C NMR (100 MHz CDCl3): δ 173.6 (C=O); 155.2, 130.4, 130.1, 125.4, 115.9, 







10.13 (4-Benzyloxyphenyl)-acetic acid methyl ester 180 
 
To a solution of methyl 2-(4’-Hydroxyphenyl)acetate (15.50 g, 93.27 mmol) in 
acetone (250 mL) was added potassium iodide (21.61 g, 130.21 mmol), 
anhydrous potassium carbonate (76.32 g, 552.26 mmol) and benzyl chloride 
(16.63 mL, 144.57 mmol). The reaction mixture was refluxed overnight at 56 0C. 
The cooled mixture filtered and evaporated under reduced pressure. The 
residue was recrystallised from n-hexane to yield the title compound as yellow 
crystals (15.32 g, 59.77 mmol) (Desage‐El Murr et al., 2006). 
Yield: 64% 
Rf of compound 180 (EtOAc: Pet. ether, 1:1): 0.79 
Mp: 58-60 0C 
Vmax (cm-1): 3034, 2959, 2930, 2871 (C-H stretching), 1723 (C=O ester), 1607, 
1582, 1508 (C=C arene), 1263, 1234, 1166 (=C-O-C), 1010 (C-H bending). 
1H NMR (300 MHz CDCl3): δ 7.36-7.49, (5H, m, Ph), 7.24, (2H, d, J 8.5, ArH), 




13C NMR (75 MHz CDCl3): δ 172.3 (C=O); 157.9, 137.0, 130.7, 130.3, 128.8, 
128.6, 128.4, 128.1, 128.0, 126.3, 115.3, 114.9 (aromatic carbons); 70.0, 52.0, 
40.3 (aliphatic carbons). 
 
10.14 2-(4’-Benzyloxyphenyl)ethanol 181 
 
Compound 181 was synthesised similarly to compound 174 from (4-benzyloxy-
phenyl)acetic acid methyl ester (15.00 g, 58.52 mmol), LiALH4 (1.5 eq) to give 
the pure alcohol as an off-white solid (12.47 g, 54.62 mmol) (Lingamurthy et al., 
2016). 
Yield: 93% 
Rf of compound 181 (EtOAc: Pet. ether, 1:1): 0.32 
Mp: 83-85 0C 
Vmax (cm-1): 3287 (O-H stretching), 3060, 3032, 2933, 2858 (C-H stretching), 
1608, 1579, 1510 (C=C arene), 1452, 1384 (C-H bending), 1234 (=C-O-C). 
1H NMR (400 MHz CDCl3): δ 7.25-7.37, (5H, m, Ph), 7.07, (2H, d, J 7.6, ArH), 
6.86, (2H, d, J 7.8, ArH), 4.98, (2H, s, OCH2), 3.75, (2H, t, J 6.1x(2), CH2OH), 
2.74, (2H, t, J 6.1x(2), CH2), 1.4, (1H, broad s, OH). 
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13C NMR (100 MHz CDCl3): δ 157.5, 137.1, 130.7, 130.0, 128.5, 127.9, 127.4, 
115.0 (aromatic carbons); 70.1, 63.8, 38.3 (aliphatic carbons). 
 
10.15 2-(4’-Benzyloxyphenyl)acetaldehyde 182 
 
DMP (2.22 g, 5.25 mmol) was added to a solution of 2-(4’-
benzyloxyphenyl)ethanol (1.00 g, 4.38 mmol) in DCM (15 mL) at 0 0C. The 
reaction mixture was allowed to stir overnight at r.t., diluted with DCM and 
washed with saturated aqueous solution of NaHCO3 (25 mL x 3) then with 
saturated aqueous solution of Na2S2O3 (25 mL x 2). The organic layer was 
washed with brine (25 mL x 2), dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by silica gel column chromatography using 
EtOAc: Pet. ether (1:2) as eluent to give the aldehyde as a pale yellow oil (0.71 
g, 3.14 mmol) (Tilley et al., 2012; Nadkarni et al., 2013).  
Yield: 71% 
Rf of compound 182 (EtOAc: Pet. ether, 1:2): 0.45 
Vmax (cm-1): 3031, 2873 (C-H stretching), 1718 (C=O aldehyde), 1610, 1582, 
1509 (C=C arene), 1453, 1382 (C-H bending), 1238, 1175 (=C-O-C), 1011. 
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1H NMR (400 MHz CDCl3): δ 9.76, (1H, t, J 2.4x(2), CHO), 7.35-7.49, (5H, m, 
Ph), 7.17, (2H, d, ArH), 7.02, (2H, d, ArH), 5.11, (2H, s, OCH2), 3.67, (2H, d, J 
2.3, CH2CHO). 
13C NMR (100 MHz CDCl3): δ 199.6 (C=O); 158.2, 136.9, 130.4, 128.7, 128.0, 
127.4, 124.0, 115.4 (aromatic carbons); 70.1, 49.7 (aliphatic carbons). 
 
10.16 2-(4’-Hydroxyphenyl)ethanol 183 
 
4-Benzyloxyphenyl ethanol (5.12 g, 22.42 mmol) was dissolved in dry MeOH 
(100 mL) and Pd/C 5% (0.93 g) was added as a catalyst. The mixture was 
degassed with N2 for 10 min then stirred overnight under H2 atmosphere. The 
catalyst was removed by filtration on a pad of silica gel and the solution was 
evaporated under reduced pressure to yield the title compound as white 
crystals (3.00 g, 21.71 mmol) (Fernandez-Pastor et al., 2016).  
Yield: 97% 
Rf of compound 183 (EtOAc: Pet. ether, 1:1): 0.26 
Mp: 90-91 0C 
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Vmax (cm-1): 3380, 3126 (O-H stretching), 3023, 2927, 2879 (C-H stretching), 
1611, 1510 (C=C arene), 1450 (C-H bending), 1359, 1343, 1228, 1050, 1013, 
815. 
1H NMR (400 MHz d6-DMSO): δ 9.15, (1H, s, OH), 7.01, (2H, d, ArH), 6.68, 
(2H, d, ArH), 4.6, (1H, t, J 5.2x(2), OH), 3.54, (2H, q, J 7.2x(2): 5.1, CH2OH), 
2.62, (2H, t, J 7.3x(2), CH2) 
13C NMR (100 MHz d6-DMSO): δ 155.9, 155.5, 130.1, 130.0, 129.9, 115.4, 
115.0 (aromatic carbons); 63.0, 38.7 (aliphatic carbons). 
 
10.17 2-(4’-Hydroxyphenyl)acetaldehyde 171 
 
To a mixture of 4-hydroxyphenyl ethanol (1.00 g, 7.23 mmol) in DMSO (8 mL), 
and TEA (2.20 mL, 16 mmol), a solution of SO3.Pyridine (2.50 g, 16 mmol) in 
DMSO (9 mL) was added dropwise under N2 atmosphere. After 1 h of stirring at 
r.t., the reaction mixture was quenched with water, acidified with 2 M HCl (10 
mL) and extracted with EtOAc. The organic layer was washed with brine, dried 
(MgSO4) and concentrated under reduced pressure. Purification by silica gel 
column chromatography using EtOAc: Pet. ether (1:2) as eluent furnished the 




Rf of compound 171 (EtOAc: Pet. ether, 1:2): 0.37 
Vmax (cm-1): 3352 (O-H stretching), 1708 (C=O aldehyde), 1612, 1595, 1513 
(C=C arene), 1443 (C-H bending), 1363, 1221, 827. 
1H NMR (400 MHz CDCl3): δ 9.73, (1H, t, CHO), 7.08, (2H, d, J 8.6, H2’,6’-Ar), 
6.86, (2H, d, J 4.4, H3’,5’-Ar), 3.64, (2H, d, J 2.3, CH2). 
13C NMR (100 MHz CDCl3): δ 200.4 (CHO); 155.3, 130.8, 123.4, 115.9 





4-(2’,3’,4’,6’-Tetra-O-acetyl-β-D-glucopyranosyloxy)benzaldehyde (3.40 g, 7.51 
mmol) was dissolved in THF (75 mL) with KOtBu (0.84 g, 7.50 mmol), 1,3-
dioxolan-2-ylmethyltriphenylphosphonium bromide (3.95 g, 9.21 mmol) was 
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added portionwise and the reaction mixture heated under reflux with stirring 
overnight. The reaction mixture was diluted with water (100 mL) and extracted 
with EtOAc, the aqueous layer was extracted with DCM (50 mL x 2). The 
combined organic layers dried (MgSO4) and concentrated under reduced 
pressure. The crude mixture was purified by silica gel column chromatography 
using EtOAc: Pet. ether (1.5:1) as eluent to yield the title compound as a 
mixture of E/Z isomers as a white powder (0.97 g, 0.93 mmol) (Ka et al., 2016). 
Yield: 25% 
Rf of compound 194 (EtOAc: Pet. ether, 1.5:1): 0.34 and 0.26 for E/Z isomers 
Vmax (cm-1): 2964 (C-H stretching), 1739 (C=O ester), 1603, 1509 (C=C 
arene), 1366 (C-H bending), 1213, 1031 (C-O stretching), 847 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 6.34-7.39, (4H, dd, H2’’,6’’-Ar), 6.96-7.00, (4H, t, 
H3’’,5’’-Ar), 6.77, (2H, dd, J 2.1, ArCH2’), 6.09, (1H, dd, J 16; 6.1, CH=CH1’), 
5.71, (1H, dd, J 11.6; 7.5, CH=CH1’), 5.51, (1H, d, J 6.7, CH2), 5.43, (1H, d, J 
6.1, CH2), 5.30-5.33, (4H, m, H3’’’,4’’’-Glu), 5.17-5.24, (2H, m, H2’’’-Glu), 5.11-
5.13, (2H, m, H1’’’-Glu), 4.29-4.35, (2H, m, H6’’’-Glu), 4.18-4.22, (2H, m, H6’’’-
Glu), 4.07-4.12, (4H, m, CH2-CH2), 3.93-4.00, (4H, m, CH2-CH2), 3.87-3.92, (2H, 
m, H5’’’-Glu), 2.06-2.11, (24H, m, OAc). 
13C NMR (100 MHz CDCl3): δ 170.5, 170.2, 169.3, 169.2 (C=O); 156.8, 156.4 
(aromatic carbon); 133.9 (ArCH=); 131.8, 131.2, 131.0, 130.3, 130.1, 128.2 
(aromatic carbons); 124.3 (=CH); 117.2, 117.0, 116.8, 116.6 (aromatic 
carbons); 103.8 (CH); 98.9, 72.7, 72.5, 72.3, 72.2, 72.1, 71.2, 71.0, 68.3, 61.9, 







The E/Z mixture of 2-{2’-[4’’-(2’’’,3’’’,4’’’,6’’’-tetra-O-acetyl-β-D- 
glucopyranosyloxy)phenyl]ethenyl}-1,3-dioxolane (1.82 g, 3.48 mmol) was 
dissolved in CCl4 (50 mL) and cooled to 0 
0C then a solution of Br2 (0.02 g, 0.13 
mmol) in CCl4 (5 mL) was added. After 5 min the mixture was stirred for 1 h at 
r.t. and water (5 mL) and AcOH (5 mL) were added and stirring was continued 
overnight. The reaction mixture was diluted with DCM (50 mL) and an aqueous 
solution of KOH was added. The aqueous layer was extracted with DCM (50 
mL x 2), the combined organic layers were washed with a saturated aqueous 
solution of Na2S2O3 (100 mL), saturated aqueous NaHCO3 (100 mL), water 
(100 mL), dried (MgSO4) and the solvent concentrated under reduced pressure. 
The crude mixture was refluxed with Et2O (50 mL) for 3 h and allowed to cool to 
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r.t. After 24 h at r.t. a white powder was collected (1.24 g, 2.6 mmol) 
(Daubresse et al., 1998). 
Yield: 74% 
Rf of compound 195 (EtOAc: Pet. ether, 1:1): 0.32 
Mp: 150-152 0C 
Vmax (cm-1): 2960 (C-H stretching), 1739 (C=O ester), 1664 (C=O aldehyde), 
1626 (C=C), 1603, 1511 (C=C arene), 1365 (C-H bending), 1211, 1033 (C-O 
stretching), 914, 825, 742, 723 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 9.70, (1H, d, J 7.7, CHO), 7.55, (2H, d, H2’,6’-Ar), 
7.46, (1H, d, J 15.9, CH3), 7.06, (2H, d, H3’,5’-Ar), 6.66, (1H, dd, J 15.9, 7.7, 
CH2), 5.30-5.37, (2H, m, H3’’,4’’-Glu), 5.18-5.24, (2H, m, H1’’,2’’-Glu), 4.32, 
(1H, dd, J 5.4, H6b’’-Glu), 4.21, (1H, dd, J 2.4, H6a’’-Glu), 3.91-3.95, (1H, m, 
H5’’-Glu), 2.11, (3H, s, OAc), 2.09, (6H, s, OAc), 2.07, (3H, s, OAc). 
13C NMR (100 MHz CDCl3): δ 193.5 (CHO); 170.5, 170.2, 169.4, 169.2 (C=O); 
158.9 (aromatic carbon); 151.7 (ArCH=); 130.2 (aromatic carbons); 129.3 
(CHCHO); 127.8, 117.3 (aromatic carbons); 98.4, 72.6, 72.3, 71.1, 68.2, 61.9 










To a solution of (E)-3-[4’-(2’’,3’’,4’’,6’’-tetra-O-acetyl-β-D-
glucopyranosyloxy)phenyl] prop-2-enal (3.85 g, 8.05 mmol) in MeOH (100 mL) 
was added 5% Pd/C (600 mg). The solution was degassed with N2 for 10 min 
then stirred under H2 atmosphere for 2 h. The reaction mixture was filtered and 
the filtrate concentrated under reduced pressure, the crude product was purified 
by silica gel column chromatography using EtOAc: Pet. ether (2:1) as eluent to 
produce white crystals of compound 167 (0.75 g, 1.56 mmol). 
Yield: 19% 
Rf of compound 167 (EtOAc: Pet. ether, 2:1): 0.61 
Mp: 139-141 0C 
335 
 
Vmax (cm-1): 2957 (C-H stretching), 1746 (C=O), 1612, 1513 (C=C arene), 
1372 (C-H bending), 1209, 1038 (C-O stretching), 909 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 9.81, (1H, t, J 1.2x(2), CHO), 7.12, (2H, d, J 8.7, 
H2’,6’-Ar), 6.92, (2H, d, H3’,5’-Ar), 5.25, (3H, m, H2’’,3’’,4’’-Glu), 5.04, (1H, d, J 
7.6, H1’’-Glu), 4.29, (1H, dd, J 5.3, H6b’’-Glu), 4.17, (1H, dd, J 2.4, H6a’’-Glu), 
3.84, (1H, m, H5’’-Glu), 2.92, (2H, t, CH2), 2.76, (2H, t, CH2), 2.08, (3H, s, OAc), 
2.06, (3H, s, OAc), 2.05, (3H, s, OAc), 2.04, (3H, s, OAc). 
13C NMR (100 MHz CDCl3): δ 201.3 (CHO); 170.5, 170.2, 169.3, 169.2 (C=O); 
155.4, 135.3, 129.3, 117.2 (aromatic carbons); 99.3, 72.7, 72.0, 71.2, 68.3, 61.9 

















10.21 Synthesis of tetra(4-
glucophenylethyl)calix[4]resorcinarene 164 
 
A solution of 3-[4’-(2’’,3’’,4’’,6’’-tetra-O-acetyl-β-D-
glucopyranosyloxy)phenyl]propanal (1.24 g, 2.58 mmol) in a mixture of Et2O 
and THF (1:1 ratio, 30 mL) was added anhydrous AlCl3 (1.5 eq) and the mixture 
was stirred under N2 for 15 min. Subsequently, resorcinol (0.28 g, 2.58 mmol) 
was added and the mixture was stirred at r.t. for a further 48 h. A precipitate 
was obtained by adding the reaction mixture to Et2O (100 mL). The precipitate 
was filtered and washed many times with Et2O. The solid was then dissolved in 
EtOAc and the organic layer was washed with water (100 mL x 3) then dried 
(MgSO4). The solvent was concentrated under reduced pressure to give the 
desired compound as a red precipitate (1.20 g, 0.52 mmol, 20%), which was 




10.22 Acylation of tetra(4-
glucophenylethyl)calix[4]resorcinarene  
 
Compound 196 was synthesised according to the general procedure. The crude 
mixture of tetra(4-glucophenylethyl)calix[4]resorcinarene 164 (1.79 g, 0.78 
mmol) was reacted with butyric anhydride (30 mL) and pyridine (5 mL), the 
crude product was separated by silica gel column chromatography using 
EtOAc: Pet. ether (2:1) as eluent to yield one product of the butyrated 
calix[4]resorcinarene glucoside as off-white powder (0.26 g, 0.09 mmol). 
Yield: 12% 
Rf of compound 196 (EtOAc: Pet. ether, 2:1): 0.35 
Mp: 106-108 0C 
338 
 
Vmax (cm-1): 2965 (C-H stretching), 1748 (C=O ester), 1609, 1509 (C=C 
arene), 1366 (C-H bending), 1216, 1132, 1034 (C-O stretching), 907 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 6.46-7.20, (24H, m, H2,5,2’’,3’’,5’’,6’’-Ar), 5.11-
5.47, (12H, m, H2’’’,3’’’,4’’’-Glu), 4.91-5.09, (4H, m, H1’’’-Glu), 4.06-4.42, (12H, 
m, ArCH + H6’’’-Glu), 3.74-3.95, (4H, m, H5’’’-Glu), 2.11-2.83, (32H, m, 
CH2CH2, COCH2), 1.96-2.05, (48H, m, OAc-Glu), 1.46-1.76, (16H, m, CH2), 
0.73-1.08, (24H, m, CH3).  
13C NMR (100 MHz CDCl3): δ 171.4, 171.1, 170.5, 170.2, 169.4, 169.2 (C=O); 
155.3, 155.2, 154.9, 147.9, 147.8, 147.2, 147.0, 146.5, 146.2, 146.0, 145.8, 
136.4, 136.2, 136.1, 135.9, 132.5, 131.2, 131.1, 129.7, 129.6, 117.9, 117.1, 
116.9, 116.8, 116.6 (aromatic carbons); 99.4, 72.7, 71.9, 71.1, 68.2, 61.9 (C-
Glucose); 35.6, 35.5 (COCH2); 32.6 (CH2-CH2); 20.7, 20.6, 20.6 (OAc-
Glucose); 18.2, 18.2, 18.2, 18.1, 18.0, 17.9, 17.4 (CH2); 13.7, 13.6, 13.6, 13.5 
(CH3). 












10.23 Synthesis of calix[4]methylresorcinarene glycosides  
(General procedure) 
To a stirred solution of glycosyl benzaldehyde (1 eq) in a mixture of Et2O and 
THF (1:1 ratio, 30 mL) was added anhydrous AlCl3 (2 eq) and the mixture was 
stirred under N2 for 15 min. Subsequently, 2-methylresorcinol (1 eq) was added 
and the mixture was stirred at r.t. for a further 48 h.  A precipitate was obtained 
by adding the reaction mixture to Et2O (100 mL). The precipitate was filtered 
and washed many times with Et2O. The solid was then dissolved in EtOAc and 
the organic layer was washed with water (100 mL x 2) then dried (MgSO4). The 
solvent was concentrated under reduced pressure to give the desired 












10.23.1 Calix[4]methylresorcinarene glucoside 215 
 
Compound 215 was synthesised according to the general procedure from 4-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)benzaldehyde (1.50 g, 3.31 
mmol), 2-methylresorcinol (0.41 g, 3.31 mmol) and anhydrous AlCl3 (0.88 g, 
6.63 mmol)  in a mixture of Et2O and THF (1:1 ratio, 30 mL) gave a red 








10.23.2 Calix[4]methylresorcinarene glucoside 217 
 
Compound 217 was synthesised according to the general procedure from 3-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)benzaldehyde (1.20 g, 2.65 
mmol), 2-Methylresorcinol (0.32 g, 2.65 mmol) and anhydrous AlCl3 (0.70 g, 
5.30 mmol) in a mixture of Et2O and THF (1:1 ratio, 20 mL) gave a red 









10.23.3 Calix[4]methylresorcinarene galactoside 219 
 
Compound 219 was synthesised according to the general procedure from 4-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-galactopyranosyloxy)benzaldehyde (0.80 g, 1.77 
mmol), 2-Methylresorcinol (0.21 g, 1.77 mmol) and BF3.Et2O (0.43 mL, 3.53 
mmol) in Et2O (15 mL) gave a yellow precipitate of the desired compound (0.57 









10.23.4 Calix[4]methylresorcinarene lactoside 223 
 
To a stirred solution of 4-(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-
lactosyl)benzaldehyde (0.46 g, 0.62 mmol) and 2-methylresorcinol (0.07 g, 0.62 
mmol) in anhydrous DCM (15 mL) was added BF3.Et2O (0.15 mL, 1.24 mmol) 
and stirring was continued overnight under N2 atmosphere. The reaction 
mixture was then diluted with water (20 mL) and DCM (40 mL), the organic 
layer was washed with brine (50 mL), dried (MgSO4) and evaporated under 






10.23.5 Calix[4]methylresorcinarene cellobioside 224 
 
Compound 224 was synthesised similarly to compound 223 from 4-
(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-cellobiosyl)benzaldehyde (0.50 g, 0.67 
mmol), 2-methylresorcinol (0.08 g, 0.67 mmol) and BF3.Et2O (0.16 mL, 1.35 








10.24 Esterfication of calix[4]methylresorcinarene 
glycosides  
10.24.1 Acylated calix[4]methylresorcinarene glucoside 216 
 
Compound 216 was synthesised according to the general procedure. The crude 
mixture of calix[4]methylresorcinarene glucoside 215 (3.05 g, 1.36 mmol) was 
reacted with butyric anhydride (30 ml) and pyridine (5 ml), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(1.5:1) as eluent to yield one product of the butyrated 
calix[4]methylresorcinarene glucoside as yellow crystals (0.93 g, 0.33 mmol). 
Yield: 24% 
Rf of compound 216 (EtOAc: Pet. ether, 1.5:1): 0.16 
Mp: 132-135 0C 
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Vmax (cm-1): 2967 (C-H stretching), 1747 (C=O ester), 1608, 1507 (C=C 
arene), 1365 (C-H bending), 1216, 1132, 1071, 1033 (C-O stretching), 907 (C-
H bending). 
1H NMR (400 MHz CDCl3): δ 6.76, (1H, brs, H5-Ar), 6.62, (16H, dd, J 15.1; 6.8, 
H2’,3’,5’,6’-Ar), 6.1, (2H, d, H5-Ar), 5.80, (1H, brs, H5-Ar), 5.11-5.64, (16H, m, 
ArCH+ H2’’,3’’,4’’-Glu), 4.96, (4H, d, J 7.9, H1’’-Glu), 3.86-4.61, (12H, m, 
H5’’,6’’-Glu), 2.20-2.65, (16H, m, COCH2), 1.96-2.17, (48H, m, OAc-Glu), 1.85, 
(6H, s, CH3-resorcinol), 1.81, (3H, s, CH3-resorcinol), 1.72, (3H, s, CH3-
resorcinol), 1.42-1.63, (16H, m, CH2), 0.65-1.13, (24H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 170.6, 170.5, 170.2, 170.0, 169.7, 169.6, 169.5, 
169.3 (C=O); 156.0, 146.8, 146.6, 146.2, 131.8, 131.6, 130.3, 129.6, 124.3, 
116.2 (aromatic carbons); 100.1, 72.9, 72.7, 72.1, 71.9, 71.7, 71.4, 71.2, 68.5, 
62.3, 62.0 (C-Glucose); 44.3 (ArCH); 35.3, 35.3 (COCH2); 20.7, 20.6, 20.6, 
20.6, 20.5, 20.5, 20.4 (OAc-Glucose); 18.1, 18.0, 17.9 (CH2); 13.8, 13.7, 13.6 
(CH3); 10.8 (CH3-resorcinol).  
Mass Spectrum: Expected: m/z 1414.5493 (M+2NH4)









10.24.2 Acylated calix[4]methylresorcinarene glucoside 218 
 
Compound 218 was synthesised according to the general procedure. The crude 
mixture of calix[4]methylresorcinarene glucoside 217 (3.00 g, 1.34 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(1.5:1) as eluent to yield one product of the butyrated 
calix[4]methylresorcinarene glucoside as a yellow powder (0.61 g, 0.22 mmol). 
Yield: 16% 
Rf of compound 218 (EtOAc: Pet. ether, 1.5:1): 0.28 
Mp: 127-130 
Vmax (cm-1): 2967 (C-H stretching), 1747 (C=O ester), 1588 (C=C arene), 




1H NMR (400 MHz CDCl3): δ 5.71-7.22 (20H, m, H5,2’,4’,5’,6’-Ar), 5.08-5.65 
(16H, m, H2’’,3’’,4’’-Glu+ ArCH), 4.74-5.03 (4H, m, H1’’-Glu), 3.65-4.57 (12H, 
m, H5’’,6’’-Glu), 2.22-3.04 (16H, m, COCH2), 1.89-2.17 (48H, m, OAc-Glu), 
1.70-1.82 (12H, m, CH3-resorcinol), 1.26-1.67 (16H, m, CH2), 0.67-1.19 (24H, 
m, CH3). 
13C NMR (100 MHz CDCl3): δ 170.5, 170.1, 169.7, 169.3 (C=O); 146.4, 128.9, 
124.6, 115.6 (aromatic carbons); 72.9, 72.8, 71.8, 71.2, 68.3, 62.0, 61.4 (C-
Glucose); 35.5, 35.4 (COCH2); 20.5, 20.5 (OAc-Glucose); 18.4, 18.2, 18.0, 17.9 
(CH2); 13.7, 13.6, 13.4 (CH3); 10.8, 10.7 (CH3-resorcinol). 
Mass Spectrum: Expected: m/z 1414.5493 (M+2NH4)
















10.24.3 Acylated calix[4]methylresorcinarene galactoside 220 
 
Compound 220 was synthesised according to the general procedure. The crude 
mixture of calix[4]methylresorcinarene galactoside 219 (0.50 g, 0.22 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(1.5:1) as eluent to yield one product of the butyrated 
calix[4]methylresorcinarene galactoside as yellow crystals (0.04 g, 0.01 mmol). 
Yield: 6% 




Vmax (cm-1): 2966 (C-H stretching), 1745 (C=O ester), 1608, 1507 (C=C 
arene), 1367 (C-H bending), 1217, 1132, 1072 (C-O stretching), 916 (C-H 
bending). 
1H NMR (400 MHz CDCl3): δ 6.76, (1H, brs, H5-Ar), 6.65, (16H, d, J 7.7, 
H2’,3’,5’,6’-Ar), 6.13, (2H, d, H5-Ar), 5.88, (1H, brs, H5-Ar), 5.40-5.74, (8H, m, 
H2’’,4’’-Gal), 5.28, (4H, d, J 7.7, H3’’-Gal+ ArCH), 5.17, (4H, d, J 7.9, H3’’-Gal+ 
ArCH), 4.92, (2H, d, J 8.1, H1’’-Gal), 4.77-4.88, (2H, brs, H1’’-Gal), 3.90-4.51, 
(12H, m, H5’’,6’’-Gal), 2.30-2.77, (16H, m, COCH2), 1.94-2.26, (48H, m, OAc-
Gal), 1.86, 1.82, 1.76 (12H, m, CH3-resorcinol), 1.27-1.65, (16H, m, CH2), 0.74-
1.08, (24H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 170.7, 170.6, 170.3, 170.2, 170.1, 169.7, 169.5, 
169.1 (C=O); 156.0, 146.6, 130.3, 128.5, 127.6, 126.9, 116.4 (aromatic 
carbons); 71.2, 71.0, 70.9, 69.1, 68.9, 67.1, 67.0, 65.3, 61.4 (C-Galatose); 44.2* 
(ArCH); 35.4, 35.2 (COCH2); 20.8, 20.6, 20.6, 20.6, 20.5 (OAc-Galactose); 
18.1, 18.0, 17.9, 17.4, 17.2 (CH2); 13.8, 13.7, 13.6, 13.6 (CH3); 10.8
* (CH3-
resorcinol). 
Mass Spectrum: Expected: m/z 1414.5493 (M+2NH4)
2+. Observed: m/z 
1414.5494 
* Peaks are not assigned in 13C NMR spectrum but clearly observed from DEPT 







10.24.4 Acylated calix[4]methylresorcinarene lactoside 227 
 
Compound 227 was synthesised according to the general procedure. The crude 
mixture of calix[4]methylresorcinarene lactoside 223 (0.40 g, 0.12 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(gradient ratio) as eluent to yield one product of the butyrated 









10.24.5 Acylated calix[4]methylresorcinarene cellobioside 228 
 
Compound 228 was synthesised according to the general procedure. The crude 
mixture of calix[4]methylresorcinarene cellobioside 224 (0.47 g, 0.14 mmol) was 
reacted with butyric anhydride (30 ml) and pyridine (5 ml), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 








10.25 Synthesis of calix[4]pyrogallolarene glycosides 
10.25.1 Calix[4]pyrogallolarene glucoside 221  
 
To a stirred solution of 4-(2’,3’,4’,6’-tetra-O-acetyl-β-D-
glucopyranosyloxy)benzaldehyde (2.87 g, 6.34 mmol) in a mixture of Et2O and 
THF (1:1 ratio, 50 mL) was added a solution of AlCl3.PhNO2 (2.70 mL, 25.37 
mmol) and the mixture was stirred under N2 for 15 min. Subsequently, 
pyrogallol (0.80 g, 6.34 mmol) was added and the mixture was stirred at r.t for a 
further 72 h. A precipitate was obtained by adding the reaction mixture to Et2O 
(200 mL). The precipitate was filtered and washed many times with Et2O. The 
solid was then dissolved in EtOAc and the organic layer was washed with water 
(100 mL x 4) then dried (MgSO4). The solvent was evaporated under reduced 





10.25.2 Calix[4]pyrogallolarene lactoside 225  
 
To a stirred solution of 4-(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-
lactosyl)benzaldehyde (0.70 g, 0.94 mmol) and pyrogallol (0.11 g, 0.94 mmol) 
in anhydrous DCM (20 mL) was added BF3.Et2O (0.23 mL, 1.89 mmol) and 
stirring was continued overnight under N2 atmosphere. The reaction mixture 
was then diluted with water (30 mL) and DCM (50 mL), the organic layer was 
washed with brine (50 mL), dried (MgSO4) and evaporated under reduced 






10.25.3 Calix[4]pyrogallolarene cellobioside 226 
 
Compound 226 was synthesised similarly to compound 225 from 4-
(2’,3’,6’,2’’,3’’,4’’,6’’-heptaacetyl-β-D-cellobiosyl)benzaldehyde (0.50 g, 0.67 
mmol), pyrogallol (0.08 g, 0.67 mmol) and BF3.Et2O (0.16 ml, 1.35 mmol) in 
anhydrous DCM (15 mL) gave the desired compound as a brown solid (0.40 g, 








10.26 Esterfication of calix[4]pyrogallolarene glycosides 
10.26.1 Acylated calix[4]pyrogallolarene glucoside 222 
 
Compound 222 was synthesised according to the general procedure. The crude 
mixture of calix[4]pyrogallolarene glucoside 221 (2.31 g, 1.03 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was purified by silica gel column chromatography using EtOAc: Pet. ether (2:1) 
as eluent to yield one product of the butyrated calix[4]pyrogallolarene glucoside 
as a yellow powder (0.23 g, 0.07 mmol).  
Yield: 7% 
Rf of compound 222 (EtOAc: Pet. ether, 2:1): 0.41 
Mp: 130-134 0C 
357 
 
Vmax (cm-1): 2967 (C-H stretching), 1746 (C=O ester), 1607, 1508 (C=C 
arene), 1436, 1365 (C-H bending), 1217, 1177, 1126, 1070, 1033 (C-O 
stretching), 907 (C-H bending). 
1H NMR (400 MHz CDCl3): δ 6.54-7.12, (16H, m, H2’,3’,5’,6’-Ar), 6.30, (2H, d, 
H5-Ar), 6.08, (2H, s, H5-Ar), 5.61, (2H, d, ArCH), 5.46, (2H, d, J 4.5, ArCH), 
4.89-5.14, (16H, m, H1’’,2’’,3’’,4’’-Glu), 3.75-4.40, (12H, m, H5’’,6’’-Glu), 2.21-
2.79, (24H, m, COCH2), 1.97-2.20, (48H, m, OAc-Glu), 1.39-1.87, (24H, m, 
CH2), 0.68-1.18, (36H, m, CH3). 
13C NMR (100 MHz CDCl3): δ 170.6, 170.6, 170.2, 170.1, 170.0, 169.7, 169.6, 
169.5, 169.4, 169.3, 169.1, 169.0, 168.9 (C=O); 156.2, 156.0, 140.5, 140.3, 
140.2, 136.2, 132.9, 132.6, 132.4, 130.5, 130.4, 116.8, 116.1 (aromatic 
carbons); 72.7, 71.9, 71.3, 71.1, 68.7, 68.2, 61.8 (C-Glucose); 43.9* (ArCH); 
35.5, 35.4, 35.1, 35.0, 34.9 (COCH2); 20.8, 20.7, 20.7, 20.6 (OAc-Glucose); 
18.3, 18.2, 18.1, 18.1, 18.0, 17.9, 17.5, 17.2 (CH2); 13.7, 13.6, 13.6, 13.5, 13.5 
(CH3). 
Mass Spectrum: Expected: m/z 1558.5916 (M+2NH4)
2+. Observed: m/z 
1558.5918 
* Peaks are not assigned in 13C NMR spectrum but clearly observed from DEPT 






10.26.2 Acylated calix[4]pyrogallolarene lactoside 229 
 
Compound 229 was synthesised according to the general procedure. The crude 
mixture of calix[4]pyrogallolarene lactoside 225 (0.50 g, 0.15 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(gradient ratio) as eluent to yield one product of the butyrated 







10.26.3 Acylated calix[4]pyrogallolarene cellobioside 230 
 
Compound 230 was synthesised according to the general procedure. The crude 
mixture of calix[4]pyrogallolarene cellobioside 226 (0.75 g, 0.22 mmol) was 
reacted with butyric anhydride (30 mL) and pyridine (5 mL), the crude product 
was separated by silica gel column chromatography using EtOAc: Pet. ether 
(gradient ratio) as eluent to yield one product of the butyrated 







10.27 Synthesis of glycol-β-D-monoglucosides 
tetraacetate (General procedure) 
To a solution of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide (4.11 g, 10 
mmol) in dry DCM (50 mL), a corresponding diol (10 mL) was added under N2 
atmosphere. After stirring for 15 min at r.t. HgBr2 (3.80 g, 10 mmol) was added 
to the mixture and stirring was continued overnight. The reaction mixture was 
diluted with DCM (50 mL) and washed with aqueous solution of KI 5% (50 mL x 
3) and water (100 mL), dried (MgSO4) and evaporated under reduced pressure. 
Colourless oil was obtained followed by silica gel column chromatography to 
yield the corresponding glycols (Wang et al., 2007). 
 
10.27.1 2-Hydroxy ethyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranoside 
234 
 
Compound 234 was synthesised according to the general procedure from 
ethylene glycol (10 mL, 179.30 mmol), the crude mixture was purified by silica 
gel column chromatography using EtOAc: Pet. ether (3:1) as eluent to give the 
title compound as a white solid (1.46 g, 3.72 mmol). 
Yield: 37% 
Rf of compound 234 (EtOAc: Pet. ether, 3:1): 0.31 
361 
 
Mp: 103-104 0C 
Vmax (cm-1): 3467 (O-H stretching), 2963 (C-H stretching), 1750, 1716 (C=O 
ester), 1380, 1363 (C-H bending), 1237, 1206, 1057, 1034 (C-O stretching), 
907. 
1H NMR (400 MHz CDCl3): δ 5.24, (1H, t, H3’-Glu), 4.99-5.09, (2H, m, H2’,4’-
Glu), 4.56, (1H, d, J 7.9, H1’-Glu), 4.2, (2H, d, J 4.2, CH2), 3.85, (2H, t, CH2), 
3.66-3.78, (3H, m, H5’,6a’,6b’-Glu), 2.46, (1H, t, OH), 2.10, (3H, s, OAc), 2.06, 
(3H, s, OAc), 2.04, (3H, s, OAc), 2.01, (3H, s, OAc). 
13C NMR (100 MHz CDCl3): δ 170.6, 170.2, 169.4, 169.4 (C=O); 101.4, 73.1, 
72.6, 71.9, 71.3, 68.4 (C-Glucose+ CH2); 62.0, 62.0 (CH2OH, C-Glucose); 20.6, 





Compound 235 was synthesised according to the general procedure from 
diethyleneglycol (10 mL, 105.35 mmol), the crude mixture was purified by silica 
gel column chromatography using EtOAc: Pet ether (4:1) as eluent to give the 




Rf of compound 235 (EtOAc: Pet. ether, 4:1): 0.22 
Mp: 85-86 0C 
Vmax (cm-1): 3528 (O-H stretching), 2970 (C-H stretching), 1752, 1721 (C=O 
ester), 1375 (C-H bending), 1209, 1028 (C-O stretching). 
1H NMR (400 MHz CDCl3): δ 5.22, (1H, t, H3’-Glu), 5.1, (1H, t, H4’-Glu), 5.01, 
(1H, dd, J 9.4, 8.1, H2’-Glu), 4.62, (1H, d, J 7.8, H1’-Glu), 4.27, (1H, dd, H6b’-
Glu), 4.15, (1H, dd, H6a’-Glu), 3.95-3.99, (1H, m, CH), 3.57-3.77, (8H, m, 
CH2CH2OCH2CH+ H5’-Glu), 2.29, (1H, t, OH), 2.10, (3H, s, OAc), 2.06, (3H, s, 
OAc), 2.03, (3H, s, OAc), 2.01, (3H, s, OAc).  
13C NMR (100 MHz CDCl3): δ 170.7, 170.2, 169.5, 169.4 (C=O); 100.7, 72.7, 
72.4, 71.8, 71.3, 70.0, 68.9, 68.3, 61.9, 61.6 (C-Glucose+ CH2CH2OCH2CH2); 














10.27.3 3-Hydroxy propyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-
glucopyranoside 236 
 
Compound 236 was synthesised according to the general procedure from 1,3-
propanediol (10 mL, 138.37 mmol), the crude mixture was purified by silica gel 
column chromatography using EtOAc: Pet. ether (3:1) as eluent to give the title 
compound as a white solid (1.08 g, 2.65 mmol). 
Yield: 26% 
Rf of compound 236 (EtOAc: Pet. ether, 3:1): 0.28 
Mp: 93-94 0C 
Vmax (cm-1): 3527 (O-H stretching), 2966 (C-H stretching), 1737 (C=O ester), 
1382 (C-H bending), 1211, 1162, 1096, 1035 (C-O stretching), 906.  
1H NMR (400 MHz CDCl3): δ 5.21, (1H, t, H3’-Glu), 5.08, (1H, t, H4’-Glu), 4.99, 
(1H, dd, J 9.5, 7.9, H2’-Glu), 4.53, (1H, d, J 7.9, H1’-Glu), 4.25, (1H, dd, J 4.9, 
H6b’-Glu), 4.17, (1H, dd, J 2.6, H6a’-Glu), 3.98-4.04, (1H, m, CH), 3.67-3.75, 
(4H, m, CH2CH+ H5’-Glu), 2.10, (3H, s, OAc), 2.06, (3H, s, OAc), 2.03, (3H, s, 
OAc), 2.01, (3H, s, OAc), 1.89, (1H, t, J 5.7x(2), OH), 1.78-1.87, (2H, m, CH2). 
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13C NMR (100 MHz CDCl3): δ 170.7, 170.2, 169.5, 169.4 (C=O); 100.7, 72.7, 
71.8, 71.2, 68.4 (C-Glucose); 67.7 (CH2); 61.9 (C-Glucose); 60.0 (CH2OH); 32.0 
(CH2CH2CH2OH); 20.7, 20.6, 20.6, 20.6 (OAc-Glucose). 
 
10.28 Synthesis of bridge aldehydes functionalised β-D-
monoglucosides tetraacetate (General procedure) 
To a stirred solution of hydroxyl alkyl glucosides (1 eq) in dry DCM (30 mL) 
under N2, DMP (1 eq) was added as a solid to the reaction mixture. After stirring 
for 3 h at r.t., saturated aqueous solution of NaHCO3 with Na2S2O3 (40 mL) was 
added to the reaction mixture with stirring for 5 min, the mixture was diluted with 
DCM and separated. The organic layer dried (MgSO4) and the solvent was 
evaporated under reduced pressure, colourless oil was obtained followed by 
silica gel column chromatography to yield the corresponding aldehyde 





Compound 237 was synthesised according to the general procedure from 2-
hydroxy ethyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranoside (1.40 g, 3.56 mmol), 
the crude mixture was purified by silica gel column chromatography using 
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EtOAc: Pet. ether (2:1) as eluent to give the title compound as a white solid 
(0.89 g, 2.28 mmol). 
Yield: 63% 
Rf of compound 237 (EtOAc: Pet. ether, 2:1): 0.30 
Mp: 98-99 0C 
Vmax (cm-1): 2954 (C-H stretching), 1734 (C=O), 1367 (C-H bending), 1205, 
1032 (C-O stretching), 906. 
1H NMR (400 MHz CDCl3): δ 9.68, (1H, d, J 0.6, CHO), 5.25, (1H, t, H3’-Glu), 
5.07-5.12, (2H, m, H2’,4’-Glu), 4.6, (1H, d, J 7.9, H1’-Glu), 4.10-4.30, (4H, m, 
H6a’,6b’-Glu, CH2), 3.70-3.74, (1H, m, H5’-Glu), 2.09, (6H, d, OAc), 2.03, (3H, 
s, OAc), 2.02, (3H, s, OAc).  
13C NMR (100 MHz CDCl3): δ 199.8 (CHO); 170.5, 170.1, 169.4, 169.3 (C=O); 
100.9 (C-Glucose); 74.1 (CH2CHO); 72.5, 72.1, 70.9, 68.2, 61.7 (C-Glucose); 















Compound 238 was synthesised according to the general procedure from 5-
hydroxy-3-oxapentyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranoside (1.46 g, 3.32 
mmol), the crude mixture was purified by silica gel column chromatography 
using EtOAc: Pet. ether (3:1) as eluent to give the title compound as a white 
solid (0.66 g, 1.52 mmol). 
Yield: 45% 
Rf of compound 238 (EtOAc: Pet. ether, 3:1): 0.31  
Mp: 102-103 0C 
Vmax (cm-1): 2964 (C-H stretching), 1744 (C=O), 1367 (C-H bending), 1211, 
1033 (C-O stretching), 908, 897. 
1H NMR (400 MHz CDCl3): δ 9.70, (1H, s, CHO), 5.21, (1H, t, H3’-Glu), 5.1, 
(1H, t, H4’-Glu), 5.01, (1H, dd, J 9.6, 8, H2’-Glu), 4.61, (1H, d, J 7.9, H1’-Glu), 
4.27, (1H, dd, J 4.8, H6b’-Glu), 4.16, (3H, m, H6a’-Glu, CH2CHO), 4.01, (1H, 
ddd, J 10.8, 4.7, 3.1, H5’-Glu), 3.70-3.82, (4H, m, CH2CH2), 2.10, (3H, s, OAc), 
2.05, (3H, s, OAc), 2.04, (3H, s, OAc), 2.02, (3H, s, OAc). 
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13C NMR (100 MHz CDCl3): δ 200.2 (CHO); 170.6, 170.2, 169.4, 169.4 (C=O), 
100.8 (C-Glucose); 76.8 (CH2CHO); 72.7, 71.8, 71.2, 70.7, 69.1, 68.3 (C-
Glucose+ OCH2CH2O); 61.8 (C-Glucose); 20.7, 20.6, 20.5 (OAc-Glucose). 
 
10.28.3 3-oxopropyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranoside 239 
 
Compound 239 was synthesised according to the general procedure from 3-
hydroxy propyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranoside (1.20 g, 2.95 
mmol) to give the title compound as a white solid (1.11 g, 2.74 mmol). 
Yield: 93% 
Rf of compound 239 (EtOAc: Pet. ether, 2:1): 0.44 
1H NMR (400 MHz CDCl3): δ 9.76, (1H, t, J 1.3x(2), CHO), 5.21, (1H, t, H3’-
Glu), 5.09, (1H, t, H4’-Glu), 4.96, (1H, dd, J 9.6, 8, H2’-Glu), 4.55, (1H, d, J 7.9, 
H1’-Glu), 4.25, (1H, dd, J 4.6, H6b’-Glu), 4.11-4.17, (2H, m, H6a’-Glu, CH), 
3.89-3.94, (1H, m, CH), 3.68-3.72, (1H, m, H5’-Glu), 2.64-2.81, (2H, m, 




13C NMR (100 MHz CDCl3): δ 199.9 (CHO); 170.6, 170.2, 169.4, 169.2 (C=O); 
100.9, 72.6, 71.8, 71.0, 68.3, 63.5, 61.8 (C-Glucose); 43.5 (CH2-CH2); 20.7, 
20.6, 20.6 (OAc-Glucose).  
 
10.29 Synthesis of tetra(glucomethyl), 
tetra(glucoethoxymethyl) & 






To a stirred solution of bridge aldehydes functionalised β-D-monoglucosides 
tetraacetate (1 eq) in a mixture of Et2O and THF (1:1 ratio, 20 mL) was added 
BF3.Et2O (2 eq) and the mixture was stirred under nitrogen for 15 min. 
Subsequently, resorcinol (1 eq) was added and the mixture was stirred at r.t for 
a further 48 h. A precipitate was obtained by adding the reaction mixture to 
Et2O (200 mL). The precipitate was filtered and washed many times with Et2O. 
The solid was then dissolved in EtOAc and the organic layer was washed with 
water (100 mL x 2) then dried (MgSO4). The solvent was evaporated under 
reduced pressure to give the title compounds as crude solids. 
 
10.29.1 Tetra(glucomethyl)calix[4]resorcinarene 240 
 
Compound 240 was synthesised according to the general procedure from 2-
(2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)acetaldehyde (1.00 g, 2.56 
mmol), resorcinol (0.28 g, 2.56 mmol) and BF3.Et2O (0.63 mL, 5.12 mmol) in a 
mixture of Et2O and THF (1: 1 ratio, 20 mL) gave the title compound as a red 
precipitate (0.83 g, 0.43 mmol, 17%).  
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10.29.2 Tetra(glucoethoxymethyl)calix[4]resorcinarene 241 
 
Compound 241 was synthesised according to the general procedure from 2-
((2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranosyloxy)ethoxy)acetaldehyde (0.83 g, 
1.91 mmol), resorcinol (0.21 g, 1.91 mmol) and BF3.Et2O (0.47 mL, 3.82 mmol) 
in a mixture of Et2O and THF (1: 1 ratio, 15 mL) gave the title compound as a 










10.29.3 Tetra(glucoethyl)calix[4]resorcinarene 242 
 
Compound 242 was synthesised according to the general procedure from 3-
oxopropyl 2’,3’,4’,6’-tetra-O-acetyl-β-D-glucopyranoside (1.00 g, 2.47 mmol), 
resorcinol (0.27 g, 2.47 mmol) and BF3.Et2O (0.61 mL, 4.94 mmol) in a mixture 
of Et2O and THF (1: 1 ratio, 20 mL) gave the title compound as a red precipitate 










10.30 Esterfication of calix[4]resorcinarene glucosides  
10.30.1 Acylated calix[4]resorcinarene glucoside 243 
 
Compound 243 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene glucoside 240 (0.68 g, 0.35 mmol) was reacted 
with butyric anhydride (30 mL) and pyridine (5 mL), the crude product was 
separated by silica gel column chromatography using EtOAc: Pet. ether (2:1) as 
eluent to yield one product of the butyrated calix[4]resorcinarene glucoside as 
an off-white powder. 
Yield: 3% 
Rf of compound 243 (EtOAc: Pet. ether, 2:1): 0.64 
Mp: 96-100 
Vmax (cm-1): 2967, 2878 (C-H stretching), 1747 (C=O ester), 1497 (C=C 




1H NMR (400 MHz CDCl3): δ 5.87-7.14, (8H, m, H2,5-Ar), 4.74-5.48, (12H, m, 
H2’’,3’’,4’’-Glu), 4.42-4.71, (6H, m, H1’’-Glu+ CH-methine), 3.48-4.40, (22H, m, 
H5’’,6’’-Glu+ CH2+ CH-methine), 2.33-2.85, (16H, m, COCH2), 1.89-2.28, (48H, 
m, OAc-Glu), 1.49-1.87, (16H, m, CH2), 0.67-1.16, (24H, m, CH3).  
13C NMR (100 MHz CDCl3): δ 171.2, 170.7, 170.3, 170.1, 169.4, 169.3 (C=O); 
147.4, 128.2 (aromatic carbons); 100.4, 72.7, 71.9, 70.9, 68.4, 68.2, 61.6 (C-
Glucose); 35.9, 35.8, 35.1 (COCH2); 20.7, 20.6, 20.3, 20.2, 20.0 (OAc-
Glucose); 18.5, 18.4, 18.3, 18.3, 18.2, 18.1, 18.0, 17.8, 17.4, 17.2 (CH2); 14.6 
(CH3). 
Mass Spectrum: Expected: m/z 1262.4867 (M+2NH4)
2+. Observed: m/z 
1262.4869 
 
10.30.2 Acylated calix[4]resorcinarene glucoside 244 
 
Compound 244 was synthesised according to the general procedure. The crude 
mixture of calix[4]resorcinarene glucoside 242 (0.59 g, 0.29 mmol) was reacted 
with butyric anhydride (30 mL) and pyridine (5 mL), the crude product was 
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separated by silica gel column chromatography using EtOAc: Pet. ether (2:1) as 
eluent to yield one product of the butyrated calix[4]resorcinarene glucoside as 
an off-white powder. 
Rf of compound 244 (EtOAc: Pet. ether, 2:1): 0.32 
Vmax (cm-1): 2968, 2878 (C-H stretching), 1745 (C=O ester), 1494, 1458 (C=C 
arene), 1365 (C-H bending), 1217, 1131, 1096, 1033 (C-O stretching), 908, 749 
(C-H bending).  
1H NMR (400 MHz CDCl3): δ 6.39-7.18, (8H, m, H2,5-Ar), 4.75-5.44, (12, m, 
H2’’,3’’,4’’-Glu), 4.37-4.67, (8H, m, H1’’-Glu+ CH-methine), 3.91-4.34, (8H, m, 
H6’’-Glu), 3.13-3.87, (20H, m, H5’’-Glu+ CH2-CH2), 2.14-2.77, (16H, m, 
COCH2), 1.88-2.13, (48H, m, OAc-Glu), 1.42-1.86, (16H, m, CH2), 0.72-1.13, 
(24H, m, CH3).  
13C NMR (100 MHz CDCl3): δ 170.6, 170.1, 169.4 (C=O); 72.9, 71.2, 68.3, 61.8 
(C-Glucose); 35.8 (COCH2); 20.7, 20.6 (OAc-Glucose); 18.2, 17.4 (CH2); 13.6, 
13.5 (CH3). 
Mass Spectrum: Expected: m/z 1290.5179 (M+2NH4)











10.31 Deacylation of rctt calix[4]resorcinarene glucoside 
137a 
 
The pure acylated calix[4]resorcinarene glucoside 137a (1.29 g, 0.47 mmol) 
was suspended in a mixture of MeOH and DCM (4:1 ratio, 20 mL), then a 
catalytic amount of sodium methoxide (0.10 g, 1.85 mmol) was added and 
stirred overnight at r.t. The reaction mixture was diluted with water (10 mL), 
then neutralised with (Amberlite IR-120 H+), filtered and evaporated under 
reduced pressure. The residue was extracted from a mixture of DIPE and water 
(100 mL x 3) to afford the deprotected glycocluster 245 as a red precipitate 
(0.59 g, 0.39 mmol). 
Yield: 83% 
Mp: > 350 
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Vmax (cm-1): 3317 (O-H stretching), 1606, 1504 (C=C arene), 1372 (O-H 
bending), 1224, 1067, 1036, 1013 (C-O stretching). 
1H NMR (400 MHz d6-DMSO): δ 6.58-7.25, (16H, m, H2’,3’,5’,6’-Ar), 5.89-6.53, 
(8H, m, H2,5-Ar), 5.44-5.61, (4H, d, ArCH), 4.91-5.42, (12H, m, OH), 4.71-4.89, 
(4H, m, H1’’-Glu), 4.45-4.69, (4H, brs, OH), 3.01-3.80, (24H, m, 
H2’’,3’’,4’’,5’’,6’’-Glu).  
13C NMR (100 MHz d6-DMSO): δ 155.8, 153.2, 132.1, 129.9, 128.9, 115.8 
(aromatic carbons); 100.8, 77.0, 73.7, 70.0, 61.0 (C-Glucose). 
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Appendix 13: Mass spectrum of 177 
 

































































Appendix 21: Mass spectrum of 245 
 
 
 
 
 
 
